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ABSTRACT OF THE DISSERTATION
Extensive Behavioral Phenotyping of Williams Syndrome Locus Relevant Mouse Models to
Assess Contributions of Oxytocin and Gtf2ird1
by
Kayla R. Nygaard
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Genetics and Genomics
Washington University in St. Louis, 2022
Professor Joseph Dougherty, PhD, Chair

The Williams Syndrome Critical Region (WSCR) at chromosome 7q11.23 provides a unique
opportunity to untangle the relationship between genotype and phenotype in complex behaviors,
from fear and anxiety to sociability and sensorimotor processing. Copy number variations (CNVs)
in this region result in two syndromes, Williams Syndrome (WS) and Duplication 7q11.23
Syndrome (Dup7), which display phenotypes that may align, indicating a common disruption of a
system, or diverge, reflecting an underlying gene dosage-dependent effect. While case studies of
atypical deletions resulting in WS have implicated telomeric genes Gtf2ird1 and Gtf2i in the
cognitive and behavioral profiles of WS, proving causation requires utilizing mouse models. Thus,
I leveraged the construct validity of a mouse line modeling the most common deletion in WS to
assess pharmacological and genetic interventions in an attempt to ameliorate deficits caused by
CNVs in the WSCR. I assessed the role of oxytocin in fear conditioning deficits observed in the
Complete Deletion (CD) mice and show that an oxytocin antagonist delivered to the central
nervous system does not rescue the contextual and cued recall impairments, suggesting no direct
xi

role for oxytocin dysregulation in these features of the CD model. No significant differences in
oxytocin receptor density or distribution were found either. I then present a novel transgenic model
designed to overexpress Gtf2ird1, one of the genes implicated in the hallmark cognitive and
behavioral features of WS and characterize the effect of its overexpression on a C57BL/6J wild
type background and its molecular rescue of Gtf2ird1 expression on the CD background in a
comprehensive assessment of sensorimotor, anxiety, fear, and social behaviors. Deficits in the CD
model are shown in all of these domains to various degrees and while Gtf2ird1 did not play a role
in the enhanced social approach or motivation observed in the CD line, it did ameliorate deficits
in three tasks (Platform, Rotarod and Light/Dark Box). These results may support the idea that
Gtf2ird1 is involved in sensory processing, which has been suggested particularly regarding the
visuospatial deficits seen in WS.

xii

Chapter 1: Introduction
The field of molecular genetics aims to understand how the genetic code influences the
variable traits expressed by organisms. This task of linking genotype to phenotype can be quite
daunting given the vast expanse of the human genome. Exploring the natural variation within the
genome is a useful starting point for studying the genetic basis of behavior, especially in the
context of neurodevelopmental disorders. With various etiologies resulting in collections of
behavioral traits that can affect sociability, anxiety, fear, and movement to varying degrees,
understanding the genetic basis and mechanistic underpinnings of the symptoms characterizing
these disorders can be difficult. Disorders with a defined genetic cause supply a concrete starting
point. For example, while both Autism and Williams Syndrome result in motor coordination
difficulties, social differences, and increased anxiety, only Williams Syndrome is caused by a
deletion of a single region of the genome with no evidence of external risk factors, thus limiting
the initial search to the genes within that locus and eliminating the need to consider environmental
effects.1
Of the phenotypes described above, social behavior presents a particular challenge. Despite
the obvious inheritability evident in numerous neurodevelopmental disorders, the mechanisms
influencing abnormal social responses in these disorders have been woefully underexplained. The
oxytocin system is a known player in social behaviors and is a favored potential pharmacological
target for social disorders, despite the challenges to measuring the neuropeptide and limited
evidence for any genetic causes potentially disrupting the oxytocin system in these disorders.
Identifying clear mechanistic avenues underlying oxytocin disruption will be imperative in
developing the most effective treatments for neurodevelopmental disorders with varied causes.
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In this thesis, I focused on the genetic locus responsible for a set of neurodevelopmental
disorders, Williams Syndrome and 7q11.23 Duplication Syndrome, to investigate genetic
contributions to motor, social, anxiety and fear behaviors. Using a mouse modeling the most
common deletion of the locus, I assessed the impact of oxytocin on fear learning by delivering an
oxytocin antagonist to the brain prior to the fear conditioning and recall. To better characterize this
same mouse model for use in future studies, I broadly evaluated behaviors using tasks to address
social, anxiety, fear, and motor domains. Simultaneously, I validated a novel mouse line and used
it to investigate the impact of a single gene within the region, Gtf2ird1, assessing both the effect
of its overexpression alone and its rescue on the complete deletion background.

1.1

The Williams Syndrome Locus
The Williams Syndrome locus, also known as the Williams Syndrome Critical Region

(WSCR), is found on chromosome band 7q11.23 where three large low-copy repeats facilitate
nonhomologous allelic recombination during meiosis, leading to a pair of neurodevelopmental
disorders caused by the deletion or duplication of 25-27 genes.2,3 While these opposite copy
number variations (CNVs) in the WSCR presumably occur at similar rates in the population, more
is known about the deletion, which causes Williams Syndrome (WS), as it was discovered decades
prior to the duplication resulting in 7q11.23 Duplication Syndrome (Dup7).4,5

1.1.1 Deletion: Williams Syndrome
Williams Syndrome (a.k.a. Williams-Beuren Syndrome) was first characterized in the
1960s separately by Dr. Williams and Dr. Beuren, who both noted distinctive facial features and
intellectual disability in patients with supravalvular aortic stenosis (SVAS).4,6 The genetic basis
2

for WS, a deletion of ~2Mb on chromosome 7, was determined in the 90s.2,7 Most individuals with
WS lose one copy of the genes between GTF2I and FKBP6, which results in diverse symptoms
spanning cardiovascular, endocrine, gastrointestinal, and neurological systems, among others. It is
a rare disorder, estimated to be found in 1 out of every 7,500 individuals, though it is likely
underdiagnosed due to variable expression of the core features.8 Initial diagnosis usually follows
discovery of abnormal cardiac features, developmental delay, or facial dysmorphism, which are
prevalent characteristics in WS.9,10
While not every individual with WS has SVAS, or aortic narrowing, it is the most common
cardiac feature, and its presence typically results in an earlier diagnosis due to the interventions
required to manage it. The distinctive facial features observed often include bitemporal narrowing,
a short nose with a flat bridge, a long, smooth upper lip, and fullness in the eyes, cheeks and lips
(Figure 1A).1,2 Other common features initially noted to affect more than 75% of the patients in a
1996 study by Pérez Jurado et al. include irritability in infancy, mild to moderate intellectual
disability, an outgoing personality with relatively strong language capabilities, a hoarse voice, and
sensitivity to sound. Despite sensitivity to sound, individuals with WS also tend to enjoy music
and have good auditory short-term memory relative to their broad cognitive abilities, which may
play into their unique cognitive profile.11

3

Figure 1. Features of Williams Syndrome. A) Characteristic facial presentation over a range of ages, adapted from Kozel et al.
(2021).1 B) Two examples of the tendency for individuals with WS to focus on details without proper integration, compared to
individuals with Down Syndrome (DS), modified from figures in Bellugi et al. (2000).12

This distinct cognitive profile of relative strengths and weaknesses defines individuals with
WS, which includes a surprising disconnect between general cognitive ability and language,
especially vocabulary acquisition.12,13 Despite lower than average IQ and a delay in language
development, individuals with WS are quite talkative; the WS deletion appears to relatively spare
expressive linguistic ability, while producing deficits in visuospatial processing, which are
reflected in their language, among other measures.12,13 Individuals with WS will often misuse
prepositions when describing the relationship between objects.12 They also pay more attention to
details but lack integration of the whole, which is illustrated in their ability to draw individual parts
of house but not orient them correctly with respect to each other (Figure 1B).12
Surprisingly, these global visuospatial processing deficits do not affect their ability to
discriminate between or remember human faces, though their facial processing is atypical.14 The
interpersonal language and facial recognition strengths of the WS cognitive profile support the
typical hypersocial personality observed in WS. In addition to loquaciousness and sociability,
other common cognitive sequalae include hyperactivity and anxiety.15 These elements will be
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addressed in more detail below, in addition to other sensorimotor and fear-related neurological
aspects of WS.

Social Behaviors
One of the most noted features of the WS personality profile is an extremely friendly,
outgoing demeanor, especially in childhood.16,17 Children with WS have higher levels of
sociability compared to developmentally similar individuals with Down syndrome as well as
typically developing children.18 This increased social behavior is evident in increased approach,
facial orienting, and emotional reactivity to social stimuli, and does not necessarily indicate
proficiency in typical social interactions. Individuals with WS have a greater tendency to approach
others regardless of familiarity, though the difference is more pronounced with strangers and in
children under 4.18 This indiscriminate approach is evident in their high ratings of approachability
for faces regardless of expression – even very angry faces appear to them quite approachable.19
The abnormally high attention to faces has even interfered with studies of emotionality in children
with WS, as the children were more engaged with the researcher than the task.20,21
Quantification of eye tracking, which has been shown to be under genetic control,22 shows
that individuals with WS look longer at eyes and faces,23–25 which may stem from trouble with
disengaging rather than quick engagement.25,26 Additionally, a recent study investigated a
hypothesis of hypo-arousal facilitates longer eye gaze; while they showed individuals with WS
have slower saccadic movement (indicative of hypo-arousal), they also revealed a deficit in the
typical ability to preferably orient to the eyes during a cued test.27 This suggests hypo-arousal
doesn’t necessarily facilitate prolonged eye gaze; it may depend on the stage of social interaction
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(initiation vs continuation). These facial processing differences may explain the challenges people
with WS face in social interactions despite their noticeably high level of social motivation.
The increased social drive may also be influenced by a difference in processing of fearrelevant facial stimuli. Social behavior measures collected by the Salk Institute Sociability
Questionnaire were correlated with amygdalar responses to fearful faces in people with WS.28 The
fMRI measurements revealed a relationship where a decreased response in left amygdala response
predicted an increase in social approach behaviors of the individual. This relationship was specific
to fearful faces. Difficulty with orbitofrontal cortex regulation of the amygdala may be a factor in
the social disinhibition, and would explain another symptom, specific phobias, that is common in
WS as well.17

Anxiety and Fear
Despite being recognized as outgoing and talkative, individuals with WS are also
noticeably insecure and anxious.29 There is a greater prevalence of generalized anxiety disorder
and specific phobias in the population, at 10-12% and 39-54% respectively.30,31 The prevalence of
GAD was greater in older subjects. A 4-year study reported persistent high levels of anxiety that
were related to performance in social and executive functioning.32 Their sociability (higher
approach, attention to faces, and emotional reactivity) appears to stem from social disinhibition
and does not provide them with the skills to navigate the intricacies of social interactions to engage
beyond surface-level conversations. Thus, in adulthood, people with WS tend to be more
withdrawn.33 Critically, the relationship between anxiety levels and social skills may be driven by
executive dysfunction. This provides a key focus for intervention and treatment of anxiety as
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executive disfunction is a symptom of ADHD, the prevalence of which reaches 65% of children
with WS.30
The nature of specific phobias provides some additional insight into the WS phenotype.
Top specific phobias reported in one study include roller coasters, shots, thunderstorms, loud
noises, and being in a fight.34 Sensitivity to sound appears to play a role in some of the fears
common to WS, including the loud noises associated with thunder, sirens, fireworks, and vacuum
cleaners. Levitin et al. report that in a group of 118 people with WS, 80% experience odynacusis,
or a decreased threshold in uncomfortable loudness, and 90% have auditory aversions, which tend
to decrease over time unlike the stable aversions present in the autistic or control group.35
Interestingly, 9% of WS individuals in this sample also had auditory “fascinations”, which are
sounds they find particularly captivating; this is made even more peculiar because the targets of
their fascinations are stimuli that had previously been aversive. Regardless, it is clear that sensory
stimuli, especially sound, are significant in triggering specific phobias, and thus sensory features
of WS are an important piece of the whole when considering WS neurocognitive behavioral
symptoms.

Sensorimotor Features
Hyperacusis is a commonly noted feature of WS and is likely responsible for the
phonophobia observed in WS, though one group of researchers clarifies that what is being called
hyperacusis is more accurately odynacusis or auditory aversion, which are both highly prevalent
in WS.34,35 In one study of 69 patients, 96% of individuals reported a sound hypersensitivity,
especially noticed in their amplified startle response to common sounds.36 This increased response
to sound appeared to influence attention issues and anxiety leading to significant behavioral
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problems. In another study of 49 children, 84% had hyperacusis from infancy and were sensitive
to sounds at levels 20dB below where control subjects reported discomfort.37 Hearing loss of high
frequencies was also observed, in addition to outer hair cell impairments indicating cochlear
dysfunction, despite normal hearing thresholds and middle-ear function.37,38 In one study of 38
Swedish individuals with WS, females were reported as more sensitive to sound and likely to have
sound-related fears.34 While the auditory system is obviously impacted in WS and should continue
to be studied to further investigate possible sex differences, it is not the only sensory system
affected.
A variety of sensorimotor differences are also characteristic of WS across domains
including balance, gait, tone, and sensory modulation.17,39 Gross developmental milestones are
delayed in children with WS, who are slower to achieve head support, sitting without support, and
walking without support, in addition to acquiring over five meaningful words.9 The low motor
tone seen in younger children is replaced with hypertonia as they get older.39,40 Individuals with
WS also commonly show motor coordination deficits in walking, especially over uneven surfaces
or descending stairs, and in using tools requiring gross and fine motor abilities.36,41,42 While these
balance deficits tend to improve as individuals age,33 coordination and gait issues persist.39 Motor
coordination deficits are especially different from nonaffected individuals when visual information
was incorporated (e.g., eyes open).43 Sensory vision is also impacted by the WSCR deletion, but
these vision deficits (strabismus, decreased visual acuity, etc.) are distinct from the challenges
individuals have with visuospatial tasks suggesting a sensory processing issue.44 Indeed,
integration of depth perception seems to be impaired more than simple depth perception, though
that is also impaired in WS.41,44 Dorsal stream visual dysfunction has been suggested to explain
the processing deficits in WS observed in an extensive battery of test measuring vision and
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visuospatial abilities.44,45 Sensory processing dysfunction may even help explain certain aspects of
sociability and anxiety, and could be considered a core feature of WS, though this hypothesis is
relatively unexplored.46

1.1.2 Duplication: 7q11.23 Duplication Syndrome
The research on Dup7 is decades behind that of WS. Though prevalence of the reciprocal
genetic syndromes should be similar, its discovery occurred by chance ~40 years after WS was
described, when the elastin gene was found to be duplicated in a boy being tested for 22q11
deletion.5 In addition to delayed discovery, underdiagnosis is a problem, likely due to the milder
and less unique suite of characteristics that result from the WSCR duplication compared to
deletion. Once Dup7 was characterized, though, similarities between the systems affected by both
syndromes were obvious. Like WS, altered facial features have been noted in Dup7, though these
craniofacial abnormalities tend to be minor and not as pervasive or distinct as in WS.47 A few of
the characteristics most often reported include a prominent forehead, a high/broad nose, a short
philtrum, and thin lips.47,48 These features are in some ways opposite those in the WS facial suite,
and cardiovascular features are similarly opposed, with aortic dilation more likely in Dup7.48–50
Developmentally, speech and motor delays are the most prominent symptoms while
visuospatial development is largely spared.47,51 Behavioral symptoms include anxiety, repetitive
and stereotyped movements, and increased difficulty with communication and social interaction.47
Hyperactivity, aggression, and self-harm were seen more in males, though a comprehensive
analysis of sex differences has not been done. These characteristics may or may not be
representative of the entire Dup7 population, however, since they are based on only a limited
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sample, and we see great variability in WS symptoms as well. As awareness, and thus diagnosis,
of Dup7 increases, the true range and prevalence of characteristics will become clearer.

Social Behaviors
Social behavior is obviously impacted in Dup7, which is associated with an increased
prevalence of autism, in addition to significant speech delays.47 The social characteristics of Dup7,
at first glance, appear to be the opposite of the hypersociability described in WS, however
significant similarities are also present. Duplication of the WSCR is associated with speech delays,
which are also seen in WS, though autistic behaviors including decreased social interactions and
the presence of repetitive interests are more obvious in Dup7.47 These features result in an
increased likelihood of an autism diagnosis.52 Interestingly, a diagnosis of autism is also more
likely in WS. The typical WS deletion is more associated with a so-called “odd-type” autism,
where the motivation subscore of the Social Responsiveness Scale is not as severe as the other
subscores, but larger or otherwise atypical deletions are associated with classical autism (i.e., all
subscores reach clinical significance).53,54

Anxiety and Fear
Anxiety and ADHD are symptoms common to both WS and Dup7, though individuals with
the duplication appear to have more of an issue with aggression, with instances of oppositional
disorder also noted in the literature.48,55 Anxiety was the feature most likely to raise concerns in
parents, affecting 38 of 53 children in a large survey of individuals with Dup7.48 Separation anxiety
and social anxiety were the most commonly mentioned concerns.
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Sensorimotor Features
Motor delays were another common feature in both Dup7 and WS. Both syndromes show
developmental delays in motor abilities. Cerebellar dysfunction and hypotonia affect over half of
people with Dup7, and abnormal gait affects is common.48 Seizures and epilepsy are more common
in Dup7 than WS (though atypical deletions can increase the likelihood).51,56 In a study of 53
children with Dup7, 26% of parents surveyed reported a high tolerance for pain in their children,
48

which appears opposite to the sensitivity (in response to sound, at least) seen in WS.
The striking differences in some of the features in WS and Dup7, along with obvious

similarities, makes the region responsible an interesting target to study the genetic basis of these
symptoms, especially as some elements appear very responsive to copy number. The system most
sensitive to copy number in Dup7 appears to be the central nervous system, with a high number of
neurological symptoms.48

1.1.3 Genotype to Phenotype Connections in WS
While WS and Dup7 are rare, the CNVs in the WSCR provide a unique opportunity to
connect genotype with phenotype. For example, elastin, a gene in the center of the WSCR, has
long been connected to abnormal cardiac phenotypes, even outside of WS or Dup7. By leveraging
the variable ploidy (haploid, triploid) of the region in WSCR CNVs, specific single nucleotide
polymorphisms (SNPs) in the elastin gene were found to be associated with aortic arteriopathies.57
The WSCR also provides potential for investigating the dose-dependence of genes; while the same
systems are often affected in WS and Dup7, opposite phenotypes can arise. In the case of the aortic
arteriopathies, stenosis (narrowing) was characteristic of WS patients while dilation is more
prominent in those with Dup7.
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While the cardiovascular features of WS and Dup7 appear to be largely monogenic, mainly
stemming from dysregulation of the elastin gene, social behavior (which also appears to be
sensitive to copy number) may be dependent on multiple genes within the region. Thus, it is more
complicated to search for the genetic causes of the aberrant behavior caused by deletion or
duplication in the WSCR. Atypical deletions have been especially important in identifying
candidates to explore further. While 95% of WS deletions span 25 genes or ~1.5 Mb, a smaller
number of cases are caused by a 1.8 Mb deletion, which includes two extra genes (GTF2IRD2 and
NCF1), and even fewer cases result from smaller deletions, which leave some genes unaffected.

Atypical Deletions
The atypically large or distal deletions have been shown to increase seizure susceptibility,
and cognitive ability, in addition to the increased likelihood of autism mentioned earlier.53,58–61
Shorter atypical deletions have been useful in narrowing the candidates for the cognitive and
behavioral profiles of WS to the telomeric end of the WSCR (Figure 2).62 As early as 1999, the
telomeric end was hypothesized to be largely responsible for the main features of WS, when an
atypically short deletion sparing the centromeric end of the region, past ELN, resulted in the full
WS phenotype.63

Figure 2. Representation of the WSCR. The typical 1.5 Mb deletion causing WS is shown as a solid line below the chromosome
representation marked with the assorted genes of the region. The GTF2I family genes (GTF2IRD1, GTF2I, and GTF2IRD2) at the
telomeric end (Tel) are indicated. GTF2IRD2 is not typically deleted. GTF2IP, found on either end of the WSCR, is a pseudogene.
Figure adapted from Karmiloff-Smith et al. (2003).62
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The GTF2I family of genes encoding transcription factors has been a particular focus in
the literature. The craniofacial features common to WS have been linked to GTF2IRD1 in a variety
of studies,64,65 and atypical deletions sparing genes within the telomeric end of the WSCR support
the idea that GTF2IRD1 and GTF2I play a role in the social and cognitive symptoms of WS.66 A
boy with an atypical Williams Syndrome deletion that did not include GTF2IRD1 or GTF2I
presented with SVAS, mild WS facial features, and slight cognitive impairment but did not show
the typical WS behavioral or cognitive profile (i.e., lacked visuospatial deficits).67 A girl with a
shorter telomeric deletion that did not include GTF2I and maybe GTF2IRD1 also lacked the
atypical increase in social approach but did have the typical cardiovascular and craniofacial
characteristics of the syndrome.18
As sequencing technology improved and breakpoints were able to be determined more
specifically, studies were able to map genotype-phenotype correlations more precisely. In a study
leveraging an atypical deletion to tease apart functions of GTF2IRD1 and GTF2I, a female
patient’s atypical deletion was caused by a breakpoint between GTF2IRD1 and GTF2I, so
GTF2IRD1 was included in the deletion but GTF2I was spared.65 In this study, the patient had
canonical WS facial features, cardiovascular deficits, abnormal gait, and attraction to music, but
lacked the typical hypersocial behavioral profile as well as attention issues, hypersensitivity to
sound, anxiety, or language and motor delays. This study suggests that GTF2IRD1 plays the
biggest roles in the WS craniofacial features and the visuo-spatial construction issues present in
WS individuals, while gaze and social attention were attributed to GTF2I.
Other studies disagree, indicating GTF2IRD1 as responsible for behavioral features. In a
family with a similar atypical deletion (where GTF2I was spared, but GTF2IRD1 deleted), the
hypersociability was present but without accompanying intellectual disability.1,66,67 The atypical
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deletion from ELN to GTF2IRD1 was associated with SVAS, an outgoing personality, and mild
WS facial characteristics, but without visuospatial abnormalities in family members with the
deletion.66,67 These studies provide support for involvement of GTF2IRD1 in social behavior,
contrary to the previous case study.
These contradictions point to some of the limitations of only using atypical deletions to
map phenotype to genotype. In addition, atypical deletions are by definition less common, making
up less than 5% of the WS population, and inconsistent collection of data precludes widespread
analysis of certain features like social behavior.53,68 Thus, while atypical CNVs can be useful in
establishing genes of interest, their rarity limits statistical confidence in any associations uncovered
and furthermore cannot establish causation, only correlation. Human iPSCs have been used to
overcome some of these challenges, allowing for single gene deletions and rescues,69,70 but have
their own limitations, including the lack of biologically relevant context and inability to represent
behavioral features or assess the effect of potential pharmacological interventions directly on those
behavioral differences. Thus, mouse models are imperative for assessing pharmacological
interventions, such as oxytocin system manipulation, which I discuss in Chapter 2, and when
combined with deep phenotyping of relevant models, as I show in Chapter 3, mouse models can
provide important information on the roles of individual genes, and highlight anomalies in
behavioral circuits that can then be leveraged to assess therapeutic approaches.

1.2

The Many Roles of Oxytocin
Oxytocin (OT), meaning ‘quick birth’ in Greek, is a neurotransmitter most well-known as

the ‘love hormone’, but has a much wider role in biology. At the turn of the 20th century, this small
molecule, which is produced in the hypothalamus and peripherally released from the pituitary
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gland, was linked to increasing blood pressure and inducing uterine contractions, where it
ultimately derived its name.71,72 In 1910, it was found to also induce milk secretion.73,74 It wasn’t
until 1927 that oxytocin was officially separated from vasopressin, which shares similar functions,
though at the time they were called pitocin and pitressin.75 Its nine peptides were determined in
1953 and first synthesized in 1954 by du Vigneaud, which help to secure him a Nobel Prize in
chemistry.76–80 The genes responsible for producing the oxytocin precursor (OXT) and oxytocin’s
single receptor (OXTR) were identified in the late 20th century.81,82
Since then, a lot of work has been done with the small nonapeptide, and oxytocin has been
connected to more than just childbirth-related purposes. While the public focus has largely been
on social behavior and oxytocin is currently being explored to treat neurodevelopmental disorders
with characteristic social behaviors,83,84 oxytocin also impacts anxiety, feeding, pain perception
and learning and more.85 In one incredibly comprehensive review, the list of features affected by
oxytocin includes cardiovascular regulation, analgesia, motor activity, thermoregulation, gastric
motility, osmoregulation, sexual, maternal, and social behaviors, stress-related behaviors, feeding
and grooming, memory and learning, and opioid tolerance and dependence.86 With such a wide
sphere of influence, fully reviewing the effects of oxytocin is not feasible here, thus I will focus
on oxytocin’s effects on social, anxiety/fear, and sensorimotor behaviors, as I did above for the
WSCR syndromes.

1.2.1 Oxytocin in the Central Nervous System
Social Behaviors
Oxytocin has been connected to numerous pro-social behaviors through human and animal
studies. In the classical studies of voles, oxytocin was shown to be critical for pair bonding and
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oxytocin receptor patterning was distinct in monogamous compared to polygamous vole
species.87–90 In an oxytocin knockout mouse, social deficits include decreased pup vocalizations
after maternal separation and failure to recognize conspecifics that should be familiar.91 Oxytocin’s
role in eye gaze, which is critical to navigating social interactions, provides a possible explanation
for the differences in social engagement when OT is dysregulated. A double-blind study with a
placebo control showed how oxytocin administration intranasally increased gaze time and number
of fixations on human faces.92 Unfortunately, this study was only done in male subjects, so whether
this effect also applies to females is unknown. Sex effects to oxytocin would not be unexpected,
when even dog breed can affect the oxytocin system: A study in dogs revealed breed differences
in reactivity to oxytocin in the context of social interaction with owners.93 Specifically, Border
Collies were more susceptible to the effects of oxytocin as measured by gaze-relevant behaviors
(looking at owner or experimenter). In addition to eye gaze behaviors, reaction to the eye gaze of
others is also affected by oxytocin. An imaging study connected oxytocin and a SNP in its receptor
to amygdala reactivity in response to direct gaze. Individuals with the CT variant were more
reactive compared to people with the TT variant.94

Anxiety and Fear
While oxytocin is generally considered to be anxiolytic, or anxiety-reducing, its
relationship with fear and fear learning is more complex. Fear and anxiety are related but defined
by distinct situations; Fear requires a threat, while anxiety occurs in the absence of any discrete
threat. In a review of oxytocin’s complicated role in fear and anxiety behaviors, it is argued that
OT can both reduce maladaptive anxiety but facilitate adaptive fear.95 This relationship may not
be so straightforward, however, as oxytocin was also shown to reduce amygdala reactivity when
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fear-inducing stimuli were presented.96 This complexity is obvious in oxytocin’s effect on fear
learning, which varies with stress, brain structure, and time of administration.95 In the central
amygdala, OT works to reduce contextual fear responses,97 but its receptors in the bed nucleus of
the stria terminalis is connected with facilitation of the fear response to a discrete cue.98

Sensorimotor Features
Oxytocin is also connected to sensory perception and motor activity. In a study in
ovariectomized rats, administration of OT increased motor activity and lowered corticosterone and
nociception.99 Automatic motor stimulation is also affected by OT,100 and delivery of OT can
prevent the motor coordination impairment that is typically induced with alcohol.101 In fact, more
broadly, oxytocin is connected to many interoceptive modalities including taste, touch, appetite,
desire, nausea, olfaction, pain, sleepiness, and feelings of warmth.102 OT’s receptors are located in
important centers of the autonomic nervous system and OT has the ability to interact with other
neurotransmitters (dopamine, GABA, glutamate, acetylcholine, norepinephrine) to apparently
modulate numerous systems. As a sense of your own body precludes working closely with others,
it is not surprising that synchrony of interpersonal movements is also impacted by oxytocin;
interestingly this effect is greater when individuals have higher scores in empathy,103 making an
interesting connection between motor coordination and social abilities.
While oxytocin seems to be a promising candidate for numerous systems related to
neurodevelopmental disorders, interindividual variability should not be overlooked. In a study on
human aggression, while OT did not have a main effect, its presence increased the positive
correlation between certain antisocial personality traits and aggressive behavior.104 Also, though
out of the scope of this thesis, oxytocin could also be involved in the gastrointestinal symptoms
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related to WS and Dup7, as it is critical for gut health. A closer look at oxytocin dysregulation in
WS reveals both alluring leads, but also key gaps that experimental biology might address.

1.2.2 Oxytocin Dysregulation in WS
Oxytocin system dysregulation has been suggested in WS by several studies, with
observations ranging from differences in the neuropeptide levels in blood and saliva to receptor
expression and epigenetic modifications to the OXT gene promoter.105–108 The earliest study to test
the hypothesis that OT is altered in WS occurred in 2012. Dai et al. measured the blood plasma of
13 individuals with WS in the context of exposure to music and cold.105 Utilizing an indwelling
catheter, they were able to take samples throughout a 45 minute period and compare OT and
vasopression (AVP) levels at baseline and after the sound and tactile stimuli were presented. Both
neuropeptides were higher at baseline in WS relative to age-, sex-, and ethnicity-matched controls.
Of the 10 timepoints where blood was collected, OT was higher at all of them, while AVP was
only increased at 4 of the 10. In addition, OT responses to the stimuli were greater and more
variable in the WS samples than controls, while AVP differences were not significantly different.

In 2015, studies emerged identifying dysregulation of the oxytocin receptor (OXTR) in the
WSCR and a potential mechanism causing the change. Haas and Smith utilized data from a
previously published dataset on WS transcriptome expression in skin fibroblasts from Henrichsen
et al. (2011) to uncover differential expression of the OXTR.107,109 OXTR expression was
significantly increased in 8 WS compared to 9 controls, while the AVPR1A receptor for AVP just
missed the significance threshold. With these data, they hypothesized an epigenetic changes
underlying expression differences based on the association of WBSCR22 with methyltransferase
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production. In the same year, a separate group published a paper detailing methylation differences
enriched at CTCF binding sites across the genome in a dose-dependent manner in WS and Dup7.110
The following year, Haas et al. published a paper assessing the relationship between DNA
methylation of the OXT gene and human sociability, though not using WS samples. They show
increased methylation in the OXT promoter region from saliva samples taken from “healthy”
participants was associated with an anxious attachment style, while lower methylation (and
presumably greater OXT expression) was correlated with better facial processing and more secure
attachment styles.108
Oxytocin was also measured in a “healthy” population in response to an empathy-inducing
video to determine whether its reactivity was associated with a variant in the WS gene GTF2I,
which had been previously identified as a SNP of interest in social behavior.106,111–113 Participants
had saliva collected before and after watching a video validated to induce an empathy reaction.
OT in the saliva was measured via an enzyme-linked immunosorbent assay specific for oxytocin
(not AVP). Percent change of OT levels varied between time points (before and after the video)
and between individuals with different alleles of SNP rs13227433 found in GTF2I, suggesting a
link between the Gtf2i SNP and OT reactivity. Whether this finding is relevant in the context of
the entire WS deletion is not yet determined.
Thus, overall, while oxytocin is a promising candidate for the WS locus pathology, only
correlational studies with humans have been done thus far. In addition, OT levels are extremely
variable making them hard to accurately measure, and blood and saliva OT levels may not be
representative of the central OT levels that would be impacting neurological phenotypes. Working
with model organisms, such as mice, can allow a modicum of control to better assess the impact
of OT, especially regarding pharmacological manipulation of the OT system. To fill the void of
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direct testing of the OT system in a mouse model relevant to WS, I chose to assess the effect of an
oxytocin antagonist on fear learning and memory in a mouse model of the WSCR deletion (Chapter
2).105,107,114–116 I focused on fear conditioning as oxytocin has been shown to both heighten adaptive
fear responses and dampen anxiety behaviors, an interesting combination of effects. In addition,
the previously demonstrated increase in social approach was not replicated in our hands at the
time.117 The limitations of previous studies highlight the need for deeper characterization of WS
models across more domains, a problem I address in Chapter 3. Below, I review current models
relevant to the WSCR, with a particular focus on larger deletions and single gene deletions of the
GTF2I family, which has been implicated in the cognitive and behavioral profiles of WS to better
illustrate the available tools and elements missing from current practice.

1.3

WSCR Animal Models

1.3.1 Benefits and Limitations
Animal models are invaluable to uncovering mechanisms underlying behavioral features
of complex neurological disorders, especially those like WS and Dup7 that are rare in the human
population. In addition to increasing sample sizes, there are numerous tools for genetic, behavioral,
and pharmacological manipulations in mice that are not possible or ethical to employ with human
patients. The WSCR is syntenic and largely conserved in mice, situated in reverse orientation on
chromosome 5 and lacking the low-copy repeats flanking the human WSCR.118 Without those
repeating domains, the region in mice is easier to characterize and less susceptible to the large
CNVs found in the human genome, making the mouse a useful model to reliably characterize this
region. Indeed, numerous lines have been developed ranging from single gene deletions to
deletions of large parts of the WSCR.119
20

While these mouse lines and other tools are very useful, cognitive and behavioral features
are not modeled in a straightforward manner. For example, you cannot model anxiety or autism in
a mouse, as these are purely human conditions. However, careful design of tasks can approximate
anxiety-like or autistic-like behaviors that may provide critical information about the mechanisms
fundamental to these different, but ideally related behaviors.120 As a single task may not
approximate all aspects relevant to human behaviors, a broad survey of related measures may be
necessary to provide the level of depth required to explain complex phenotypes.121–123 Statistical
interpretation is also a critical factor in interpreting behavioral results. Prior to my work for this
thesis, I surveyed literature in the field of autism and noted a common error in social approach
analysis; different groups were being compared based on statistical calculations that are only
applicable for within-group analysis. This erroneous comparison is explained and the appropriate
statistical workflow for such behavioral paradigms is outlined in my paper, which I present in the
Appendix.124
Once proper behavioral and statistical paradigms have been determined, the right animal
model can reveal the conserved circuits allowing the study of human disease or complex disorders
without the restrictions of a human model. Here I review a few of the most relevant models for the
WSCR and highlight a single gene, GTF2IRD1, which will be a focus of my work in Chapter 3.

1.3.2 WSCR Mouse Models
Complete Deletion
The mouse line with the greatest construct validity for WS is the Complete Deletion (CD)
model, also referred to as Del(5Gtf2i-Fkbp6)1Vcam in the Mouse Genome Informatics (MGI)
database. In this line, the most common deletion seen in individuals with WS was recreated
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through Cre-mediated recombination between Gtf2i and Fkpb6 on mouse chromosome 5, where
the syntenic WSCR lies.125 Homozygous deletion of the region is lethal in mice, but the more
relevant hemizygous CD mice are viable, despite slightly lower survival rates, and recapitulate
many of the features of WS.
The cardiac features of WS are reflected in an increased arterial pressure and cardiac
hypertrophy in the CD mice. A decreased mandible size is representative of the craniofacial
differences. CD mice also exhibit a decrease in brain weight, cell density in the basolateral
amygdala, dendritic length, CA3 hippocampal volume, and YFP+ neurons in motor,
somatosensory, and hippocampal CA1 regions of the brain, while an increase in immature neural
density was observed in the dentate gyrus. While no difference in gait or activity in an open field
task were observed, CD mice did have a decrease in motility tonus strength and latency to fall on
a Rotarod task, revealing possible balance or sensorimotor integration issues, which have also been
investigated in WS.43 Social approach behavior was also assessed in this model, though the
increase observed was based only on quantifying male behavior with a single, non-standard task.
The CD model has a high degree of construct validity, by closely mirroring the genetic
cause of WS, making it an ideal candidate to assess possible treatments.126 Gtf2i intracisternal
therapy on the model showed a decrease in the typically high social approach behaviors.127 Another
study used the model to address the short term memory and cardiac hypertrophy with a green tea
extract.128 While this model may be the most relevant for the human condition, it wasn’t developed
until 2014, and a deep characterization of its various behavioral phenotypes has not been provided,
a gap I fill in Chapter 3.
Prior to development of this CD model, only partial deletions or single gene deletions had
been researched. These models, while lacking the ideal construct validity of the CD model, offer
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valuable insight the impact of specific genes and which regions in the locus may mediate the key
WS phenotypes, such as the distinct cognitive and behavioral profiles.

Distal/Proximal Deletions
The model that provided additional support for which segment of the WSCR had the
greatest impact on the WS phenotype split the region into two larger deletions, a proximal deletion
(PD; closer to the centromeric breakpoint and representative of the telomeric end of the human
WSCR) that lacked the genes between Gtf2i and Limk1, and a distal deletion (DD), which
encompassed the telomeric end, which is related to the centromeric region in humans.129 Using
these two deletion models in combination and alone, it was shown that motor phenotypes were
worse when the entire region was deleted, while sociability and startle response were more
associated with the proximal end. This provided support that Gtf2i was likely involved with the
social aspects of WS, and numerous single gene models were made to investigate the claim and
the roles of the associated Gtf2ird1.

Monogenic Deletions
At least 11 of the 26 genes commonly deleted at the WS locus have knockout mouse models
developed.119 While these models have been imperative in isolating the functions of the individual
genes, which provide insight to their potential impact on features of WS and Dup7, reviewing them
all is beyond the scope of my work, thus I will narrow my focus to the GTF2I family, especially
GTF2IRD1, as I explain below.
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1.4

GTF2IRD1
GTF2IRD1 along with its close family member GTF2I have been implicated in key WS

phenotypes based on atypical deletion case studies, as noted previously. These genes are likely
involved in the behavioral and cognitive profiles in WS and warrant future investigation.

1.4.1 The GTF2I Family
The TFII-I protein family includes GTF2I, GTF2IRD1, and GTF2IRD2. These proteins
contain I-repeats, which are helix-loop-helix-like domains not seen in other helix-loop-helix
proteins. Each gene is alternatively spliced producing multiple isoforms. While the GTF2I protein,
TFII-I, has been extensively researched, biochemical information on the GTF2IRD1 protein (also
known as BEN, MusTRD1, or CREAM-1) is less advanced.130 In addition, while mouse lines
modeling the duplication and deletion of Gtf2i have been developed, only deletions of the related
Gtf2ird1 have been attempted thus far, and were met with varied success, thus I will focus on
Gtf2ird1 from here.64,117,131–139

1.4.2 GTF2IRD1 and WS
As noted above, GTF2IRD1 encodes a general transcription factor that is ubiquitously
expressed. It was initially described and characterized in 1999.140 Two transcripts produced by
alternative splicing were observed, though we know now these represent two groups of many more
alternatively spliced transcripts. They hypothesized its function to be similar to that of GTF2I, as
a transcription factor and putative negative regulator, which were later confirmed.139 GTF2IRD1
actually engages in negative autoregulation.132 In 2002, the mouse ortholog for GTF2IRD1 was
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characterized, revealing significant conservation between the species; the intronic regions were
more compact in the mouse Gtf2ird1 but the coding sequence was largely unaltered.141
GTF2IRD1 has been connected to various WS phenotypes, often in conjunction with the
highly related GTF2I due to their close proximity in the WSCR. Many of these associations have
been ascertained by utilizing atypical human deletions, as discussed previously, which do not
provide proof of causation. The difficulty in separating GTF2I from GTF2IRD1 and the
acknowledged limitations of correlational findings revealed a need for independent analysis of
these genes in animal models to fully understand the relationship between GTF2IRD1 and the WS
profile.

1.4.3 GTF2IRD1 mouse models
Some of the various phenotypes connected to GTF2IRD1 include visuospatial
processing,142 craniofacial development,64 fear, aggression, and social behaviors.131 In 2005,
GTF2IRD1 was implicated in the craniofacial features and growth deficits seen in WS by utilizing
heterozygous and homozygous Gtf2ird1-null animals created by a transgenic insertion that induced
a deletion of the region, including the first exon of Gtf2ird1.64 This same Gtf2ird1-null mutant also
revealed anxious and hypoactive phenotypes.137 A different Gtf2ird1 mutant created via
replacement targeting did not find any anxiety-related phenotypes, but reported increased
sociability and decreased aggression and fear behaviors, in addition to body weight.131 The
differences in these various models may be a result of differences in creating the models or the
background strain on which they were developed. In some former Gtf2ird1 models, downstream
initiation produces a viable product, which was often missed due to poor antibody availability to
verify protein levels in many of these earlier models.139
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The unreliability of the earlier deletion models of Gtf2ird1, combined with its relevance to
many WS phenotypes, warrants continued investigation of the gene. To avoid the issues with
deleting Gtf2ird1, I use a novel transgenic line in Chapter 3 to tease apart its function by rescuing
its expression on a WS-relevant background –the CD mice described previously– allowing me to
isolate its function within the larger deletion. The CD line provides important context for single
gene experiments. Allelic interactions (seen in motor phenotype) seem to be common in the region
and any results from a single gene in the region may not be valid when combined with the entire
deletion. This new Gtf2ird1 transgenic line can also be used to assess the effects of Gtf2ird1
overexpression alone, which may connect to features observed in Dup7.

1.5

Conclusion
The WSCR is a valuable genetic background that can be used to investigate the genetic

origins of the myriad symptoms associated with CNVs at the locus. When applying our
understanding to neurodevelopmental disorders including WS and Dup7, however, context is
imperative. Single gene models, usually modeling a deletion, can provide some insight but
especially when trying to elucidate mechanisms underlying complex behaviors like social
approach, these models may be insufficient. A more appropriate model to use would have better
construct validity, such as the Complete Deletion mouse that models the most common WS
deletion. In Chapter 2, I attempted to identify OT’s effects on conditioned fear by administering
an oxytocin antagonist directly to the central nervous system, using the CD model.
Characterization of the phenotypes produced by such a model is necessary to best utilize the
resource. Deep phenotyping of motor, social, anxiety, and fear-relevant features, as I did in Chapter
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3, can provide important insights; for example, it could help determine which behavioral tasks may
be most sensitive or informative in future pharmacological studies.
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Chapter 2: Oxytocin receptor activation does not mediate
associative fear deficits in a Williams Syndrome model
Kayla R. Nygaard, Raylynn G. Swift, Rebecca M. Glick, Rachael E. Wagner, Susan E. Maloney,
Georgianna G. Gould, and Joseph D. Dougherty
From:
Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome
model.
Nygaard KR, Swift RG, Glick RM, et al. Oxytocin receptor activation does not mediate associative
fear deficits in a Williams Syndrome model. Genes, Brain and Behavior. 2022; 21(1):e12750.
doi:10.1111/gbb.12750

2.1

Abstract
Williams Syndrome results in distinct behavioral phenotypes, which include learning

deficits, anxiety, increased phobias and hypersociability. While the underlying mechanisms
driving this subset of phenotypes is unknown, oxytocin (OT) dysregulation is hypothesized to be
involved as some studies have shown elevated blood OT and altered OT receptor expression in
patients. A “Complete Deletion” (CD) mouse, modeling the hemizygous deletion in Williams
Syndrome, recapitulates many of the phenotypes present in humans. These CD mice also exhibit
impaired fear responses in the conditioned fear task. Here, we address whether OT dysregulation
is responsible for this impaired associative fear memory response. We show direct delivery of an
OT receptor antagonist to the central nervous system did not rescue the attenuated contextual or
cued fear memory responses in CD mice. Thus, increased OT signaling is not acutely responsible
for this phenotype. We also evaluated OT receptor and serotonin transporter availability in regions
related to fear learning, memory and sociability using autoradiography in wild type and CD mice.
While no differences withstood correction, we identified regions that may warrant further
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investigation. There was a nonsignificant decrease in OT receptor expression in the lateral septal
nucleus and nonsignificant lowered serotonin transporter availability in the striatum and
orbitofrontal cortex. Together, these data suggest the fear conditioning anomalies in the Williams
Syndrome mouse model are independent of any alterations in the oxytocinergic system caused by
deletion of the Williams locus.

2.2

Introduction
Williams Syndrome (WS), a multisystemic neurodevelopmental disorder, is caused by a

1.5–1.8 Mbp hemizygous deletion on chromosome 7q11.23, altering the copy number of 26–28
contiguous genes in the WS critical region (WSCR). The complex phenotypic characteristics of
WS include craniofacial dysmorphology, connective tissue abnormalities and cardiac problems
such as supravalvular aortic stenosis and peripheral artery stenosis. In addition, WS is
characterized by distinct cognitive features, including intellectual disability, profoundly impaired
visuospatial construction,143 atypical facial processing, deficits in motor coordination and control,
odynacusis35 and

impaired

auditory

processing.17,24,36,40,42,144–148 Interestingly,

however,

individuals with WS possess relatively intact expressive language and verbal skills,12,149 as well as
heightened sensitivity and emotional response to music.35,150 One of the most striking phenotypes
of individuals with WS is hypersociability and strong social motivation,16,151,152 despite high nonsocial anxiety32 and deficits in social cognition and awareness.153
A substantial body of research indicates the neuropeptide oxytocin (OT) plays a key role
in mediating the regulation of social behavior and cognition, fear conditioning and extinction,
observational fear,154 fear modulation via social memory155 and anxiety in humans and rodents.156–
158

Given the aberrant social behavior and anxiety in individuals with WS, recent studies have
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tested the hypothesis that OT is dysregulated in WS. Indeed, one study found elevated blood levels
of OT in individuals with WS compared with controls.105 However, the findings on the OT receptor
(OXTR) have been contradictory. One study suggested increased gene expression,107 while another
demonstrated downregulation and hypermethylation of OXTR in WS.114
While we did not see altered social behavior in a recent application of the standard social
approach task, we did see differences in freezing during a conditioned fear task.117 Another mouse
model, which deletes the entire WS-homologous region, has also shown alterations in fear
conditioning,159 and individuals with WS have heightened phobias and non-social anxieties.
Alterations in the brain OT system play an important role in social fear conditioning, contextual
fear-induced freezing and social fear extinction.160,161 Additionally, peripheral administration of
an OT receptor agonist has been shown to inhibit fear-induced freezing,162 and evoked OT release
via channelrhodopsins also results in attenuation of fear.97
In this study, we investigated whether OT dysregulation is a mechanism underlying the
fear conditioning phenotype following deletion of the WSCR using the mouse experimental
system. We employed the model reflecting the most common deletion found in WS patients: the
hemizygous loss of the entire genomic region between the Gtf2i and Fkbp6 genes.159 These
heterozygous Complete Deletion (CD) mice show reduced freezing in fear conditioning recall,
which is consistent with the expected consequences of OT elevation. Therefore, we probed
whether OT activity could be responsible for the decreased expression of associative fear memory
in CD mice. Further, to complement the prior human studies of OXTR expression in peripheral
cells,107,114 we tested whether OXTR expression differs in CD versus wild type (WT) mice across
the brain, but we found no differences after statistical correction in this system, nor in a second
neurotransmitter system (serotonin, 5HT), which had previously been shown to cooperate with OT
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in social learning,158 and can be influenced by OT.163 Together, these data suggest there is not a
direct role for the OT system in associative fear learning in WS.

2.3

Results

2.3.1 Complete deletion mice show impaired contextual and cued fear
conditioning
OT has been shown to modulate the freezing response of rodents in conditioned fear tasks.
Specifically, central administration of OT results in decreased levels of freezing in response to
avoidance-associated cue or context.164 Thus, because of the suggested increase in OT production
in WS, we sought to determine whether the CD mouse model also had altered associative fear
learning. Previously a decrease in overall freezing time during fear conditioning was shown in the
CD model using only male mice;159 here we replicate and expand on these findings by confirming
the phenotype in both sexes.
We found that CD mice responded to shock during conditioning (Day 1) by increasing
freezing to the same extent as WT mice (main effect of minute, F(2, 36) = 77.81, p = 8.5 × 10−14).
There was no main or interaction effect of genotype observed (Figure 1B, complete statistical
analysis available in Table S1). WT and CD mice both exhibit significantly higher freezing (F(3,
36) = 9.6, p = 8.5 × 10−5) in the first 2 min of the contextual memory test (context) compared with
the first 2 min of training (baseline), indicating each group successfully associated the fear stimuli
with the context (Figure 1C).
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Figure 1. Complete Deletion mice have altered associated fear responses in a conditioned fear task. A) Overview of the
conditioned fear task protocol. B) Day 1. CD and WT mice show increased freezing with subsequent footshock deliveries. C) All
mice increased freezing in the context associated with the footshock. Baseline is the average of the first two minutes of Day 1.
Context is the average of the first two minutes of Day 2. Black bars indicate the mean average percent freezing. Data points of
individual mice are connected. D) Day 2. All mice increased freezing to context relative to Day 1 baseline, though CD mice freeze
less than WT mice. E) Day 3. CD mice have significantly decreased freezing relative to WT mice during minute 4 of tone delivery
(p=0.036). WT: n=10; CD: n=10. Connected data points in B, D, and E are means ± SEM. Individual scores are represented by
colored circles in the background.

On Day 2, CD mice froze less compared with WT mice when placed in the same context
(chamber/odor) used for fear conditioning (Figure 1D), main effect of genotype, F(1,
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18) = 7.95, p = 0.011), indicating impaired contextual associative fear memory. The response to
the conditioned cue was also decreased in CD mice but not as broadly, with a main effect of minute
(F[9162] = 22.0195, p = 2 × 10−16), and a borderline minute by genotype interaction (Figure 1E,
F(9,162) = 1.9151, p = 0.053), but no main effect of genotype. Post hoc analysis revealed the mean
freezing of CD mice was almost 24% less than WT freezing at minute 4 (p = 0.036). Overall, CD
mice show a deficit in contextual fear conditioning that is consistent with elevated OT activity.

2.3.2 CD conditioning deficits are not reversed by central infusion of an
oxytocin receptor antagonist
We next sought to determine if CD mice had elevated OT levels in the blood, as had been
reported in patients.105 We used the same ELISA approach, but did not see a significant difference
between genotypes (t = 0.003, df = 21.664, p = 0.9976; CD (n = 13): M = 1138.191 pg/ml, SD =
503.682; WT (n = 11) M = 1138.791 pg/ml, SD = 478.916). However, even WT mice had a
remarkable range of OT levels in blood (82–1731 pg/ml), likely driven by the periodic nature of
OT release, coupled with its short half-life (<5 min).165 Thus, it can be hard, at a single point in
time, to detect and make conclusions about average OT levels. Furthermore, blood OT levels may
not reflect OT levels in the brain. Therefore, we took an experimental approach; if elevated central
OT was responsible for decreased associative fear learning in CD mice, then blocking central
OXTR activity should reverse the phenotype. We implanted CD and WT mice with ICV cannulas
to directly administer an OXTR peptide antagonist (OTA) and block all receptor activity during
the fear conditioning procedure (Figure 2A).
There were no baseline freezing differences between CD and WT animals, as measured in
minutes 1 and 2 of the first day of testing (F(1, 39)=1.58, p = 0.22). During the conditioning phase,
we found an interaction of genotype and treatment. The OTA had an opposite effect on freezing
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in CD and WT animals. Specifically, WT mice receiving the OTA froze more than their CD
counterparts (Figure 2B, F(1, 39) = 7.32, p = 0.0101).
During contextual fear recall, both CD and WT animals showed evidence of learning, as
freezing increased in all groups from Day 1 baseline compared with the first 2 min of Day 2.
Overall, a main effect of genotype on contextual fear memory (Figure 2C, F(1, 39) = 19.96, p <
6.6 × 10−5) reflects a significant reduction in freezing within CD mice compared with WT mice,
regardless of treatment. While this replicated results from our first experiment, there was no main
effect of treatment or a genotype by treatment interaction, thus administration of the OTA did not
significantly alter contextual fear responses. This was also true on Day 3 for cued fear responses
(Figure 2D), where there was only a main of effect of time (F[2273] = 26.45, p = 2.2 × 10−16)
and an interaction between time and genotype (F[2273] = 5.88, p = 2.26 × 10−6) driven by the
decreased freezing of CD mice compared with WT mice at minute 4 (p = 0.0083). Thus, we show
OT signaling at the OXTR does not account for the impaired associative fear response in this
model.

2.3.3 Autoradiography reveals no changes in oxytocin receptor density or
distribution in CD mice
In parallel to the experimental approach, we investigated OXTR availability in the mouse brain
through a discovery-based approach, as elevated levels in the amygdala might influence fear
conditioning.165 Particularly, given opposite directions of effect of the OTA in WT and CD mice
on Day 1 freezing (Figure 2B), we suspected genotype differences in OXTR expression in regions
related to fear learning. Furthermore, it is of interest to study this binding given the findings of
OXTR dysregulation in brains of humans with the WSCR deletion.107,114
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Figure 2. Central administration of an oxytocin receptor antagonist does not rescue reduced contextual or cued fear
responses in CD mice. A) Schematic of the experiment. Grey boxes show rest days. Syringes indicate ICV infusions of OTA or
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vehicle, which occurred at least 1 hour prior to testing. B) Day 1 of conditioned fear. CD and WT mice show increased freezing
with subsequent footshock deliveries. WT OTA-treated mice freeze significantly more than CD OTA-treated mice. C) Day 2. All
mice show increased freezing to context (minutes 1 and 2) relative to Day 1 baseline. CD mice freeze less than WT mice but there
is no main or interaction effect of treatment. D) Day 3. CD mice have significantly decreased freezing relative to WT during minute
4 of tone delivery (p=0.008), but there is no effect of treatment. WT Veh: n=16; WT OTA: n=13; CD Veh: n=7; CD OTA: n=7.
Connected data points are means ± SEM. Individual scores are represented by smaller unconnected circles. Veh = vehicle; OTA =
oxytocin receptor antagonist.

Therefore, we conducted an autoradiography study using radiolabeled OVT ligand on
coronal sections of WT and CD brains (Figure 3A). As well as measuring regions relevant to fear
conditioning (BLA and LA166,167; LSN160), we measured areas of where OT has been shown to
affect sociability or memory (AON168; LSN169; ACC170,171; CA2/3172,173; Pir174; PVN175; and
CPu158; Figure 3B), as hypersociability and cognitive impairments are characteristic of WS. We
found no significant differences in OXTR binding between genotypes within regions of interest in
CD and WT brains when corrected for multiple testing (Figure 3C, Table S2). There was a
nominally significant change in the LSN (p = 0.034), but it did not meet the corrected
experimentwise critical alpha level (α = 0.006). Given the role of the LSN in fear and anxiety and
future focused studies of this region may be warranted.

Figure 3. No significant differences in oxytocin receptor density in Complete Deletion mice. A) Coronal sections from a
representative mouse brain used in iodinated ornithine vasotocin analog ([ 125I]OVT) autoradiography analysis with corresponding
distance from bregma. B) Example tracing of regions of interest including anterior olfactory nucleus (AON), cingulate cortical
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areas 1 and 2 (ACC), striatum (CPu), lateral septal nucleus (LSN), hippocampal CA 2 and 3 regions, paraventricular nucleus (PVN),
basolateral (BLA) and lateral (LA) amygdala, and piriform cortex (Pir). C) Results of oxytocin receptor autoradiography comparing
[125I]OVT binding (fmol/mg of protein) in regions of interest between CD mice and WT mice. Colored bars show means ± SEM
(brackets). Individual averaged measurements for each mouse are represented by circles. For each genotype, n ≥ 9.

2.3.4 Autoradiography reveals no changes in serotonin transporter density or
distribution in CD mice
Finally, with no changes in OXTR availability, we examined an additional alternative
neurotransmitter: serotonin (5HT). Disruption to the 5HT system in WS has been suggested in
prior studies. Specifically, Proulx et al. (2010) determined that there are enhanced 5HT1A receptor-mediated currents in a WS mouse model with low innate anxiety.176 More recently,
Lew et al. (2020) compared serotonergic innervation in the amygdala between autism and WS in
human postmortem samples, concluding that there is decreased innervation in WS brains compared
with neurotypical brains.177 Therefore, we focused on the SERT, as it should provide a measure of
serotonergic innervation to different structures.
We measured SERT binding in several brain regions (Figure 4A). We focused on
amygdalar regions relevant to the human postmortem studies177 and fear conditioning
phenotypes,178 assessing BLA, central amygdala (CeA) and LA regions independently based on
findings that they differ in the amount of serotonergic innervation in some species.179 We then
included other areas where SERT has been implicated in behaviors relevant to the WS phenotype,
patient findings and knowledge of 5HT biology. These included the nucleus accumbens (NAc)
based on 5HT's role on social reward in this region,158 the BNST for its role in adaptive
anxiety,180 and additional hypothalamic and cortical regions of interest, including the ACC, lateral
parietal association (PtA), orbitofrontal cortex (OFC) and the peduncular part of the lateral
hypothalamus (PLH) which is where the medial forebrain bundle is found, representing a major
ascending pathway for nearly all 5HT axons (Figure 4B).181
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Figure 4. No significant differences in serotonin transporter density in Complete Deletion mice. A) Coronal sections with
corresponding distance from bregma from a representative mouse brain used in [125I]RTI-55 autoradiography analysis. B) Example
tracing of regions of interest including orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), striatum (CPu), nucleus
accumbens (NAc), the bed nucleus of the stria terminalis (BNST), insular cortex (IC), hippocampal CA 2 and 3 (CA 2/3) regions,
basolateral (BLA), lateral (LA), and central (CeA) amygdala, lateral parietal association (PtA), and the peduncular part of the lateral
hypothalamus (PLH). C) Results of serotonin transporter (SERT) autoradiography comparing [125I]RTI-55 binding (fmol/mg
protein) in regions of interest between CD mice and WT mice. Colored bars show means ± SEM (brackets). Individual
measurements for each mouse (regional average) are represented by circles. For each genotype, n ≥ 5.

Overall,
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was

a

(F(12) = 2.41; p = 0.07),

with
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(F(12) = 0.49; p = 0.89)

of

sex

effect

of

genotype

(Figure 4C).

Nonsignificant decreases in SERT density in CD mice compared with WT were found in the CPu
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(p = 0.067) and OFC (p = 0.060), and these may be potential regions of interest for future, focused
studies better powered to study smaller effects.

2.4

Discussion
We and others have previously observed altered fear conditioning in WS

models.117,159 Expanding on previous studies that used only male mice, we found, using both sexes,
that CD animals on a C57BL/6J background had a suppressed fear response to the context and cue
presented in the fear conditioning paradigm. Thus, CD mice enable investigation of the underlying
circuit disruptions mediating this phenotype. We hypothesized that the altered associative fear
memory response in CD mice was because of the increased availability of OT based on human
findings of elevated OT in WS.105 We focused our efforts on functional studies, which would be
definitive with regards to a role for OT in fear conditioning of CD mice. Using an intraventricular
cannula, we treated mice with an OT receptor antagonist during each day of conditioned fear to
attempt to counteract any possible effect of increased OT production on the fear response. The
OTA did not alter the subdued freezing response in CD mice. Therefore, the associative fear
conditioning phenotype that results from loss of the WS critical region is not mediated by OXTR
activity.
Our results tell us less about the role of OT in WT mice. While many prior studies show
OT modulating fear conditioning,97,162,164,167,182 Pisansky et al. (2017) found OT enhances fear in
a social paradigm of observational fear learning, but does not affect non-social fear learning.154 We
did not see a significant difference in WT mouse behavior in response to OTA (p < 0.083, Day 2),
but as there was a small difference in the means of WT mice given Vehicle compared with those
given OTA, there may be an effect below our power to detect. Therefore, we are hesitant to weigh
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in on this debate. In the end, the discrepancy across studies could be a result of dosage. GunduzCinar et al. (2020) show different concentrations of OT have opposing effects on other fear-related
tasks.183 We have also observed an effect of genetic background on fear conditioning in the CD
mice, with elevated freezing in CD mutants on an FVB/AntJ x C57BL/6J F1 hybrid
background.117 These hybrids show different levels of baseline freezing in response to cues even
in WT animals, suggesting the impact of the CD deletion interacts with other genes in the genome
to modulate conditioned fear effects. Thus, if OT is not involved, a genetic screen for interacting
loci using mouse strain panels may help identify the relevant pathways. Another option would be
to investigate genes based on dysregulated expression in models of WS, such as the serotonin
5HT1B receptor, which is among the top 10 dysregulated genes in a cell model of WS.70
In addition, given some of the prior work suggesting OXTR receptor gene expression and
methylation in WS patient blood cells, we were curious if receptor availability was also altered in
the brain following deletion of these genes. We used autoradiography because it can measure the
availability of the receptor at the surface, which should reflect protein level and localization
changes in addition to changes in gene expression. Further, it provides an opportunity for spatially
informed analyses. As such, it is the best single measure for assessing if the OXTR is modulated
in a conserved way by these mutations. We assessed regions previously associated with fear
conditioning and those where OT had been shown to modulate social reward (CPu). Overall, we
found no significant changes in OXTR binding in the CD mouse brain compared with controls,
although there was a nominally significant difference in the LSN prior to correction, in the same
direction of effect as seen in WS patient blood cells. The LSN is an interesting center integrating
a variety of fear and anxiety signals, for example, playing a role in how stressful social cues are
received.184 In addition, the LSN has been associated with fear-enhancing effects of the OXTR,
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but as modulation of the OXTR did not alter contextual conditioned fear responses, it is thought
to be through indirect means.185 These data motivate future studies focusing on the role of the LSN
in behavioral abnormalities observed in the CD mouse model.
Despite ruling out a direct role for OT in fear conditioning deficits in this model, altered
OT might play a role in the increased social motivation in this population. While it is of interest
scientifically to assess this, hypersociality is not as much of a concern therapeutically as other
phenotypes, such as learning deficits, ADHD, phobias and anxiety. Beyond OT and serotonin,
dopamine has also been implicated in WS,42 and has been previously connected to fear
conditioning,186 other anxiety-avoidance tasks,187 and ADHD-related hyperactivity.188 Thus, it is
possible deletion of the WSCR disrupts dopamine signaling to result in these behavioral
alterations. Understanding the roles of any of these systems in patient-related phenotypes of the
CD mice might help highlight potential treatments in WS, as a wide range of therapeutics working
on these systems are currently available.

2.5

Materials and Methods

2.5.1 Animals
CD mice contain a hemizygous deletion of the WSCR and were maintained on the
C57BL/6J background (Jackson #000664).159 Animals were bred by crossing CD heterozygotes to
C57BL/6J WT animals to produce heterozygous CD experimental mice along with WT littermates
for the control group. Tissue collection and genotyping PCR occurred in the second postnatal
week. Mice were housed by sex and treatment, when relevant, and were kept on a 12:12 h
light/dark schedule with food and water provided ad libitum. All studies were approved by and
conducted in accordance with the Institutional Animal Care and Use Committee at Washington
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University in St. Louis. All behavioral testing occurred during the light phase and was conducted
by a female experimenter. Four independent cohorts were used in this study. Cohort 1 included 13
CD and 11 WT male mice from 8 independent litters and was used to assess blood OT levels via
ELISA. Cohort 2 comprised 10 CD (4 females (F), 6 males (M)) and 10 WT (8 F, 2 M) mice from
four independent litters and were behaviorally examined as adults (postnatal day [P] 97–106) with
the conditioned fear task. Cohort 3 comprised 14 CD (8 F, 6 M) and 29 WT (12 F, 17 M) mice
from 16 independent litters and served to evaluate the role of the OT system in associative fear
and avoidance learning as adults (P68–118). Cohort 4, comprising 22 WT (12 F, 10 M) and 14 CD
(5 F, 9 M) from 11 independent litters, was used to evaluate OXTR and serotonin transporter
(SERT) expression in specific brain regions of interest. Tissue was collected post-mortem to
confirm initial genotyping results.

2.5.2 Oxytocin ELISA
Blood was drawn from the retro orbital sinus of isoflurane-anesthetized mice at P30 using
heparinized glass capillary tubes. Samples were collected in 1.8 ml EDTA-coated tubes, spun at
1600 g for 5 min at 4°C, then split into two aliquots, placed on dry ice and stored at −80°C until
use. An ELISA kit was used for colorimetric quantification of OT per the manufacturer's protocol
(ADI-900-153A, Enzo Life Sciences, Farmingdale, NY, USA). Prior to use, samples were diluted
1:3 with 200 μl of assay buffer. Absorbance measurements were read at 405 nm and OT
concentration was calculated using a standard curve produced using the provided OT standards.
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2.5.3 Conditioned fear task
Associative fear and avoidance learning were evaluated in the CD mice using the
conditioned fear paradigm (Figure 1A), as described in our previous studies.189 Briefly, each
mouse was habituated to and tested in an acrylic apparatus, which measured 26 cm × 30 cm
× 30.5 cm tall and contained a metal grid floor, an LED light bulb and an inaccessible peppermint
odorant, housed within a sound-attenuating chamber (Actimetrics, Wilmette, IL, USA). The
chamber light turned on at the start of each trial and remained illuminated for the duration. On Day
1, the testing session was 5 min. An 80 dB white noise tone sounded for 20 s each at 100 s, 160 s
and 220 s. A 1.0 mA shock was paired with the last 2 s of the tone. The baseline freezing behavior
(first 2 min) and freezing behavior during the last 2 min was quantified via the computerized image
analysis software program FreezeFrame (Actimetrics). This measure allowed for simultaneous
visualization of behavior while adjusting a “freezing threshold,” which categorized behavior as
freezing or not freezing during 0.75 sec intervals. Freezing was defined as no movement except
for normal respiration and data were presented as percent of time spent freezing. Testing on Day
2 lasted 8 min, during which no tones or shocks were presented. This procedure enables evaluation
of freezing behavior in response to contextual cues associated with the shock stimulus from Day
1. For the 10 min testing session on Day 3, the context was changed to an opaque Plexiglass-walled
chamber containing a different (coconut) odorant. The 80 dB tone began at 120 s and lasted the
remainder of the trial. Freezing during habituation to the new context was quantified across the
first 2 min. Freezing behavior to the auditory cue associated with the shock stimulus from Day 1
was quantified for the remaining 8 min. Each day of testing, males were run first, followed by
females. Assigned boxes were counterbalanced by genotype. Between runs, the apparatus was
cleaned with 70% ethanol (Days 1 and 2) or 0.02% chlorhexidine diacetate solution (Day 3; Zoetis,
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Parsippany-Troy Hills, NJ, USA). Animals were put in a holding cage until all cagemates had been
tested, then animals were returned to their home cage. Shock sensitivity was evaluated after testing
as previously described to verify differences in freezing were not the result of altered sensitivity
to the shock stimulus itself.190

2.5.4 Intracerebroventricular infusion of oxytocin receptor antagonist during
conditioned fear task
The surgical area of adult mice was shaved a day prior to insertion of the guide cannula to
facilitate the intracerebroventricular (ICV) injections. Mice were anesthetized with 2.5–5%
isoflurane and placed in a stereotaxic apparatus. Prior to the procedure, mice received a local
anesthetic, 1 mg/kg of Buprenorphine SR (ZooPharm, Laramie, WY, USA), and an antibiotic, 2.5–
5 mg/kg of Baytril (Bayer Healthcare LLC, Shawnee Mission, KS). An incision was made along
the skull to visualize bregma to lambda. The periosteum was removed by lightly scratching the
surface of the skull and the area was cleaned three times with a betadine solution (Purdue Products
L.P., Stamford, CT, USA) on sterile cotton swabs followed by a quick hydrogen peroxide swab.
The guide cannula was placed in a stereotaxic cannula holder (#51636–1, Stoelting, Wood Dale,
IL, USA). Using a rapid, fluid motion, the 26-gauge unilateral guide cannula (C315GS-5/SPC,
Plastics One, Roanoke, VA, USA) with dummy cap was inserted at the following coordinates:
M/L = +1, A/P = −0.4, D/V = −2.2, based on prior work.191–193 The guide cannula was cut to a
length of 2 mm so that it entered the lateral ventricle. The dummy cap (C315DCS-5/SPC) and
internal cannula (C315IS-5/SPC) were cut to protrude 0.2 mm from the end of the guide. C&B
Metabond dental cement (Parkell, Edgewood, NY, USA) was mixed on a chilled ceramic dish and
used to secure the cannula to the skull and seal the surgical area. The dental cement dried
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completely before the animal was transferred to a recovery cage. Animals were housed together
after fully awake and provided 0.25 mg of the chewable anti-inflammatory Rimadyl (Bio-Serv,
Flemington, NJ, USA). During daily monitoring, dummy caps were replaced and tightened as
needed. Mice were euthanized at the first sign of distress or damage to the surgical area and had
at least 3 days for recovery prior to testing.
All mice received 1-μl infusions at least 1 h before each day of the conditioned fear task.
Each mouse was given either vehicle (artificial cerebrospinal fluid solution, Tocris Bioscience,
Bristol, UK; WT n = 16, CD n = 7) or an OT receptor antagonist (OTA) (desGly-NH2,d(CH2)5
[Tyr(Me)2Thr4]OVT, Bachem, Torrance, CA, USA; WT n = 13, CD n = 7). The OTA, dissolved
in vehicle at 1 ng/μl, is a peptidergic ornithine vasotocin analog chosen because of its broad
applicability, long half-life and prior use in ICV injections.194–196 The solutions were unilaterally
delivered into the lateral ventricles through the 33-gage internal cannula via a PlasticsOne Cannula
Connector (C313CS) over the course of 1 min using a Quintessential Stereotaxic Injector
(Stoelting #53311) and a 1 μl Hamilton syringe. After injection, 15–30 s passed before removing
the internal cannula to ensure proper diffusion. The conditioned fear task was performed as
described above. Following completion of behavioral testing, cannula placement was confirmed
by injecting enough dye to flood the ventricles and immediately euthanizing the animal via
isoflurane overdose. Brains were extracted and sliced coronally at the injection site with a razor
blade. Infusion of the dye into the ventricles was then confirmed by eye and samples that missed
the ventricles were excluded from the final analysis.
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2.5.5 Quantitative autoradiography of OXTR and SERT in mouse brain
Naïve mice were rapidly euthanized by cervical dislocation. Brains were removed, placed
in an ice-cold saline solution for 1 min, then excess saline solution was wicked onto a paper towel.
Brains were frozen on crushed dry ice and then stored at −80°C until sliced into 20 μm coronal
sections in a cryostat (Leica Biosystems 1850, Buffalo Grove, IL, USA) at −16 to −18°C. Slides
were thaw-mounted onto gelatin-coated microscope slides, vacuum-desiccated overnight (18 h) at
4°C, then stored at −80°C until use. Adjacent sections were used for two distinct ligands, [125I]OVT
and [125I]RTI-55, to assess OXTR and SERT availability, respectively.

OXTR quantitative autoradiography
Binding of iodinated ornithine vasotocin analog ([125I]OVT) to OXTR in the mouse brain
was performed as described previously,197 with minor modifications. Mounted sections were
thawed for 30 min at 22–23 °C, then pre-incubated for 30 min in 50 mM Tris HCl buffer pH 7.4 at
22–23 °C. Next, sections on slides were incubated for 90 min in upright cytomailers filled with
10 ml buffer containing 10 mM MgCl2, 0.1% bovine serum albumin and 50 pM [125I]OVT
(NEX2540, PerkinElmer, Boston, MA, USA). Non-specific binding was obtained by incubating
representative adjacent sections on slides from the series in buffer containing unlabeled OT (1 μM,
Ascent Scientific, Bristol, UK). Sections on slides were then washed twice for 5 min each in glass
staining dishes containing 300 ml of 4°C buffer and were dipped for 2 s in 4°C deionized water.
Slides were dried on a benchtop slide warmer for 1 h or until sections were opaque and any droplets
had evaporated.

SERT quantitative autoradiography
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Slides were defrosted at 22–23°C for 30 min and pre-incubated in 30 mM sodium
phosphate, 120 mM sodium chloride buffer, pH 7.4 at 22–23°C, for 30 min. For incubation,
100 mM sucrose, 100 nM GBR12909 (to block binding to dopamine transporter) and 50 pM
[125I]RTI-55 (NEX272, Perkin Elmer) were added to the buffer. To measure non-specific binding,
10 μM mazindol was added to a subset of slide mailers containing a representative set of duplicate
slides. All unlabeled ligands were from Sigma. Incubation was carried out for 2 h at 22–23 °C.
Sections were rinsed twice for 1 min in 4°C buffer (without sucrose), then dipped for 2 s in 4°C
deionized water, drained and placed on a slide warmer (Lab-Line, Fisher Scientific, Pittsburgh,
PA, USA), at moderate setting (4 on 10 scale) for 2 h.

Exposure and imaging
Sections on slides were exposed to Biomax MR film (Carestream/Kodak, Rochester, NY,
USA) in a cassette for 48 h along with tritium standards (ART0123A, American Radiolabeled
Chemicals, St. Louis, MO, USA) calibrated to [125I]-incubated brain mash, as previously
described.198 Films were developed using an automatic film processor. Digital images of
autoradiograms were captured using a 12-bit CCD monochrome digital camera (CFW-1612 M,
Scion, Frederick, MD, USA) with a 60 mm lens (f-stop = 4)(Nikon, Melville, NY, USA) mounted
on a copy stand (RS-1, Kaiser Fototechnik, White Plains, NY, USA) with a Kaiser Slimlite Plano
LED lightbox. Pixel intensity was calibrated to measure density in units of femtomoles/mg
(fmol/mg)

protein

using

a

linear

(https://imagej.nih.gov/ij/download.html).199

OXTR data collection
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function

with

ImageJ

software

OVT binding to the OXTR was measured in the anterior olfactory nucleus (AON), lateral
septal nucleus (LSN), anterior cingulate cortex (ACC), striatum (CPu), hippocampal CA2 and CA3
regions (CA 2/3), paraventricular hypothalamic nucleus (PVN), piriform cortex (Pir), and the
combined basolateral and lateral amygdala (BLA & LA) by tracing each region in ImageJ based
on coordinates from the Franklin and Paxinos mouse brain atlas.200 The AON was traced at
Bregma 2.68 mm. The LSN, ACC and CPu were traced between Bregma 0.68 mm and 0.26 mm.
The hippocampal CA 2/3 region, PVN and BLA & LA were traced between Bregma −1.58 mm
and −1.82 mm. To mitigate potential variability across sections, each region was measured at
multiple predetermined locations across consecutive sections within each sample. Nine or more
animals were measured per genotype (Table S2).

SERT data collection
SERT availability was measured in the BLA, LA, central amygdala (CeA), ACC, CPu, CA
2/3, insular cortex (IC), lateral parietal association (PtA), nucleus accumbens (NAc), orbitofrontal
cortex (OFC), peduncular part of the lateral hypothalamus (PLH) and the bed nucleus of the stria
terminalis (BNST). The BLA, LA and CeA were traced between Bregma −1.58 and −1.82 mm.
The ACC was traced at Bregma 0.74 mm, the IC was traced at Bregma −1.06 mm and the NAc
was traced at 0.74 mm. The CPu was traced between Bregma 0.74 mm and 0.26 mm. The
hippocampal CA 2/3 region was traced between Bregma −1.34 mm and −1.58 mm. The PtA and
PLH were traced at Bregma −1.58 mm to −1.70 mm. The BNST was traced between Bregma
0.62 mm and −0.22 mm. Up to four independent measurements were taken at the same
predetermined locations on consecutive sections within a sample. At least five animals were
measured per genotype (Table S2).
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2.5.6 Statistical analysis
Analysis for ELISA and the conditioned fear task was completed in R using RStudio
(Version 1.2.5019). ELISA analysis utilized the “drc” package.201 Conditioned fear data were
condensed by minute then assessed for normality, homogeneity of variance and outliers. Data were
analyzed with a linear mixed effect model using the “lme4” package,202 with genotype as the main
factor, and minute as a repeated measure. Tukey's HSD was employed for post hoc analysis. An
effect of sex was screened for but not included in the final analysis, as there was no significant
effect on any outcome. Detailed outputs for conditioned fear are included in Table S1.
Autoradiography analysis was performed using IBM SPSS Statistics for Windows, Version
26.0. Measurements within a region were averaged to compute the binding value of that region for
each sample. These values were normalized by film to compute the total binding value for each
region by subtracting the nonspecific binding value of a control sample from the sample binding
value. Values less than zero after normalization were treated as zero. Normality, outliers and
variance were assessed prior to hypothesis testing. Total OXTR binding values were transformed
using a square root transformation to resolve normality violations. A 2 × 2 Analysis of Covariance
with fixed factors of sex and genotype and a covariate of age was performed on each region of
interest for OXTR autoradiography. For SERT, no transformations were necessary. A 2 × 2
multivariate Analysis of Variance was used to assess factors of sex and genotype across 12 regions
of interest. Detailed outputs of statistical tests for all autoradiography experiments are in Table S2.
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2.7

Supplementary Tables

Table S1. Statistical Analysis for Conditioned Fear Task in Figures 1 and 2.
CONDITIONED FEAR TASK
Wild Type (WT)
10

MICE

AGE
P97-P106

Figure

Parameter (unit)

Figure 1C

Figure 1B

Acquisition Baseline
(%
Freezing)

Acquisition Conditioned
Stimulus
(% Freezing)

Contextual Fear
Memory
(Average %
Freezing)

SAMPLE SIZE (n):
Comparison
Independent Variables
Baseline Minute 1
Baseline Minute 2

Figure 1D

Descriptive Statistics
Average ± SEM
Median (2Q,3Q)
WT: 0 ± 0
WT: 0 (0, 0)
CD: 0 ± 0

CD: 0 (0, 0)

WT: 0 ± 0

WT: 0 (0, 0)

Linear mixed model, Random effect:
Animal; Anova to test fixed effects;
Tukey's HSD multiple comparison
within minute

CD: 0 (0, 0)
WT: 2.43 (0, 5.4225)

CD: 5.978 ± 1.6756

CD: 5.75 (1.665, 7.99)

Conditioned Stimulus
Minute 4

WT: 23.239 ± 4.3305

WT: 21.24 (17.835, 28.54)

CD: 24.44 ± 4.9038

CD: 22.62 (17.26, 30.97)

Conditioned Stimulus
Minute 5

WT: 49.539 ± 5.7833

WT: 52.89 (33.78, 61.3325)

CD: 51.038 ± 5.7448

CD: 46.225 (40.69, 67.79)

Average % Freezing
Baseline

WT: 0 ± 0

WT: 0 (0, 0)

CD: 0.487 ± 0.4183

CD: 0 (0, 0)

WT: 27.7675 ± 5.8102

WT: 22.82 (12.88, 40.555)

Average % Freezing
Context (First 2 Minutes)

Contextual Fear Minute 4
Contextual Fear Minute 5
Contextual Fear Minute 6
Contextual Fear Minute 7
Contextual Fear Minute 8
Baseline Minute 1
Baseline Minute 2
Cued Fear Minute 3
Cued Fear Minute 4
Cued Fear Minute 5
Cued Fear Minute 6
Cued Fear Minute 7
Cued Fear Minute 8
Cued Fear Minute 9
Cued Fear Minute 10

CD: 18.059 ± 6.6325

Male
2
Statistical Analysis

Statistical Test

WT: 4.824 ± 2.1754

Contextual Fear Minute 3

Figure 1E

Female
8

Conditioned Stimulus
Minute 3

Contextual Fear Minute 2

Cued Fear
(% Freezing)

Complete Deletion (CD)
10
Male
6

CD: 0.974 ± 0.8367

Contextual Fear Minute 1

Contextual Fear
(% Freezing)

Female
4

Significance
Genotype: F(1,18) = 1.355, p = 0.2596
Time: F(1,18) = 1.355, p = 0.2596
Time*Genotype Interaction:
F(1,18) = 1.355, p = 0.2596
D1M3: CD - WT p = 0.997

CD: 8.54 (5.98, 19.66)

Linear mixed model, Random effect: Time: F(2,36) = 77.809, p = 8.503x10 -14
Animal; Anova to test fixed effects; Genotype: F(1,18) = 0.0768, p = 0.7848
Tukey's HSD multiple comparison
Time*Genotype Interaction:
within minute
F(2,36) = 0.0013, p = 0.9987

D1M4: CD - WT p = 0.996

Linear mixed model, Random effect: Time: F(1,18) = 26.6553, p = 6.517x10 -5
Animal; Anova to test fixed effects; Genotype: F(1,18) = 1.0801, p = 0.3124
Post hoc comparison within
Time*Genotype Interaction:
genotypes between context
F(1,18) = 1.3479, p = 0.2608

WT baseline - CD baseline p = 0.999826

D1M5: CD - WT p = 0.993

WT baseline - WT context p = 0.0004
CD baseline - CD context p = 0.037928
WT context - CD context = 0.41626

WT: 22.758 ± 5.3559

WT: 23.23 (8.535, 27.89)

D2M1: CD - WT p = 0.946

CD: 16.746 ± 7.2904

CD: 7.315 (2.33, 23.4525)

D2M2: CD - WT p = 0.308

WT: 32.777 ± 6.933

WT: 27.655 (15.8925, 43.3375)

D2M3: CD - WT p = 0.123

CD: 19.372 ± 6.9001

CD: 11.335 (6.2025, 26.215)

D2M4: CD - WT p = 0.0014

WT: 32.747 ± 6.4617

WT: 32.3 (18.805, 42.6975)

D2M5: CD - WT p = 0.147

CD: 15.898 ± 5.192

CD: 9.98 (4.33, 26.1225)

D2M6: CD - WT p = 0.0809

WT: 42.403 ± 5.8707

WT: 42.475 (30.63, 50.775)

CD: 14.705 ± 3.7242

CD: 12.445 (7.0875, 20.1325)

WT: 32.32 ± 6.2531

WT: 34.96 (19.4425, 42.145)

CD: 16.087 ± 3.8355

CD: 12.195 (8.63, 22.015)

WT: 31.034 ± 4.7758

WT: 29.425 (23.4225, 44.44)

CD: 12.85 ± 4.1328

CD: 7.37 (3.7775, 14.725)

WT: 26.613 ± 3.9524

WT: 31.195 (13.38, 36.14)

CD: 13.3 ± 2.6011

CD: 11.75 (8.18, 16.6075)

WT: 33.377 ± 5.3107

WT: 33.66 (20.1125, 43.9975)

CD: 9.955 ± 3.1435

CD: 5.33 (3.255, 14.2225)

WT: 4.118 ± 1.3881

WT: 2.21 (1.33, 5.11)

CD: 1.422 ± 1.0962

CD: 0 (0, 0.9975)

WT: 9.337 ± 1.9484

WT: 8.185 (5.4225, 11.945)

Linear mixed model, Random effect: Genotype: F(1,18) = 7.9504, p=0.01135
Animal; Anova to test fixed effects;
Time: F(7,126) = 1.6189, p = 0.13586
Tukey's HSD multiple comparison
Genotype*Time Interaction:
within minute
F(7,126) = 1.8853, p = 0.07723

D2M7: CD - WT p = 0.315
D2M8: CD - WT p = 0.0114

Time: F(1,18) = 16.9901, p = 0.00064
Linear mixed model, Random effect: Genotype: F(1,18) = 2.1989, p = 0.1554
Animal; Anova to test fixed effects
Genotype*Time Interaction:
F(1,18) = 0.326, p = 0.57506

CD: 5.371 ± 2.375

CD: 3.545 (1.66, 5.445)

WT: 48.178 ± 5.402

WT: 47.005 (33.33, 63.6075)

D3M3: CD - WT p = 0.905

CD: 38.751 ± 6.7536

CD: 44.915 (25.96, 50.5075)

D3M4: CD - WT p = 0.0364

WT: 48.717 ± 7.7196

WT: 57.965 (27.655, 63.7175)

D3M5: CD - WT p = 0.368

CD: 24.823 ± 4.9433

CD: 20.13 (13.9375, 31.8625)

D3M6: CD - WT p = 0.996

WT: 32.212 ± 5.2023

WT: 31.195 (21.3475, 42.5875)

CD: 16.238 ± 4.4482

CD: 11.285 (8.96, 16.0375)

WT: 24.556 ± 4.3495

WT: 22.345 (14.71, 31.415)

CD: 18.936 ± 6.5093

CD: 8.625 (4.42, 28.98)

WT: 29.486 ± 6.6092

WT: 22.395 (17.5325, 29.205)

CD: 17.577 ± 6.7742

CD: 12 (4.2025, 18.365)

WT: 25.108 ± 5.3123

WT: 21.46 (12.6475, 33.1075)

CD: 19.055 ± 5.9164

CD: 15.045 (6.5225, 26.11)

WT: 24.845 ± 3.5911

WT: 23.5 (19.135, 25.55)

CD: 19.868 ± 6.7176

CD: 16.595 (4.885, 21.1525)

WT: 21.466 ± 3.5788

WT: 19.555 (13.6675, 27.445)

CD: 20.401 ± 7.8675

CD: 9.555 (5.5575, 26.225)

D3M7: CD - WT p = 0.732
D3M8: CD - WT p = 0.993
-16

Linear mixed model, Random effect: Time: F(9,162) = 22.0195, p < 2x10
Animal; Anova to test fixed effects; Genotype: F(1,18) = 2.1895, p = 0.1562
Tukey's HSD multiple comparison
Genotype*Time Interaction:
within minute
F(9,162) = 1.9151, p = 0.05315

*p-values < 0.1 are bolded

51

D3M9: CD - WT p = 0.998
D3M10: CD - WT p = 1.00

CONDITIONED FEAR TASK with ICV TREATMENT
MICE

AGE
P68-P118

Figure

Parameter (unit)

SAMPLE SIZE (n):

WT - Vehicle
16
Female | Male
8
|
8

Baseline Minute 1
Acquistion Baseline
(% Freezing)
Baseline Minute 2

Average ± SEM

Median (2Q,3Q)

WT-Veh: 0 ± 0

WT-Veh: 0 (0, 0)

WT-OTA: 0.1362 ± 0.1362

WT-OTA: 0 (0, 0)

CD-Veh: 1.7071 ± 1.7072

CD-OTA: 0 (0, 0)
WT-Veh: 0 (0, 0)

WT-OTA: 0.2731 ± 0.1916

WT-OTA: 0 (0, 0)

CD-Veh: 0.3814 ± 0.3814

CD-Veh: 0 (0, 0)

CD-OTA: 0.19 ± 0.19

CD-OTA: 0 (0, 0)

Figure 2B

Conditioned Stimulus
Minute 4
Acquisition Conditioned
Stimulus
(% Freezing)

Conditioned Stimulus
Minute 5

CD - OTA
7
Female | Male
3
|
4
Statistical Analysis
Significance

Statistical Test

CD-Veh: 0 (0, 0)

CD-OTA: 0 ± 0
WT-Veh: 0.0831 ± 0.0831

WT-Veh: 4.7894 ± 1.4969
Conditioned Stimulus
Minute 3

CD - Vehicle
7
Female | Male
5
|
2

Descriptive Statistics

Comparison
Independent Variables

WT - OTA
13
Female | Male
4
|
9

Linear mixed model, Random effect:
Animal; Anova to test fixed effects

Time: F(1,39) = 0.2699, p = 0.6063
Genotype: F(1,39) = 1.5766, p = 0.2167
Treatment: F(1,39) = 0.3356, p = 0.5657
INTERACTIONS:
Freeze*Genotype: F(1,39) = 2.3043, p = 0.1371
Freeze*Treatment: F(1,39) = 1.5034, p = 0.2275
Genotype*Treatment: F(1,39) = 2.2488, p =
0.1418
Freeze*Genotype*Treatment:
F(1,39) = 2.4906, p = 0.1226

WT-Veh: 2.43 (0, 6.5225)

D1M3: CD Veh - WT Veh p = 0.9999

WT-OTA: 9.6577 ± 2.5153

WT-OTA: 10.67 (0, 17.7)

D1M3: WT OTA - WT Veh p = 0.9842

CD-Veh: 6.4557 ± 1.8984

CD-Veh: 7.52 (2.67, 8.865)

D1M3: CD OTA - WT Veh p = 0.9999

CD-OTA: 2.7886 ± 1.2213

CD-OTA: 3.11 (0, 3.76)

WT-Veh: 19.855 ± 3.079

WT-Veh: 15.115 (9.297, 27.762)

WT-OTA: 30.9408 ± 5.9432

WT-OTA: 25.78 (8.44, 46.9)

CD-Veh: 26.9214 ± 3.2769

CD-Veh: 29.2 (22.83, 31.71)

Genotype: F(1,39) = 1.7043, p = 0.19938
Treatment: F(1,39) = 0.5815, p = 0.45032
-16

Time: F(2,78) = 155.1855, p < 2x10
Linear mixed model, Random effect:
INTERACTIONS:
Animal; Anova to test fixed effects;
Genotype*Treatment: F(1,39) = 7.3211, p = 0.01
Tukey's HSD multiple comparison
Genotype*Time: F(2,78) = 0.3276, p = 0.72163
within minute
Treatment*Time: F(2,78) = 0.0271, p = 0.97329

D1M3: WT OTA - CD Veh p = 0.9998
D1M3: CD OTA - CD Veh p = 0.9998
D1M3: CD OTA - WT OTA p = 0.9658
D1M4: CD Veh - WT Veh p = 0.9497

CD-OTA: 13.38 ± 3.0608

CD-OTA: 12.44 (8.21, 16.41)

WT-Veh: 41.3312 ± 4.3103

WT-Veh: 36.665 (29.78, 53.11)

WT-OTA: 50.8969 ± 4.3256

WT-OTA: 51.56 (48.21, 58.48)

CD-Veh: 46.0129 ± 7.6612

CD-Veh: 46.67 (28.89, 63.33)

D1M4: CD OTA - CD Veh p = 0.5260

CD-OTA: 33.2943 ± 2.3647

CD-OTA: 31.56 (29.78, 34.97)

D1M4: CD OTA - WT OTA p = 0.0779

Genotype*Treatment*Time:
F(2,78) = 1.8232, p = 0.16833

D1M4: WT OTA - WT Veh p = 0.3034
D1M4: CD OTA - WT Veh p = 0.9709
D1M4: WT OTA - CD Veh p = 0.9993

D1M5: CD Veh - WT Veh p = 0.9970
D1M5: WT OTA - WT Veh p = 0.5101
D1M5: CD OTA - WT Veh p = 0.8949
D1M5: WT OTA - CD Veh p = 0.9968
D1M5: CD OTA - CD Veh p = 0.6124
D1M5: CD OTA - WT OTA p = 0.0765

not pictured

WT-Veh: 0.04156 ± 0.0415

Contextual Fear
Memory
(Average %
Freezing)

Average % Freezing
Baseline

CD-Veh: 1.044 ± 1.0443
CD-OTA: 0.095 ± 0.095
WT-Veh: 27.758 ± 3.122

Average % Freezing
Context (First 2 Minutes)

Contextual Fear Minute 1

Contextual Fear Minute 2

Contextual Fear Minute 3

Contextual Fear Minute 4

Figure 2C

WT-OTA: 0.2046 ± 0.1577

WT-OTA: 35.01 ± 3.6576
CD-Veh: 13.513 ± 3.2704
CD-OTA: 10.959 ± 3.3

CD-OTA: 5.540 (4.768, 18.942)
WT-Veh: 15.705 (12.952, 27.655)

D2M1: CD - WT p = 0.07126

WT-OTA: 27.2877 ± 3.5031

WT-OTA: 25.22 (18.58, 38.94)
CD-Veh: 11.11 (7.74, 15.045)

D2M2: CD - WT p = 9.7218x10-5
D2M3: CD - WT p = 0.00826

CD-OTA: 7.27 ± 2.2227

CD-OTA: 6.64 (2.875, 9.735)

D2M4: CD - WT p = 0.00037

WT-Veh: 35.3519 ± 4.1518

WT-Veh: 32.82 (26.1925, 45.69)

D2M5: CD - WT p = 0.00116

WT-OTA: 42.7385 ± 4.6455

WT-OTA: 39.56 (30.67, 55.31)

D2M6: CD - WT p = 0.00886

CD-Veh: 15.0729 ± 3.5278

CD-Veh: 17.33 (9.73, 18.805)

D2M7: CD - WT p = 0.13113

CD-OTA: 14.6486 ± 4.9996

CD-OTA: 8.89 (4.655, 23.06)

D2M8: CD - WT p = 0.19205

WT-Veh: 29.0006 ± 4.8913

WT-Veh: 24.385 (13.3875, 47.9)

WT-OTA: 37.5815 ± 5.5208

WT-OTA: 35.56 (21.24, 49.56)

CD-Veh: 11.9529 ± 3.3111

CD-Veh: 13.5443 ± 3.2708

CD-Veh: 13.72 (8.43, 15.3)

CD-OTA: 16.6529 ± 4.6414

CD-OTA: 13.33 (9.09, 17.955)

WT-Veh: 29.6837 ± 3.2344

WT-Veh: 34.955 (18.557, 37.997)

WT-OTA: 37.9792 ± 6.3412

WT-OTA: 42.67 (18.67, 54.22)

CD-Veh: 12.5529 ± 1.8664
WT-Veh: 27.4537 ± 4.936

Contextual Fear Minute 5

WT-OTA: 37.1962 ± 6.0902
CD-Veh: 14.61 ± 3.0534
CD-OTA: 7.8471 ± 2.9955

Contextual Fear Minute 6

Contextual Fear Minute 7

Contextual Fear Minute 8

Baseline Minute 1
Cued Fear
Baseline
(% Freezing)
Baseline Minute 2

Cued Fear Minute 3

Cued Fear Minute 4

Figure 2D

Cued Fear Minute 5

Cued Fear Minute 6
Cued Fear
(% Freezing)

CD Baseline - WT Baseline p = 0.9983
-16

Time: F(1,39) = 196.2863, p = 2.2x10
WT Context - WT Baseline p = 0
Genotype: F(1,39) = 22.5684, p = 3.216x10 -5
Linear mixed model, Random effect:
CD Context - CD Baseline p = 0.0022
Treatment: F(1,39) = 1.0977, p = 0.3012
Animal; Anova to test fixed effects;
INTERACTIONS:
CD-OTA: 0 (0, 0)
CD Context - WT Context p = 2.9878x10 -9
Post hoc comparison within
Time*Genotype: F(1,39) = 26.7991, p =
WT-Veh: 25.183 (20.630, 32.709)
7.159x10-6 Time*Treatment: F(1,39) = 1.4433, p
genotypes between context not
=
0.2369
Genotype*Treatment:
F(1,39)
=
1.9603,
WT-OTA: 31.29 (21.97, 45.13)
considering treatment
p = 0.1694 Time*Genotype*Treatment:
CD-Veh: 12.19 (9.75, 16.925)
F(1:39) = 1.3381, p = 0.2544

CD-Veh: 0 (0, 0)

WT-Veh: 20.1638 ± 2.7597

CD-OTA: 10.0829 ± 4.1256

Contextual Fear
(% Freezing)

WT-Veh: 0 (0, 0)
WT-OTA: 0 (0, 0)

Genotype: F(1,39) = 19.9632, p = 6.6x10-5
Time: F(7,273) = 3.2942, p = 0.002221

Linear mixed model; Animal id
Treatment: F(1,39) = 1.1557, p = 0.288966
random effect; Anova to test fixed
INTERACTIONS:
CD-OTA: 7.52 (4.445, 9.53)
Time*Genotype: F(7,273) = 1.3534, p = 0.225352
effects; Tukey's HSD multiple
WT-Veh: 19.245 (12.875, 37.1025)
Time*Treatment: F(7,273) = 0.2155, p =
comparison within time only
0.981667 Genotype*Treatment: F(1,39) =
WT-OTA: 29.2 (25.22, 44.89)
considering genotype
2.4705, p = 0.124 Time*Genotype*Treatment:
CD-Veh: 17.26 (9.54, 20.795)
F(7:273) = 0.5370, p = 0.806138
CD-Veh: 12.39 (8, 16.85)

CD-OTA: 3.98 (1.99, 13.085)

WT-Veh: 28.3244 ± 3.6164

WT-Veh: 23.23 (18.67, 37.4)

WT-OTA: 39.2915 ± 5.8313

WT-OTA: 37.17 (33.78, 48.89)

CD-Veh: 21.2857 ± 3.3255

CD-Veh: 24.44 (15.085, 26.99)

CD-OTA: 10.01 ± 3.4947

CD-OTA: 9.33 (2, 16.2)

WT-Veh: 28.5981 ± 4.621

WT-Veh: 25.11 (15.83, 37.18)

WT-OTA: 34.5492 ± 7.312

WT-OTA: 28.89 (13.72, 55.56)

CD-Veh: 19.4743 ± 3.8466

CD-Veh: 22.57 (11.08, 23.895)

CD-OTA: 18.2829 ± 5.1421

CD-OTA: 19.03 (10.4, 23.275)

WT-Veh: 26.7512 ± 3.9562

WT-Veh: 26.06 (16.225, 34.667)

WT-OTA: 33.1485 ± 6.9856

WT-OTA: 20.89 (20.09, 48.21)

CD-Veh: 23.7514 ± 7.9418

CD-Veh: 17.78 (8.93, 31.38)

CD-OTA: 12.6029 ± 4.1604

CD-OTA: 10.27 (3.34, 19.115)

WT-Veh: 6.7538 ± 1.7976

WT-Veh: 3.98 (1.33, 9.1825)

WT-OTA: 4.6977 ± 1.8858

WT-OTA: 3.1 (0, 4)

CD-Veh: 2.91 ± 1.0616

CD-Veh: 1.77 (1.33, 3.765)

CD-OTA: 2.8486 ± 0.8253

CD-OTA: 3.1 (1.325, 4.22)

WT-Veh: 17.6231 ± 4.0732

WT-Veh: 12 (6.8575, 21.6825)

WT-OTA: 14.3885 ± 3.1284

WT-OTA: 10.62 (6.19, 21.78)

CD-Veh: 7.9814 ± 2.8593

CD-Veh: 4 (1.555, 14.16)

Linear mixed model, Random effect:
Animal; Anova to test fixed effects

Time: F(1,39) = 24.2008, p = 1.641x10 -5
Genotype: F(1,39) = 5.2402, p = 0.02757
Treatment: F(1,39) = 0.7865, p = 0.38059
INTERACTIONS:
Time*Genotype: F(1,39) = 3.3477, p = 0.07495
Time*Treatment: F(1,39) = 0.2473, p = 0.62176
Genotype*Treatment: F(1,39) = 0.0549, p =
0.8159
Time*Genotype*Treatment:
F(1,39) = 0.0429, p = 0.83691

CD-OTA: 5.2657 ± 2.8701

CD-OTA: 2.65 (0, 7.105)

WT-Veh: 58.7388 ± 3.9924

WT-Veh: 61.78 (50.165, 69.247)

D3M3: CD - WT p = 0.080759

WT-OTA: 55.6 ± 2.6732

WT-OTA: 56.44 (48.44, 64.6)

D3M4: CD - WT p = 0.008288

CD-Veh: 43.3286 ± 6.6848

CD-Veh: 49.12 (33.335, 55.53)

D3M5: CD - WT p = 0.433508

CD-OTA: 37.1 ± 8.9436

CD-OTA: 38.22 (21.505, 52.345)

D3M6: CD - WT p = 0.971907

WT-Veh: 60.6531 ± 5.2684

WT-Veh: 67.18 (46.18, 75.66)

D3M7: CD - WT p = 0.999868

WT-OTA: 49.6308 ± 4.1193

WT-OTA: 46.46 (44.25, 55.11)

D3M8: CD - WT p = 0.997868

CD-Veh: 34.0129 ± 7.7645

CD-Veh: 25.66 (19.555, 43.14)

D3M9: CD - WT = 1

CD-OTA: 33.3957 ± 12.1127

CD-OTA: 16.81 (11.54, 57.385)

D3M10: CD - WT p = 0.985158

WT-Veh: 46.6925 ± 6.7533

WT-Veh: 50.335 (25.137, 65.795)

WT-OTA: 40.2008 ± 2.7712

WT-OTA: 38.94 (32.74, 44.69)
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CD-Veh: 31.0643 ± 7.5289

CD-Veh: 30.67 (13.495, 41.7)

CD-OTA: 32.2329 ± 11.8144

CD-OTA: 21.68 (8.865, 48.67)

WT-Veh: 40.1825 ± 6.546

WT-Veh: 39.025 (13.095, 58.22)

WT-OTA: 36.0385 ± 3.8887

WT-OTA: 33.19 (26.55, 42.04)

CD-Veh: 29.8943 ± 8.6538

CD-Veh: 24.34 (18.22, 29.33)

CD-OTA: 34.6143 ± 11.9848
WT-Veh: 32.3075 ± 5.1365

Time: F(2,273) = 26.447, p = 2.2x10 -16
Genotype: F(1,39) = 1.0398, p = 0.3142

Treatment: F(1,39) = 0.0596, p = 0.8085
Linear mixed model, Random effect:
INTERACTIONS:
CD-OTA: 23.45 (14, 48.965)
Animal; Anova to test fixed effects;
Time*Genotype: F(7,273) = 5.8774, p =
WT-Veh: 30.365 (16.595, 46.0175) Tukey's HSD multiple comparison 2.262x10-6 Time*Treatment: F(7,273) = 1.1599,
within time for genotype alone
p = 0.3261 Genotype*Treatment: F(1,39) =

Contextual Fear Minute 8

Baseline Minute 1
Cued Fear
Baseline
(% Freezing)
Baseline Minute 2

Cued Fear Minute 3

Cued Fear Minute 4

Figure 2D

Cued Fear Minute 5

Cued Fear Minute 6

CD-Veh: 23.7514 ± 7.9418

CD-Veh: 17.78 (8.93, 31.38)

CD-OTA: 12.6029 ± 4.1604

CD-OTA: 10.27 (3.34, 19.115)

WT-Veh: 6.7538 ± 1.7976

WT-Veh: 3.98 (1.33, 9.1825)

WT-OTA: 4.6977 ± 1.8858

WT-OTA: 3.1 (0, 4)

CD-Veh: 2.91 ± 1.0616

CD-Veh: 1.77 (1.33, 3.765)

CD-OTA: 2.8486 ± 0.8253

CD-OTA: 3.1 (1.325, 4.22)

WT-Veh: 17.6231 ± 4.0732

WT-Veh: 12 (6.8575, 21.6825)

WT-OTA: 14.3885 ± 3.1284

WT-OTA: 10.62 (6.19, 21.78)

CD-Veh: 7.9814 ± 2.8593

CD-Veh: 4 (1.555, 14.16)

CD-OTA: 5.2657 ± 2.8701

CD-OTA: 2.65 (0, 7.105)

WT-Veh: 58.7388 ± 3.9924

WT-Veh: 61.78 (50.165, 69.247)

D3M3: CD - WT p = 0.080759

WT-OTA: 55.6 ± 2.6732

WT-OTA: 56.44 (48.44, 64.6)

D3M4: CD - WT p = 0.008288

CD-Veh: 43.3286 ± 6.6848

CD-Veh: 49.12 (33.335, 55.53)

D3M5: CD - WT p = 0.433508

CD-OTA: 37.1 ± 8.9436

CD-OTA: 38.22 (21.505, 52.345)

D3M6: CD - WT p = 0.971907

WT-Veh: 60.6531 ± 5.2684

WT-Veh: 67.18 (46.18, 75.66)

D3M7: CD - WT p = 0.999868

WT-OTA: 49.6308 ± 4.1193

WT-OTA: 46.46 (44.25, 55.11)

D3M8: CD - WT p = 0.997868

CD-Veh: 34.0129 ± 7.7645

CD-Veh: 25.66 (19.555, 43.14)

D3M9: CD - WT = 1

CD-OTA: 33.3957 ± 12.1127

CD-OTA: 16.81 (11.54, 57.385)

D3M10: CD - WT p = 0.985158

WT-Veh: 46.6925 ± 6.7533

WT-Veh: 50.335 (25.137, 65.795)

WT-OTA: 40.2008 ± 2.7712

WT-OTA: 38.94 (32.74, 44.69)

CD-Veh: 31.0643 ± 7.5289

CD-Veh: 30.67 (13.495, 41.7)

CD-OTA: 32.2329 ± 11.8144

CD-OTA: 21.68 (8.865, 48.67)

WT-Veh: 40.1825 ± 6.546

WT-Veh: 39.025 (13.095, 58.22)

WT-OTA: 36.0385 ± 3.8887

WT-OTA: 33.19 (26.55, 42.04)

CD-Veh: 29.8943 ± 8.6538

CD-Veh: 24.34 (18.22, 29.33)

CD-OTA: 34.6143 ± 11.9848

Cued Fear
(% Freezing)

WT-Veh: 32.3075 ± 5.1365
Cued Fear Minute 7

Cued Fear Minute 8

Cued Fear Minute 9

Cued Fear Minute 10

Linear mixed model, Random effect:
Animal; Anova to test fixed effects

Time: F(1,39) = 24.2008, p = 1.641x10 -5
Genotype: F(1,39) = 5.2402, p = 0.02757
Treatment: F(1,39) = 0.7865, p = 0.38059
INTERACTIONS:
Time*Genotype: F(1,39) = 3.3477, p = 0.07495
Time*Treatment: F(1,39) = 0.2473, p = 0.62176
Genotype*Treatment: F(1,39) = 0.0549, p =
0.8159
Time*Genotype*Treatment:
F(1,39) = 0.0429, p = 0.83691

WT-OTA: 30.5985 ± 4.0338

Time: F(2,273) = 26.447, p = 2.2x10 -16
Genotype: F(1,39) = 1.0398, p = 0.3142

Treatment: F(1,39) = 0.0596, p = 0.8085
Linear mixed model, Random effect:
INTERACTIONS:
CD-OTA: 23.45 (14, 48.965)
Animal; Anova to test fixed effects;
Time*Genotype: F(7,273) = 5.8774, p =
WT-Veh: 30.365 (16.595, 46.0175) Tukey's HSD multiple comparison 2.262x10-6 Time*Treatment: F(7,273) = 1.1599,
within
time
for
genotype
alone
p
=
0.3261
Genotype*Treatment:
F(1,39) =
WT-OTA: 26.55 (21.68, 38.67)

CD-Veh: 30.9157 ± 9.9984

CD-Veh: 22.12 (10.635, 47.02)

CD-OTA: 37.7671 ± 11.4266

CD-OTA: 25.22 (20.8, 53.045)

WT-Veh: 22.945 ± 4.4636

WT-Veh: 16.37 (14.16, 29.3325)

WT-OTA: 27.6538 ± 4.5452

WT-OTA: 29.2 (19.56, 35.56)

CD-Veh: 27.4043 ± 2.0588

CD-Veh: 26.55 (23.945, 28.83)

CD-OTA: 30.9014 ± 10.2019

CD-OTA: 22.67 (14.16, 43.505)

WT-Veh: 27.0338 ± 5.3605

WT-Veh: 20.135 (9.975, 46.68)

WT-OTA: 25.1954 ± 3.5282

WT-OTA: 20.8 (14.16, 37.17)

CD-Veh: 28.29 ± 7.1723

CD-Veh: 19.11 (17.56, 35.015)

CD-OTA: 23.23 ± 8.9934

CD-OTA: 16.37 (9.345, 27.775)

WT-Veh: 23.5981 ± 6.0351

WT-Veh: 14.51 (6.5875, 24.7775)

WT-OTA: 25.5585 ± 3.4353

WT-OTA: 25.89 (16, 32.59)

CD-Veh: 25.2943 ± 6.221

CD-Veh: 22.22 (15.775, 30.075)

CD-OTA: 34.6057 ± 12.4249

CD-OTA: 23.56 (9.12, 59.11)
*p-values < 0.1 are bolded, Veh = Vehicle
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0.1607, p = 0.6907 Time*Genotype*Treatment:
F(2,273) = 0.4794, p = 0.8492

Table S2. Statistical Analysis for OXTR and SERT Autoradiography in Figures 3 and 4.
OXTR Autoradiography Statistical Analysis
Region

Full Region Name

ACC

anterior cingulate
cortex

AON

aortic optic nucleus

BLA

Genotype Total n Female n Female Mean +/- SEM Male n Male Mean +/- SEM

ANCOVA Resultsa,b

Corrected p-value

WT

17

10

99.3212 ± 34.1635

7

132.8717 ± 47.3068

GENO: F(1,22)=0.324, p=0.575

p = 4.6

CD

10

3

77.4752 ± 55.1005

7

101.0427 ± 41.3338

SEX: F(1,22)=0.375, p=0.546

p = 4.368

WT

14

9

763.0854 ± 48.2315

5

886.8484 ± 72.0676

GENO: F(1,20)=0.355, p=0.558

p = 4.464

CD

11

4

793.2109 ± 73.2264

7

779.8056 ± 54.9005

SEX: F(1,20)=0.740, p=0.4

p = 3.2

basolateral & lateral
amygdala

WT

15

10

528.4022 ± 54.7091

5

482.8567 ± 74.3161

GENO: F(1,21)=1.57, p=0.224

p = 1.792

CD

11

5

613.8502 ± 83.4951

6

578.4987 ± 73.9358

SEX: F(1,21)=0.319, p=0.578

p = 4.624

hippocampus regions
CA 2/3
CA 2 & 3

WT

20

12

486.5112 ± 32.1591

8

582.4017 ± 43.729

GENO: F(1,28)=0.234, p=0.632

p = 5.056

CD

13

5

569.4905 ± 54.1236

8

539.5399 ± 41.4852

SEX: F(1,28)=0.599, p=0.445

p = 3.56

WT

17

10

17.8168 ± 15.4067

7

23.1842 ± 21.0416

GENO: F(1,21)=0.023, p=0.88

p = 7.04

CD

9

3

18.6106 ± 28.783

6

30.0852 ± 25.9221

SEX: F(1,21)=0.126, p=0.726

p = 5.808

WT

17

10

443.7764 ± 41.7528

7

462.5080 ± 51.0552

GENO: F(1,22)=5.118, p=0.034

p = 0.272

CD

10

3

282.1728 ± 60.8088

7

388.4841 ± 46.9098

SEX: F(1,22)=1.595, p=0.22

p = 1.76

WT

15

10

746.1092 ± 58.0171

5

723.9866 ± 81.3129

GENO: F(1,20)=0.847, p=0.368

p = 2.944

Cpu

caudate
putamen/striatum

LSN

lateral septal nucleus

Pir

piriform cortex

PVN

paraventricular
nucleus

CD

10

4

634.4353 ± 85.2362

6

696.4849 ± 72.3641

SEX: F(1,20)=0.077, p=0.784

p = 6.272

WT

20

12

646.8375 ± 55.0879

8

654.8481 ± 69.093

GENO: F(1,27)=0.477, p=0.496

p = 3.968

CD

12

4

641.9636 ± 96.3819

8

560.0322 ± 62.8069

SEX: F(1,27)=0.27, p=0.608

p = 4.864

By genotype and sex from estimated marginal means; SEM = standard error of the mean, GENO = genotype
a

Fixed factors: sex and genotype, covariate: age; b Bonferroni Correction, critical α = 0.00625

SERT Autoradiography Statistical Analysis
Genotype Total n Female n Female Mean +/- SEM Male n Male Mean +/- SEM Multivariate ANOVA Resultsa,b

Region

Full Region Name

ACC

anterior cingulate
cortex

WT

22

CD

14

5

211.2059 ± 75.0746

9

218.0609 ± 62.2096

SEX: F(1,23)=0.166,p=0.687

BLA

basolateral
amygdala

WT

21

11

1542.0245 ± 136.8943

10

1326.6276 ± 149.6572

GENO: F(1,23)=0.002,p=0.965

CD

14

5

1525.4806 ± 151.2241

9

1266.8352 ± 119.4666

SEX: F(1,23)=0.638,p=0.432

BNST

bed nucleus of the
stria terminalus

WT

21

12

611.3552 ± 90.9035

9

531.8985 ± 127.1372

GENO: F(1,23)=0.146,p=0.706

hippocampus regions
CA 2/3
CA 2 & 3
CeA

central amygdala

Cpu

caudate
putamen/striatum

IC
LA
NAc
OFC

insular cortex
lateral amygdala
nucleus accumbens
orbital frontal cortex

PLH

hypothalamus

PtA

lateral parietal
association

12

289.4284 ± 61.8965

10

289.1077 ± 79.0262

Between-Subjects Effects
GENO: F(1,23)=0.527,p=0.475

CD

11

5

722.652 ± 114.8744

6

503.8346 ± 97.9522

SEX: F(1,23)=0.328,p=0.572

WT

22

12

978.7105 ± 108.5505

10

873.5517 ± 137.29

GENO: F(1,23)=2.065,p=0.164

CD

14

5

781.6372 ± 150.0473

9

643.6365 ± 87.8401

SEX: F(1,23)=0.106,p=0.747

WT

21

11

1374.99 ± 133.9068

10

1108.807 ± 126.8176

GENO: F(1,23)=1.315,p=0.263

CD

14

5

1125.4029 ± 88.5061

9

WT

22

12

1622.2558 ± 74.8469

10

CD

14

5

1409.6564 ± 131.3332

9

WT

21

12

606.6271 ± 96.5621

9

CD

13

5

701.5797 ± 137.3324

8

WT

20

11

1167.0251 ± 109.2435

9

Genotype:
SEX: F(1,23)=0.227,p=0.638
F(12,12) = 2.141, p = 0.07, Wilks'
1446.2245 ± 156.5769
GENO: F(1,23)=3.7,p=0.067
Lambda = 0.293
Sex:
1281.6204 ± 128.598
SEX: F(1,23)=0.110,p=0.744
F(12,12) = 0.489, p = 0.885, Wilks'
678.7568 ± 152.4349
GENO: F(1,23)=0.125,p=0.727
Lambda = 0.672
Genotype*Sex:
511.0048 ± 78.1395
SEX: F(1,23)=0.003,p=0.956
F(12,12) = 1.301, p = 0.328, Wilks'
1278.5066 ± 123.0872
GENO: F(1,23)=0.569p=0.458
Lambda = 0.435

CD

14

5

1176.4828 ± 180.1849

9

908.4341 ± 127.2575

SEX: F(1,23)=0.022,p=0.883

WT

21

12

1379.1824 ± 65.8827

10

1131.0983 ± 160.7995

GENO: F(1,23)=1.326,p=0.261

1055.1931 ± 89.3567

CD

14

5

1252.071 ± 149.5267

9

1044.5984 ± 95.8042

SEX: F(1,23)=1.551,p=0.226

WT

21

11

486.3343 ± 59.6736

9

539.8918 ± 84.9561

GENO: F(1,23)=3.903,p=0.06

CD

13

5

305.4111 ± 89.3258

8

297.4236 ± 63.7359

SEX: F(1,23)=0.155,p=0.698

WT

22

12

1687.884 ± 65.4506

10

1366.4643 ± 112.7004

GENO: F(1,23)=2.64,p=0.118

CD

13

5

1711.2213 ± 156.022

8

1558.616 ± 161.5287

SEX: F(1,23)=0.608,p=0.444

WT

21

12

297.6349 ± 55.9814

9

385.0822 ± 107.0252

GENO: F(1,23)=0.41,p=0.528

CD

12

5

342.1413 ± 117.7591

7

206.3785 ± 30.2895

SEX: F(1,23)=0.113,p=0.74

SEM = standard error of the mean, GENO = genotype
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Chapter 3: Extensive characterization of a Williams
Syndrome murine model shows Gtf2ird1-mediated rescue of
select sensorimotor tasks, but no effect on enhanced social
behavior
Kayla R. Nygaard, Susan E. Maloney, Raylynn G. Swift, Katherine B. McCullough, Rachael E.
Wagner, Stuart B. Fass, Krassimira Garbett, Karoly Mirnics, Jeremy Veenstra-VanderWeele, and
Joseph D. Dougherty

3.1

Abstract
Williams Syndrome (WS) is a rare neurodevelopmental disorder exhibiting cognitive and

behavioral abnormalities, including increased social motivation, yet also risk of anxiety and
specific phobias along with motor delay. WS is caused by a microdeletion of 26-28 genes on
chromosome 7, including the GTF2IRD1 transcription factor, which has been suggested to play a
role in the behavioral profile of the WS. Duplications of the full region also lead to frequent autism
diagnosis, social phobias, and language delay. Thus, genes in the region appear to regulate social
motivation in a dose-sensitive manner. A complete deletion (CD) mouse, heterozygously
eliminating the syntenic WS region, has been deeply characterized for cardiac phenotypes, but
direct measures of social motivation have not been assessed. Furthermore, the role of Gtf2ird1 in
these behaviors has not been addressed in a relevant genetic context. Here, we have generated a
mouse overexpressing Gtf2ird1, which can be used both to model duplication of this gene alone
and to rescue Gtf2ird1 expression in the CD mice. Using a comprehensive behavioral pipeline and
direct measures of social motivation, we provide evidence that the CD locus regulates social
motivation along with motor and anxiety phenotypes, but that Gtf2ird1 complementation is not
sufficient to rescue most of these traits, and duplication does not decrease social motivation.
However, Gtf2ird1 complementation does rescue light-aversive behavior and performance on
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select sensorimotor tasks, perhaps indicating a role for this gene in sensory processing or
integration.

3.2

Introduction
Microdeletion of the 7q11.23 region results in the neurodevelopmental disorder known as

Williams Syndrome (WS). Hemizygosity of the 26-28 genes in this region, also known as the
Williams Syndrome Critical Region (WSCR), causes multisystemic symptoms which match some
features and mirror others from reciprocal 7q11.23 Duplication Syndrome (Dup 7), revealing the
importance of gene dosage in the pathophysiology of these disorders.69,110,203 Both syndromes
result in altered craniofacial features, cardiac issues, motor coordination deficits, and behavioral
challenges.1,48 Many people with WS exhibit hypersociability and tend to approach strangers with
little apprehension, though the lack of social anxiety does not preclude a more generalized anxiety
and occasional extreme phobias, both of which are more prevalent in WS than the general
population.18,35,47 Unfortunately, the underlying mechanisms of these behavioral differences are
not well understood and thus there are no targeted treatments to help individuals with WS navigate
the expectations of society, similar to the struggle autistic individuals face. However, unlike the
complex etiology of idiopathic autism, the discrete genetic foundation of WS provides a unique
opportunity to uncover these mechanisms, as a relatively small deletion leads to such a
recognizable behavioral profile.
As WS and Dup7 are rare, understanding the complex etiology and circuit pathology
underlying behavioral phenotypes in humans, or with human brain samples, is challenging. While
cellular phenotypes can be investigated in iPSC models,69 animal models are still required to
uncover the link between gene dosage and behavioral phenotypes. Fortunately, the WSCR is
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syntenic in mice, and a complete deletion (CD) mouse model has been developed that recapitulates
many features of WS.159
An initial survey of various features in the CD mouse line discovered mild cardiac deficits,
craniofacial anomalies, and some alterations in behavior. Specifically, the authors reported deficits
in motor performance in a Rotarod task and a decreased habituation to social stimuli in an open
field social interaction test.159 However, the classic three-chamber social approach task showed no
difference in CD mice (albeit on a FVB/AntJ x C57BL/6J hybrid background);117 the FVB strain
generally shows less social approach than C57BL/6J,124 suggesting this background may be less
sensitive for CD social phenotyping. However, the previous measures showing increased social
interest were only conducted in males and social motivation, the amount of work an animal is
willing to do to engage with a conspecific, was not directly measured. Likewise, while motor
learning has been assessed on the Rotarod apparatus,159 less work has characterized motor strength
or coordination generally and the results were not consistent on the hybrid background with
slightly different test parameters.117 Finally, anxiety has also been a difficult domain to assess
consistently in mice, as transient emotionality can affect the results.122 Similar mouse models
deleting a single gene in the WSCR, Gtf2ird1, show opposite results in anxiety-like behavior.131,137
Overall, a deeper phenotyping of these domains would be of use, especially to best address the
effects of WSCR copy number variation at the level of mechanisms or circuits.
Prior to the development of the CD line modeling the full deletion, single gene deletions
were the most common approach in trying to elucidate function, and Gtf2ird1 is one gene that has
been implicated in a variety of hallmark WS phenotypes, from craniofacial to cognitive and
behavioral differences. Gtf2ird1 is often implicated alongside its neighbor and family member
Gtf2i, as these genes occur in tandem in the WSCR and are rarely found separately affected by
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atypical deletions, thus it is difficult to isolate their effects using human studies alone. While both
genes are conserved in the mouse genome, there has been more difficulty with reliably producing
a Gtf2ird1 knockout animal. Alternative and frame-shifted start codons allow truncated versions
of the protein to be expressed, even preserving much of its function outside of its negative
autoregulation.139 Verifying Gtf2ird1 expression, or lack thereof, was also unreliable prior to the
development of decent antibodies.
To avoid the trouble of deleting this elusive gene, we adopt a different strategy to gage the
influence of Gtf2ird1 on relevant phenotypes; we designed a study to both assess the impact of
Gtf2ird1 while also providing an extensive characterization of the CD model, as both of these
contributions would benefit our understanding of the WSCR. Thus, we present a novel Gtf2ird1
transgenic expression line, which we use to thoroughly assess the role of Gtf2ird1; we test the
hypothesis that Gtf2ird1 plays a dose-dependent role in the cognitive and behavioral symptoms of
WS, concurrently examining the effects of Gtf2ird1 overexpression on the background of both
C57BL/6J and CD mouse lines. We used a comprehensive battery of tasks designed to elucidate
the contributions of Gtf2ird1 to the WS phenotype. Simultaneously, using the same extensive suite
of behavioral measures, we provide a detailed assessment of the CD mouse, providing key
information on phenotypes related to motor, anxiety, fear, and social behaviors.
As hypersociability is a key feature of WS, we characterized social behavior of these mice
by measuring a suite of relevant behaviors using 3-Chamber Social Approach, Open Field Social
Approach,159 Social Motivation Operant, Maternal Isolation-induced Pup Ultrasonic Vocalization
(USV), and Resident Intruder tasks. To measure anxiety-relevant behaviors in the CD mice, we
utilized Open Field, Elevated Plus Maze, Light/Dark Box, and Novel Object avoidance tasks, and
assessed fear learning and recall with the Conditioned Fear task. In addition to atypical sociability
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and anxiety, WS results in a variety of sensory and motor symptoms. These characteristics were
measured here by performance in a sensorimotor battery as well as Rotarod, Acoustic Startle/PrePulse inhibition, and Marble Burying tasks.
We replicated and extended the previously reported social differences in the CD mice,
showing enhanced social approach and motivation, in addition to sensorimotor differences and
greater avoidance behavior in some anxiety-related tasks. An open-space aversion noticed in
multiple paradigms was not apparent when a social stimulus was available. Finally, we rule out
Gtf2ird1 as being the sole mediator of the social changes, as duplication of this gene did not
decrease these behaviors, nor did its complementation of the complete deletion rescue any notable
social phenotypes. However, it does appear to mediate aspects of light-induced anxiety-related
behaviors (Light/Dark Box) and sensorimotor coordination (Platform, Rotarod), as
complementation can ameliorate the deficits observed in the CD mice, suggesting a role for
Gtf2ird1 in sensorimotor processing.

3.3

Results

3.3.1 A novel overexpression mouse rescues Gtf2ird1 expression in the context
of a complete deletion of the syntenic Williams Syndrome Critical Region
Evidence from atypical deletions show the telomeric end of the Williams Syndrome
Critical Region (WSCR) as important for most of the key WS features. Two specific genes, Gtf2i
and Gtf2ird1, within the telomeric end are suspected to play important roles in the cognitive and
behavioral profiles of WS. While a Gtf2i mouse line has been developed, no such line exists for
Gtf2ird1. Here we fill that gap with a novel transgenic line that expresses Gtf2ird1 and test the
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hypothesis that Gtf2ird1 is critical for features of WS by rescuing its expression on the most
relevant background, the complete deletion of the WSCR.
To determine the role Gtf2ird1 plays in the WS behavioral repertoire, we first generated
and validated a novel mouse overexpressing the general transcription factor GTF2IRD1 (TGGtf2ird1-HA) via its endogenous regulatory elements, engineered using a bacterial artificial
chromosome with an HA tag that was inserted just prior to a stop codon of Gtf2ird1 (Fig 1A). The
line was validated through qPCR and Western blot analysis of heterozygous animals which reveal
increased production of Gtf2ird1 RNA (Fig 1B; t=-5.247, p<0.001) and protein (Fig 1C; t=-1.991,
p=0.048, one-tailed).
Next, we demonstrated the ability of the TG-Gtf2ird1-HA mouse to rescue Gtf2ird1
expression in the Complete Deletion (CD) mouse, a line that effectively deletes the syntenic
Williams Syndrome Critical Region,159 by crossing heterozygous TG-Gtf2ird1-HA and CD
animals to produce four distinct progeny: wildtype (WT), TG-Gtf2ird1-HA (TG), Complete
Deletion (CD), and the putative rescue (TG/CD), which combines the transgene and the complete
deletion (Fig 1D). Molecular validation via qPCR confirmed Gtf2ird1 overexpression in TG
heterozygotes and decreased expression in CD animals relative to WTs, while RNA expression in
the TG/CD group was not significantly different from WT, indicative of a molecular rescue (Fig
1E; F(3,20)=22.190, p<0.001). To ensure altered expression was specific to Gtf2ird1, we also
measured relative expression of the nearby related gene, Gtf2i. The overexpression of Gtf2ird1 did
not significantly alter RNA expression of Gtf2i, which was significantly lower on the CD
background regardless of transgene presence (Fig 1F; F(3,20)=12.818, p<0.001). To confirm
protein expression was also affected, we ran a Western blot, probing for GTF2IRD1 using GAPDH
as a control (Fig 1G). CD GTF2IRD1 protein levels were significantly lower than WT, TG, and
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TG/CD GTF2IRD1 levels, which did not differ from each other significantly (Fig 1H;
F(3,8)=9.918, p=0.005).

Figure 1. Novel Gtf2ird1 overexpression mouse rescues Gtf2ird1 RNA and protein levels in a Complete Deletion mouse
modeling deletion of the syntenic Williams Syndrome Critical Region. A) Location of the BAC clone used to create the TGGtf2ird1-HA mouse line along with a cartoon of the HA-tag added just prior to the stop codon of one of the Gtf2ird1 isoforms. B)
RNA expression of Gtf2ird1 relative to Gapdh in WT and TG littermates. C) Relative GTF2IRD1 protein levels in WT and TG
littermates, n=3 WT, 5 TG. D) Heterozygous (+/-) CD and TG animals were crossed to directly compare WT, TG, CD, and TG/CD
progeny. E) Gtf2ird1 RNA expression in progeny from cross outlined in panel D, n=6 per genotype. F) Gtf2i RNA expression from
the same animals as in E. G) Western blot of TG x CD progeny probed with antibodies for GTF2IRD1 and GAPDH, colored circles
above the lanes indicate genotype, - and + represent negative and positive controls for the transgene. H) GTF2IRD1 protein levels
quantified from the blot in panel G, n=3 per genotype. All RNA and protein levels were normalized to Gapdh expression. For E
and F only, square = male, circle = female; * = p<0.05.

Having thus validated the expression of the Gt2ird1 allele and complementation of
Gtf2ird1 levels in the CD background, we then utilized this same breeding scheme to generate a
set of litter-matched behavioral cohorts for comprehensive behavioral testing (Table 1, see
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Methods), enabling a study of main effects of each allele, as well as detection of interactions. We
likewise included sex in all subsequent analyses, and report sex effects when significant.

3.3.2 Gtf2ird1 restoration ameliorates select sensorimotor coordination deficits
in Complete Deletion mice
Both WS and Dup7 are associated with strength deficits and motor delays. While Gtf2ird1
has been connected to the WS craniofacial phenotype and is suspected to play a role the unique
cognitive profile (which includes visuospatial processing deficits) and behavioral features of WS,
its role in sensorimotor features of WS has not been thoroughly defined. To address both the impact
of Gtf2ird1 on these features and the complete WS deletion in CD mice, we devised a
comprehensive assessment of sensorimotor abilities, which also provided information necessary
to properly interpret tasks relying on adequate motor performance. The wide-ranging compilation
of tasks addressed a variety of basic motor abilities and more complex tasks requiring integration
of sensory information (in mice, coordinated movement often is informed by their whiskers, rather
than their eyes).204 We split relevant tasks across two cohorts; in one cohort (Fig 2A, above
midline), we tested activity in over 1-hour in an open field apparatus and natural digging behaviors
observed in the Marble Burying task. Animals in the other cohort (Fig 2A, below midline) were
tested using Rotarod, Pre-Pulse inhibition, and a sensorimotor battery, which included Walk,
Inverted Screen, Pole, Platform, and Ledge tasks to assess a variety of movement related abilities,
such as motor initiation, strength, coordination, and balance, as well as sensory processing.
At P30, results were not significant across a 1-hour open field activity task (Fig 2B,C). At
P60, motor initiation, coordination, balance and strength were tested using a battery of
sensorimotor tasks. There was no difference in motor initiation in a Walk task (Fig 2D,E), though
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differences in balance and strength were observed. Specifically, the CD animals were unable to
hold on to an inverted screen as long (Fig 2F,G; H(3)=30.208, p<0.001) but climbed down the
pole faster than WT animals (Fig 2H,I; H(3)=16.709, p<0.001). A balance deficit was observed
in CD animals as fewer animals in this group were able to remain on a thin, acrylic ledge for a full
minute (Fig 2J; H(3)=29.487, p<0.001) or on a small platform just large enough for the mice to
stand atop (Fig 2K,L; H(3)=16.919, p<0.001). Interestingly, rescue of Gtf2ird1 partially restored
performance on the Platform task, as TG/CD animals stayed on the platform significantly longer
than their CD counterparts (p=0.046). To examine motor coordination more directly, we used the
Rotarod task (Fig 2M), which revealed another partial rescue (Fig 2N; CD*TG interaction:
F(1,69)=6.977, p=0.01). While all mice learned the task and generally improved over subsequent
trials, CD and CD/TG animals had a shorter latency to fall relative to WT and TG animals
(F(1,69)=35.227, p<0.001). The interaction between CD and TG alleles (e.g., rescue) was most
apparent in females (Fig 2O; Sex*CD*TG: F(1,69)=4.461, p=0.038).
In the Marble Burying task, both CD and CD/TG mice buried far fewer marbles than the
WT and TG groups (Fig 3P,Q; H(3)=34.458, p<0.001). This finding is confounded by a matching
decrease in total distance traveled, represented here by the lower number of center entries by the
CD groups (Fig 2R; F(1,90)=76.712, p<0.001). Thus, the fewer marbles buried may simply be a
factor of hypoactivity, though what is causing the hypoactivity here and not in the open field task
is not known. The effect is perhaps enhanced by the novel bedding used in the Marble Burying
task, which was not present in the other apparatus.
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Figure 2. Gtf2ird1 restoration affects a subset of sensorimotor deficits observed in the CD mice. A) Tasks were split between
two cohorts: OF = Open Field, MB = Marble Burying, SMB = sensorimotor battery, PPI = Pre-Pulse Inhibition. B) A 50x50cm
arena under red illumination at 9 lux was used for the 1-hour open field task. C) No significant differences were observed between
groups in total distance travelled in the open field task. D) In the “walk” task, the time for mice to exit the white square in the center
of a large open space was measured as a proxy for motor initiation. E) No differences in motor initiation were observed. F) The
inverted screen task measures how long a mouse can hold on for up to 60 seconds G) CD and TG/CD mice were not able to hold
on to the screen for the full minute. H) Mice were placed on a textured pole for up to 120 seconds. I) CD and TG/CD mice were
significantly faster to leave the pole. J) CD and TG/CD mice were unable to stay on an acrylic ledge for a full minute. K) Time on
a small platform was measured. L) CD animals had a decreased latency to fall that was ameliorated with the presence of the
transgene. M) The Rotarod apparatus used to measure ability to stay on a moving rod. N) Animals with the CD allele fell off an
accelerating rod faster than WT, but presence of the transgene improved the outcome. O) This partial rescue was especially clear
in females. P) Mice have 30 minutes to explore a chamber with 20 evenly spaced marbles. Q) Animals with the CD allele (CD and
TG/CD animals) buried significantly fewer marbles than WT and TG animals. R) CD and TG/CD animals travel less distance
overall, reflected here in significantly fewer center entries. S) In the Acoustic Startle/Pre-Pulse Inhibition paradigm, mice are
exposed to an acoustic stimulus while confined within a sound-attenuated box on a force plate to measure the startle reflex. T)
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Transgenic expression of Gtf2ird1 resulted in a greater startle response (in Newtons) across various sound levels; each trial reflects
sound level in decibels, NS = no sound. * p<0.05, ** p<0.005 relative to WT.

Sensory sensitivity is another feature of WS that warrants investigation, as WS individuals
are more reactive to sounds.35,37 In the Acoustic Startle/Pre-Pulse Inhibition (PPI) task (Fig 2S),
animals are presented with acoustic stimuli designed to induce the startle response in mice. The
CD allele alone did not influence response to an acoustic startle stimulus, but mice harboring the
TG allele responded with greater startle magnitude force to all levels of sound (Fig 2T;
F(1,45)=12.898, p<0.001). These data may indicate a unique feature of unbalanced Gtf2ird1
expression relative to the rest of the WSCR. There was also an interaction between CD and TG
alleles and sex (not shown; Sex*CD*TG: F(1,45)=6.295, p=0.016), suggesting a possible
difference in sensitivity to genotype based on sex. The PPI trials revealed an interaction between
CD and TG alleles on sensorigating ability, with the TG/CD animal showing lower percent
inhibition than the other groups (not shown; CD*TG: F(1,45)=5.227, p=0.027).

3.3.3 Restoring Gtf2ird1 expression in CD mice rescues light-avoidant but not
center-avoidant anxiety-like behaviors
Anxiety is another feature common to WS and Dup7, though the specific forms differ.
Non-social anxiety and increased prevalence of phobias are over-represented in the WS
population, while Dup7 is characterized by greater social anxiety and separation anxiety, with no
clear phenotype related to fear. As there are no specialized treatments for these symptoms among
patients, having a well characterized model for preclinical screening of therapeutics may
eventually lead to better care. Thus, we thoroughly assessed non-social anxiety-like avoidance
features in the CD mouse model to identify tasks sensitive to this mutation and evaluate the
potential impact of Gtf2ird1.
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Anxiety-like behavior is measured in rodents by quantifying passive avoidance behavior
in low-threat situations in which perceived danger is diffuse and uncertain (PMID: 33005134).
These situations for a rodent include open spaces and brightly lit spaces. One common trigger for
passive avoidance behavior in rodents is the center space of an open field (Fig 2B). Similarly, the
Elevated Plus Maze (EPM) measures an animal’s passive avoidance of the open arms. In contrast,
light and open space is leveraged together in the Light/Dark Box task, and a decrease in time in
the light side of the box has been used to indicate passive avoidance behavior, rather than relying
on avoidance of the open space alone. Together, these tasks should inform us of the anxiety-like,
passive avoidance features of the CD mice and whether Gtf2ird1 expression has any effect on these
behaviors.
In the 1-hr Open Field task conducted under red light at 9 lux, both CD and TG alleles
resulted in a decrease in center time (Fig 3A,C, CD: F(1,86)=13.175, p<0.001; TG: F(1,86)=7.935,
p=0.006). As the overall distance traveled was not different between groups (Fig 2C), these results
are consistent with heightened anxiety-like behavior. Regardless of genotype, females spent less
time in the center than their male counterparts (Fig 3B, F(1,86)=12.210, p<0.001). In contrast to
the avoidance behaviors observed in the open field, there were no observed differences in the
percent time spent in the open arms of the EPM under complete darkness (Fig 3D,E).
Interestingly, during the Light/Dark Box task (Fig 3F), we observed a significant interaction of
CD and TG alleles on the percent time spent in the light (Fig 3G; F(1,73)=7.460, p=0.008). CD
animals spent significantly less time in the light relative to their WT (p=0.009) and TG/CD
(p=0.018) counterparts, while TG/CD animals were not significantly different from the WT group,
reflective of the TG allele rescuing CD deficits in this task. Thus, Gtf2ird1 complements the CD
mutation for this phenotype.

66

Figure 3. Gtf2ird1 corrects CD-induced decreased time in light but not in center space. A) Transgene and CD allele decrease
time spent in center of an open field. B) Females consistently spend less time in the center compared to males. C) Representative
track plots of open field task, chosen based on group mean. D) Diagram of elevated plus maze apparatus. E) No difference in
percent time spent in open arms of the EPM was observed. F) Diagram of the Light/Dark Box task. G) Decreased time in light side
caused by CD allele is rescued with expression the Gtf2ird1 transgene. H) No significant differences in freezing were observed
during the training day of the Conditioned Fear task. I) Day 2 of the Conditioned Fear task also revealed no significant differences.
J) TG allele increases percent freezing during cued recall in the 3rd day of Conditioned Fear. K) The TG affect on percent time
freezing during cued recall is greater in female mice. T+S = Tone + Shock

In contrast to the passive avoidance of anxiety-like measures, fear responses, which have
a component of anxiety, are active avoidance behaviors quantified in situations where a threat is
imminent and well-defined (PMID: 33005134). We used the fear conditioning task to further
evaluate active avoidance and associative memory by quantifying freezing behavior in response
to a shock paired with a novel auditory cue and spatial context. No differences in freezing response
to the pairing of the shock and tone+context were observed between genotypes on Day 1 (Fig 3H).
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However, females froze more than males overall (Day 1, min 3-5; F(1,85)=5.606, p=0.02). This
sex effect was also observed during contextual fear recall on Day 2 when mice were re-exposed to
the spatial context to test hippocampal-dependent spatial conditioning (Fig 3I; F(1,85)=5.650,
p=0.02). The CD mice also showed reduced freezing, similar to our previous reports, but did not
pass the significance threshold due to low power.
During amygdalar-dependent cued fear recall on Day 3, animals with the TG allele
overexpressing Gtf2ird1 showed increased freezing in response to the auditory cue (Fig 3J;
F(1,85)=29.860, p<0.001). This increased freezing was especially pronounced in females with the
TG allele (Fig 3K; F(1,85)=11.861, p<0.001). Mice with only the CD allele show reduced freezing
behavior compared to all other groups, replicating our previous effect,115 although the comparison
to WT mice did not quite pass the significance threshold (p=.078), likely due to power here. Shock
sensitivity was comparable across groups.

3.3.4 Enhanced social approach and motivation is independent of Gtf2ird1
Finally, given the interesting contrasting social motivation phenotypes in WS and Dup7
patients,18,47 we conducted a comprehensive phenotyping of social behavior in our cohorts. To
identify early signs of social behavior changes, we first assessed pup social communication via a
maternal isolation-induced ultrasonic vocalization (USV) paradigm (Fig 4A,B). Given elevated
aggression in Dup7 patients,55 we included standard measures of social dominance (tube test) and
aggression (resident intruder). Sociability differences in the CD model was originally identified in
a modified single chamber version of social approach (Open Field Social Approach), rather than
the typical 3-chamber task widely used in ASD models.120,159 Previous work in our lab failed to
identify differences in the 3-chamber task alone, though on a C57BL/6J x FVB hybrid background
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that shows lower social approach in general.117,124 Thus, our comprehensive battery here included
a deliberate precise replication of the Open Field Social Approach conditions as a baseline
control,134,159 the standard 3-chamber social approach assay,120,205 and finally a 14-day social
operant task we recently designed to be a direct measure of social motivation in rodents.206,207
Early differences in communication were evident across the three days of the USV task.
CD animals demonstrate a delay in USV production and TG/CD animals show sustained deficits
in the number of calls made (Fig 4C). These differences do not appear to be due to gross
developmental delays, as weights were comparable between CD and TG/CD animals (Fig 4D).
Also, at P14, all pups had the ability to flip themselves upright, with no difference in time to right
(Fig 4E). This suggests there is an early disruption to social communicative behavior with
haploinsufficiency for the WSCR. In adults, previous research showed decreased dominance in
the Tube Test and aggression in the Resident Intruder paradigms. Though CD animals seem to win
less, there was no statistically significant difference in Day 1 of the Tube Test paradigm (Fig 4F;
H(7)=11.102, p=0.134). In addition, there were also no significant differences in attacks (Fig 4G;
CD: F(1,32)=1.167, p=0.288). However, the total numbers of wins and attacks, respectively, were
low in both paradigms regardless of group, which may have had an impact.
Similar to Segura-Puimedon et al. (2014), in the Open Field Social Approach task we found
CD animals spent more time investigating the social stimulus mouse relative to WT animals
(p=0.013).159 In fact, we observed increased social approach in all groups relative to WT levels
(Fig 4H, H(3)=8.916, p=0.03). The significance of this difference appeared to be driven by the
lack of habituation, as WT levels of approach fell after 10 minutes while the other groups remained
more interested in the social stimulus (Fig 4I, H(3)=13.160, p=0.004).
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Figure 4. Increased social approach and motivation in CD model of WS deletion is independent of Gtf2ird1. A) Cohort 1 was
used to test USVs over postnatal (P) days 5, 7, and 9 and righting reflex at P14. B) Maternal separation induced pup USV workflow:
Remove dam, place pups in warming chamber without moving them, measure their temperature while in the nest, individually
records each pup’s USVs, then weigh. C) Calling rate was altered in mice with CD alleles, though TG/CD mice sustained the
deficit over all three days. D) Pup weight after USV recordings show decreased weight in pups with the CD allele. E) No differences
observed in righting at P14. F) No significant differences measured in the Tube Test for Social Dominance task. G) No differences
in average number of attacks by resident on intruder. H) TG, CD, and TG/CD animals spent more time investigating a social
stimulus. I) WT show habituation at 15 minutes that is not seen in the other groups. J) Only mice with the CD allele show longer
mean bouts of investigation. K) Representation of the Open Field Social Approach apparatus. L) Open Field Novel Object
apparatus. M) Novel object avoidance seen in CD and TG/CD animals. N) CD allele caused increased mean investigation bout in
the novel object task. O) Social preference index in the 3-chamber social approach task was greater in animals harboring the CD
allele. P) Male animals had higher social preference for the social cup than females. Q) Representative heat maps of 3-chamber
social approach. R) Social Motivation Operant apparatus. S) CD allele results in greater mean rewards during FR1. T) Males with
the CD allele had increased mean rewards during FR3. U) The breakpoint during PR3 was greater in CD and TG/CD animals.
circle = female, square = male, * <0.05, ** < 0.005 relative to WT group.

While all groups showed sustained interest in the stimulus, the mean social investigation
bout was only higher in CD and TG/CD animals (Fig 4J, H(3)=13.16, p=0.006). Regardless, it is
clear that the deletion of the WSCR increases social approach behaviors here as measured in
investigation time and average investigation bout.
To control for the potential impact of novelty on the Open Field Social Approach task (Fig
4K), we next tested the reaction to another novel object, a translucent square placed in the center
of the familiar open field arena (Fig 4L). CD and CD/TG animals spent significantly less time near
the novel object (Fig 3M; F(1,86)=4.203, p=0.043). In addition to the effect of the CD allele,
females of all groups spent less time investigating the novel object as well (F(1,86)=11.901,
p<0.001). Though less time was spent investigating the object, mean investigation bout was higher
in animals with the CD deletion, just as it was in the Open Field Social Approach task (Fig 3N;
H(3)=11.271, p=0.01).
The increased social approach also holds in the classic 3-Chamber Social Approach task.
Deleting the WS region results in a greater preference for the social cup, compared to an empty
cup (Fig 4O,Q; F(1,71)=5.527, p=0.022). This preference was especially pronounced in males
across all genotypes (Fig 4P; F(1,71)=6.061, p=0.016). The effects on social novelty were not as
straightforward, and no differences across groups were significant (not shown).
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Finally, we applied our social operant task to precisely investigate social motivation (Fig
4R). Animals were trained to nosepoke to open a door on a to reveal a novel mouse as a social
reward. During training, or fixed ratio 1 (FR1) one poke results in one reward. As animals reach
criteria (sufficient total nosepokes, active:inactive ratio, and interactions per reward), they progress
to a fixed ratio of 3 (FR3) for three days. After 3 days of FR3 (for learners) or 10 days at FR1
(nonlearners), each animal undergoes testing at a progressive ratio of 3 (PR3), where an animal’s
maximum motivation, or breakpoint, is assessed by continuously increasing the difficulty to attain
each reward by 3 nosepokes. Learners with the complete deletion allele (CD and CD/TG
genotypes), reached a higher number of total rewards during FR1 (Fig 4S; F(1,47)=14.07,
p<0.001). During FR3, an interaction between sex and CD allele emerged, showing that only males
with the CD allele reach more rewards (Fig 4T; CD*Sex: F(1,44)=4.932, p=0.032). Subsequently,
the CD allele results in a higher breakpoint during PR3 (Fig 4U; H(3)=8.092, p=0.044). These
results show that complete deletion of the WSCR in mice results in higher social motivation,
meaning they are willing to work harder to keep accessing the social stimuli. While this appears
to be driven by an increase in males, the limited number of animals who met criteria to be
considered learners (and thus be included in our analysis) constrains our power to assess sex
effects.

3.4

Discussion
In this extensive characterization of mouse models relevant to the WSCR, the

consequences of complete deletion of the region were obvious. We found a widespread effect of
WSCR deletion in the CD model, causing deficits in sensorimotor abilities (i.e., performance in
Inverted Screen, Ledge, Platform, Rotarod, Marble Burying tasks), select anxiety-like behaviors
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(i.e., time in Open Field center, and time in light side of the Light/Dark Box), and enhanced social
interest (i.e., approach behaviors in open field and 3-chamber set-ups, and increased motivation in
the social operant paradigm). We also presented a novel transgenic line expressing a gene of
interest, Gtf2ird1, and used this line to genetically rescue Gtf2ird1 expression in the CD line to
examine its ability to rescue any of the atypical phenotypes presented. The transgenic Gtf2ird1
line highlighted a role for Gtf2ird1 in sensorimotor coordination (as evidenced in the Platform and
Rotarod tasks) and potentially sensory processing more generally (sound sensitivity and potentially
light). While Gtf2ird1 affected a few features clearly, most features where not significantly
impacted by its rescue or overexpression, suggesting either Gtf2ird1 is not involved or is only part
of the underlying etiology and would require prohibitively large samples to observe its small effect
in those domains.
Interestingly, Gtf2ird1 seems linked with a hyper-response to sound (in force produced
during acoustic startle trials during PPI, and in increased freezing during contextual fear) is clearly
correlated with expression of the transgene. This could mean one of two things: either the HAtagged beta isoforms are altered in a way that specifically affects these phenotypes, or uneven
Gtf2ird1 expression relative to the other genes in the WSCR is causing dysregulation relevant to
these phenotypes. Either way, we can derive useful information from the issue. If it is an issue of
the HA tag, we learn that a specific subset of Gtf2ird1’s isoforms is definitely involved in
responsivity to sound, or if it’s an issue of discordant expression within the WSCR, we learn there
is definitely interplay between Gtf2ird1 and at least one other gene in the region.
Beyond its usefulness here, the novel transgenic Gtf2ird1 line may also provide
opportunities to research into the various roles Gtf2ird1 isoforms may play in typical development.
Gtf2ird1 is an extensively alternatively spliced gene, with numerous uncharacterized isoforms.
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Our TG-Gtf2ird1-HA mouse tags less than half of the isoforms (only the beta variants that contain
the full exon 30)208; leveraging this fact, we can investigate how these two groups of isoforms
differ. Utilizing an HA antibody in a pull-down assay would effectively separate these isoform
groups for downstream analysis to compare their functions, particularly in regard to genomic
binding.
Synthesizing the results of this study beyond the contributions of Gtf2ird1, we show the
Complete Deletion mouse may not be a straightforward model for anxiety-related phenotypes
relevant to the Williams Syndrome deletion. Avoidance of the center in the Open Field task
suggesting an anxiety-like phenotype, which was replicated in the decreased time in the light side
of the Light/Dark Box, but no differences were apparent in the EPM. Whether the EPM is not
sensitive to the particular anxiety-inducing features relevant to WS or whether the EPM requires
specific parameters for peak performance needs to be determined. It is possible that the differences
observed in the Open Field and EPM tasks (Fig 3) may be due to differences in the length the tasks
(60 vs 5 min), the limited time animals spent in the EPM open arms at all (<10% of time on
average), or the age of the animals in both tasks (not yet adults). Without answers to why a
phenotype wasn’t observed in the EPM, use of that task and interpretation of other anxiety-relevant
phenotypes may need to be done cautiously.
In conclusion, while linking individual genes to specific features is difficult due to varied
expressivity despite identical genetic lesions, the WS critical region (WSCR) still provides a
unique genetic landscape to investigate genotype-phenotype connections and the pathological
effect of copy number variations. Modeling single gene deletions of candidates within the WSCR
limits our ability to address polygenic features, as they may not provide an accurate picture of the
consequences (or possible functional restoration) within the context of the full deletion. The CD
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mouse modeling the full WSCR deletion is the most relevant genetic context, providing excellent
construct validity to study polygenic traits of WS and can be used to study a broad suite of
characteristics, as shown here. Future studies focusing on mechanism discovery for behavioral
symptoms could be a way to provide meaningful answers despite complicated etiology, as
suggested by Kozel et al. (2021).1

3.5

Materials and Methods
All experimental protocols were approved by and performed in accordance with the

relevant guidelines and regulations of the Institutional Animal Care and Use Committee of
Washington University in St. Louis and were in compliance with US National Research Council's
Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on
Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory
Animals.

3.5.1 Gtf2ird1 Transgenic Mouse Creation
We selected a bacterial artificial chromosome (BAC) clone (RP24-508D22) which
contained the entirety of the 100 kb Gtf2ird1 gene, and 89 kb (60 kb at the 5’ end and 28 kb at the
3’) of flanking regulatory sequence (e.g., the Gtf2ird1 promoter, etc.), but no additional intact
genes or their promoters. This was then recombineered using standard methods to insert an HA
tag in-frame directly before the stop codon of the beta isoforms.208,209 Specifically, we used
homologous recombination via transient expression of RecA, followed by Neomycin selection of
an inserted FRT flanked cassette. The selection cassette was then removed after the expression of
FLPe, leaving on a single FRT site downstream of the stop codon. Transgenic mice (TG)
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overexpressing Gtf2ird1 (TG-Gtf2ird1-HA) were created by injecting this modified BAC into
C57BL/6NTac mouse oocytes and transplanting these eggs into pseudo pregnant surrogates to
carry them to term. Transgene-specific primers (BgenoF3 – CAACATTCCCAAGCGCAAGAG
and BgenoR3 – GATAACTGATCGCGGCCAGC, which produce a 440 bp product in TG animals
and no product in WT animals) were used for identification of TG founder animals. BAC copy
number was determined to be 2-4. Multiple founders were evaluated to confirm transgenic RNA
production by RT-PCR, and a single line was taken forward for evaluation. Lines were
backcrossed to C57BL6/J for over 4 generations prior to commencing experiments.

3.5.2 Husbandry
All mice used in this study were maintained and bred in the vivarium at Washington
University in St. Louis on a 12/12 hour light/dark cycle with food and water provided freely. Three
distinct mouse lines were used: C57BL/6J (WT, RRID:IMSR_JAX:000664), the Complete
Deletion (CD) mouse modeling deletion of the Williams Syndrome critical region,159 and a novel
transgenic line (TG) overexpressing Gtf2ird1 with an HA tag. CD and TG lines were maintained
as heterozygotes by crossing to WT animals. Heterozygous CD and TG mice were crossed to
produce behavioral cohorts containing WT, TG, CD, and TG/CD littermates to best compare
across genotypes. Animals were housed by genotype and sex at weaning. Tissue was collected
from pups for first genotyping and after death to verify genotype via PCR amplification.

3.5.3 Molecular Validation
Molecular analysis to assess RNA and protein levels via RT-qPCR and Western blotting
was performed as previously described.139 Brains were collected from pups ~E13.5 for initial
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characterization of the novel line and just prior to postnatal day 21 (P21) for validation of the
crosses. RNA expression and protein levels were assessed relative to Gapdh using primers and
antibodies described previously.139 Expression of the transgenic allele was verified by a Western
blot using an antibody to the HA tag, which is included only on some transcripts due to alternative
splicing of the last exon.

3.5.4 Behavioral Testing
For behavioral analysis, three separate cohorts of mice were used to assess a variety of
characteristics with the fewest number of animals possible (Table 1). All tasks were run by female
experimenters. Tasks within each behavioral battery were ordered from least to most stressful to
minimize the effect one task had on subsequent tasks. Adolescent and adult mice were handled for
5 days prior to starting the first behavioral task and mice in Cohorts 2 and 3 were marked with a
non-toxic, permanent marker during weight collection to easily distinguish them during testing.
Males were run before female animals. Tail samples were collected post-mortem to verify
genotypes.

Table 1. Behavioral cohort sample size and task order.
Cohort
1 - 031120
2 - 020420
Max n
91
94: 48F, 46M
Task 0 Temp/Weight (P5,7,9) Weight
(P26-35)
Task 1 USVs
(P5,7,9) Open Field
(P27-36)
Task 2 Righting Reflex (P14) Social Approach
(P28-39)
Task 3
Marble Burying
(P30-40)
Task 4
Elevated Plus Maze
(P33-45)
Task 5
Novel Object
(P38-47)
Task 6
Social Operant
(P40-64;90-112)
Task 7
Conditioned Fear (P59-70;119-128)

3 - 021521
77: 40F, 37M
Weight
(P50-86)
Sensorimotor Battery (≥P56)
Rotarod
Light/Dark Box
3-Chamber Social Approach
Tube Test
Pre-Pulse Inhibition
Resident Intruder (P88-123)

COHORT 1
Maternal separation induced ultrasonic vocalizations and righting reflex
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Briefly, pups were tested in their colony room by the same female experimenter (REW) on
postnatal (P) days 5, 7, and 9. Mice were identified and genotyped by toe clipping, which was
performed after the P5 recording session. All recordings occurred after 12 PM CST between March
and September of the same year. Prior to recording, the parents were removed, and pups in the
nest were placed in a warming chamber at 33°C without removing them from their nest to maintain
a surface body temperature of 31.1–37.5°C. After 10 minutes to acclimate body temperature, each
pup was placed in an empty cage in a sound attenuating box (36x64x60 cm) and recorded for 3
minutes. The Avisoft UltraSoundGate CM16 microphone was positioned 5 cm from the top of the
cage and an Avisoft UltraSoundGate 116H amplifier (gain = 8, 16 bits, sample rate = 250 kHz)
was used for all measurements. Ultrasonic vocalizations (USVs) were recorded using the AvisoftRECORDER software. Raw WAV files were processed using a custom MATLAB pipeline to
extract call numbers and spectral and temporal call features.206,210
In addition to USVs, weight and temperature were recorded for each mouse at each time
point. A non-contact HDE Infrared Thermometer was used to take the temperature of each mouse
before they were removed from the nest for USV recording. Mice were weighed after recording.
Pinnae detachment was also assessed at P5, and eye opening was documented at P14. At P14, the
righting reflex was evaluated for each mouse by measuring the time for pup to right itself after
being held on its back for 5 seconds. Three trials, limited to 1 minute, were performed for each
mouse, averaged for analysis, and direction of righting was noted.

COHORT 2
All tasks performed on the 3 batches of cohort 2 took place within a sound- and scentattenuated white opaque box (70.5 x 50.5 x 60 cm) to minimize external stimuli. Males were run
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prior to females when possible, and a run order was created to counterbalance groups across
apparatuses and runs. Between trials, 70% ethanol was used to clean glass marbles and wire cups
and 0.2% Nolvasan was used for everything else.

Open Field
Mice were placed in a 50 x 50 x 45 cm plexiglass enclosure under red light at 9 lux and
allowed to explore for 60 minutes, adapted from our previously published methods.206 Any-Maze
software (Stoelting, Co) tracked the movement via the body center, beginning when the doors to
the chamber were closed via video captured with an overhead CCTV camera. A center zone was
designated as the middle 50% of the total chamber area.

Open Field Social Approach
Replicating previously published methods,134,159 we examined social approach behavior in
an open field setting, under white light at 50 lux. In the center of the Open Field enclosure, a novel,
sex- and age-matched stimulus animal was placed under a wire pencil cup (with a clear plastic cup
on top to prevent climbing). The experimental animal was then added to the chamber and allowed
to explore and interact with the social stimulus. After 15 minutes, recording was stopped, the
experimental animal was removed to a clean holding chamber, and the stimulus animal was
switched out with a novel mouse. The experimental animal was returned to the chamber for 5
additional minutes of recorded exploration. Any-Maze video tracking was used for both trials, and
measured time spent in an investigation zone defined as 2cm out from the circumference of the
center cup.
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Elevated Plus Maze
Anxiety-like behaviors were tested as previously described.117 Briefly mice were placed in the
center of the apparatus, which contained two open and two closed arms, and allowed to explore
for 5 minutes in the dark. This was repeated for two more days. Trials were recorded under red
light illumination with an overhead camera using Ethovision software (Noldus Information
Technology) to track movement.

Marble Burying
Mice were introduced to a novel, transparent enclosure (47.6x25.4x20.6 cm) with 20
evenly spaced, clear marbles on clean, novel, autoclaved aspen bedding. Animals were allowed to
explore freely for 30 minutes and were tracked via Any-Maze software. After the animals were
removed, two independent scorers recorded the number of marbles buried (defined as at least 75%
covered with bedding). These scores were averaged for analysis.

Open Field Novel Object Exploration
Adapting previously published methods,159 we examined novel object exploration in an
open field setting to control for potential novel effects in the Open Field Social Approach task. A
translucent cube was placed in the center of the same Open Field chamber used for Open Field,
and Open Field Social Approach, also under white light at 50 lux. Mice were placed in the
apparatus to explore freely for 20 minutes while movement was recorded and tracked using AnyMaze software. A 2-cm investigation zone was defined around the object, in addition to center and
perimeter areas.
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Social Motivation Operant Conditioning
Based on previously published methods,206 social motivation –how hard an animal will
work for access to a social partner– was assessed using our social motivation operant assay. Our
16-day paradigm allows for assessment of both social reward seeking and social orienting, two
components of social motivation.211 An operant conditioning chamber was modified to include a
door that raised in response to a nosepoke in the active hole to provide 12 seconds of access to a
novel sex- and age-matched partner stimulus mouse. To assess social reward seeking, the number
of active (i.e., elicits a reward) versus inactive nosepokes were quantified. To assess social
orienting, the behavior of the animal was tracked using Ethovision (Noldus) and number of
interactions with the stimulus mouse and time spent near the stimulus mouse were quantified.
Following two days of habituation (door remained open and the nosepoke holes were not
accessible), mice received at least 3 days of fixed ratio 1 (FR1) conditioning, where 1 nosepoke in
the active hole resulted in a reward. Mice that had at least 40 active nosepokes, 75% accuracy
(active:inactive), and 65% interactions during rewards were considered to have met conditioning
criteria and progressed to a fixed ratio of 3 (FR3), where 3 nosepokes were required to receive the
reward. After 3 days of FR3 (or 10 days of FR1 for mice who failed to reach criteria), mice were
tested in a progressive ratio of 3 (PR3), where the first reward was provided after 3 active
nosepokes and each subsequent reward required 3 additional nosepokes to obtain. The breakpoint
was measured as the number of rewards a mouse was able to acquire before 30 minutes of
nosepoke inactivity.

Conditioned Fear
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To assess associative and anxiety-related memory, mice were tested in a Conditioned Fear
task over 3 days following previously published methods.139,206,212 Shock sensitivity was evaluated
as we previously described.139

COHORT 3
Sensorimotor Battery
Adult mice were evaluated with a battery of sensorimotor measures to assess motor
initiation, balance, strength, and coordination using previously published methods.139,206 The
battery included walk evaluation of walk initiation, balance (Ledge and Platform tests), fine motor
coordination (Pole test), and strength with coordination (Inclined and Inverted Screen tests).

Rotarod
Motor coordination was assessed using the Rotarod following our previously published
methods.212 Briefly, latency to fall was measured for each mouse in three different situations: a
stationary rod (for up to 60 sec), a continuously rotating rod (3.0 rpms; for up to 60 sec), and an
accelerating rod (3.0-17 rpms; for up to 180 seconds).

Light/Dark Box
The Light/Dark Box was used to assess anxiety-related avoidance behavior leveraging the
mouse's innate preference for dark spaces. Mice were placed in the dark side of a chamber (47.6 x
25.4 x 20.6 cm) and were allowed to explore freely. The light side, which was twice as large as
the dark side, was illuminated at 65 lux with incandescent desk lamps. Beam brakes were used to
measure time spent in each chamber during the 20-minute task. Time spent in the light side was
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used as a proxy for anxiety-like behavior, with more anxious-like mice avoiding the brightly lit
open space.

3-Chamber Social Approach
Sociability and preference for social novelty were examined in the Social Approach task,
following our previously published methods.206 The mice received two, 10-min habituation trials:
first to the center chamber of the apparatus and then to the entire chamber including the empty
social investigation cups. Next, sociability was assessed for 10 min during which a novel age- and
sex-matched conspecific was placed under one cup (the side used was counterbalanced across
groups). During the fourth 10-min trial, a second, age- and sex-matched novel conspecific was
placed under the other cup to assess preference for social novelty. The time spent investigating
and number of investigations for each investigation cup, as well as time in and entries into each
chamber and total distance traveled, was quantified using Any-Maze video tracking software.

Tube Test of Social Dominance
As social creatures, mice create social hierarchies within their social groups. Thus,
laboratory mice acquire social hierarchical rank behaviors within their cage environments between
six-eight weeks of age, which can be leveraged to examine normal social dominance behavior. We
tested for this normal hierarchical behavior in our mice using the tube test for social dominance
following our previously described methods.206

Acoustic Startle/Pre-Pulse Inhibition Task
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Sensorimotor gating and startle reactivity were assessed using the Acoustic Startle/PrePulse Inhibition (PPI) task following our previously published methods.139,206 Briefly, acoustic
startle to a 120 dB auditory stimulus pulse (40 ms broadband burst) and PPI (response to a prepulse plus the startle pulse) were measured concurrently using computerized instrumentation
(StartleMonitor, Kinder Scientific) over 65 randomized trials. A percent PPI score for each trial
was calculated using the following equation: % PPI = (startle pulse alone − (pre-pulse + startle
pulse))/startle pulse alone × 100.

Resident Intruder
Male mice were single housed prior to testing, which was performed as previously
described.117,213 Briefly, after 10 days of single-housing to establish a territory, male cages were
placed in a sound-attenuating box in the dark. Using infrared illuminators, the task was recorded
by a digital camera on the night vision setting. Over three days, resident males received a different
C57BL/6J WT stimulus animal and interactions were allowed for 10 minutes.
For analysis, we used neural networks for pose estimation followed by random forest
classifiers from the pose estimates for classification of attack behaviors across each video, and
then compared counts of each attack by genotype using SPSS. The random forest classifier
program used was simple behavior annotator (simBA) version simba-uw-tf 0.85.3,214 and the
neural network used for body part tracking was deeplabcut (DLC), version 2.2rc3, using the
resnetv50.215
Specifically, we labeled 240 frames taken from 120 approximately ten-minute videos that
were converted from MTS to mp4 using ffmpeg. Each frame was labeled with sixteen unique body
parts, eight per animal as according to the simBA 16bp user manual. The DLC neural net trained
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using 80% of the labeled frames for approximately 370,000 iterations with default parameters.
With a p-cutoff of 0.9 the trained network was able to predict high confidence mouse body part
positions within 2.26 millimeters of human-labeled positions in the testing set, and the general
quality of labels were confirmed by visual inspection of several videos. Estimates of pose were
then exported to .csv for analysis by simBA. SimBA was trained to identify attack behavior
(resident attacking intruder, RI) using 180 annotated behavior files, downloaded from
https://osf.io/tmu6y/ in addition to four in-house annotated videos. All training files were
annotated according to definitions found in the simBA preprint.214
In addition to these RI annotated files, a custom script was created to reverse the direction
of attack in order to estimate instances of the intruder attacking the resident (IR). Both training
sets were trained using 6000 trees, 20% training set, Gini impurity function, number of estimators
equal to the squared number of features, and 1 min leaf. Probability thresholds for each model
were chosen based on a maximum F1 score curve from the testing set. To ensure IR and RI datasets
were mutually exclusive, a custom script was written to calculate the mean of random forest
probability of overlapping frames of RI and IR behaviors and keep only the behavior with the
larger mean probability across the overlap. Scoring by algorithms was visually inspected by trained
behaviorists for a subset of videos to confirm accuracy. Finally, we tested for group differences in
attacks in SPSS as described below. All custom code is available here upon request.

3.5.5 Data Analysis
Analyses were conducted in SPSS v27. Prior to analyses, data was screened for missing
values and fit of distributions with assumptions underlying univariate analysis. This included the
Shapiro-Wilk test on z-score-transformed data and qqplot investigations for normality, Levene’s

85

test for homogeneity of variance, and boxplot and z-score (±3.29) investigation for identification
of influential outliers. Means and standard errors were computed for each measure. All variables
were examined via 3-way ANOVA with Bonferroni correction to assess the effects of the CD and
TG alleles with sex included as a predictor. If appropriate, sex was dropped from the model to
achieve best fit. Weight was used as a covariate for data analysis in the Acoustic Startle/Pre-Pulse
Inhibition Task. For tasks with multiple timepoints measured per animal, a repeated measures
ANOVA was applied if no data points were missing, otherwise a linear mixed model was used
with the repeated predictor included as a random factor nested with subject to create hierarchy. To
achieve normality for a given variable, outliers with a z-score ± 3.29 were removed or a square
root transformation was applied. If normality could not be achieved and/or variance was not
homogenous, nonparametric analysis was performed. All graphed data represents the raw values
and the standard error of the mean.

Data Availability Statement
All data and detailed protocols are available upon reasonable request.
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3.7

Supplementary Tables

Table S1. Statistical information for Figure 1 – Molecular Validation
Figure Panel Method Target Genotype
WT
B
qPCR Gtf2ird1
TG
WT
C
Western Gtf2ird1
TG
WT
TG
E
qPCR Gtf2ird1
CD
TG/CD
1
WT
TG
F
qPCR
Gtf2i
CD
TG/CD
WT
TG
H
Western Gtf2ird1
CD
TG/CD

n
5
5
3
5
6
6
6
6
6
6
6
6
3

3
3
3

Sex n Mean
1.00
not sexed
1.65
1.05
not sexed
1.95
M,F 4,2 1.03
M,F 3,3 1.62
M,F 3,3 0.61
M,F 3,3 1.07
M,F 4,2 1.01
M,F 3,3 1.23
M,F 3,3 0.68
M,F 3,3 0.61
1.01
not sexed

SD
0.09
0.26
0.37
0.90
0.27
0.21
0.07
0.25
0.15
0.29
0.18
0.13

0.20
1.30 0.10
0.59 0.09
1.13 0.23

SEM

0.04
0.12
0.22
0.40
0.09
0.09
0.09
0.09
0.08
0.08
0.08
0.08
0.10
0.10
0.10
0.10

Age

Test

BY

Results

Notes

E13.5

t-test

Geno

t=-5.247, p<0.001

two-sided, equal variances
assumed

E13.5

t-test

Geno

t=-1.991, p=0.048

one-sided, equal variances not
assumed

main effect of Genotype;

P19/20 ANOVA Geno F(3,20)=22.190, p=0.000001 originally ran w/sex but no effect so
dropped from model

main effect of Genotype;

P19/20 ANOVA Geno F(3,20)=12.818, p=0.000068 originally ran w/sex but no effect so
dropped from model

P0/1
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ANOVA Geno

F(3,8)=9.918, p=0.005

main effect of Genotype
significant individual differences:
WT>CD, TG>CD, CD<TG/CD.

Table S2. Statistical information for Figure 2 – Sensorimotor Tasks

D

Distance travelled (m)
Time to Leave Square (s)

Open Field

Variable Geno

Time on Screen (s)

E

SMB:Walk

C

Task

SMB: Inverted Screen

Figure Panel

WT
TG
CD
TG/CD
WT
TG
CD
TG/CD
WT
TG
CD
TG/CD

Time on Pole (s)

I

SMB: Pole

WT
TG
CD
TG/CD

Time to Turn (s)

not
shown

SMB: Pole

WT
TG
CD

Average Success

J

SMB: Ledge

TG/CD
WT
TG
CD
TG/CD

PLAT

L

SMB

WT
TG
CD

Latency to Fall (s)

CD

Latency to Fall (s)

WT
TG
CD

Latency to Fall (s)

WT
TG
CD
TG/CD
WT

Marbles Buried

Rotarod: Continuous

TG

TG/CD

TG
CD
TG/CD
WT

Center Entries

R

WT

TG/CD

TG
CD
TG/CD

o 120 dB

Q

Rotarod: Accelerating

N/O

MARBLE BURYING

not
shown

MARBLE BURYING

not
shown

ibition

2

Rotarod: Stationary

TG/CD

WT

n Sex n
F 16
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 16
29
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 16
29
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 7
15
M 8

19

Mean
132.70
122.21
121.77
107.44
119.08
117.59
112.02
104.75
2.14
2.00
2.80
1.80
1.98
2.01
1.82
2.11
58.50
58.36
60.00
57.43
36.42
47.36
44.93
52.19
38.75
31.70
23.90
33.96
10.94
20.57
13.11
19.64
39.00
37.22
17.61
39.39
51.42
30.35
19.21
47.92
0.78
0.68
0.92
0.88
0.33
0.56
0.33
0.25
59.39
53.38
53.53
51.61
34.86
34.40
49.99
41.89
59.37
60.00
60.00
59.04
54.00
58.29
56.26
59.53
56.26
57.76
57.63
56.54
46.35
52.58
54.96
54.65
129.39
127.89
116.15
123.23
59.41
88.73
106.67
90.80
2.6
3.1
3.0
2.2
0.2
0.2
0.0
0.2
162.4
157.3
149.2
161.9
96.3
98.1
114.5
102.4
0.05
0.15
0.14

SD
25.46
16.65
19.55
25.71
36.32
33.84
25.58
33.18
1.65
1.04
1.86
0.76
2.07
1.37
0.76
0.99
4.50
5.43
0.00
7.26
14.63
18.20
12.67
11.32
24.06
35.02
18.54
35.07
5.52
20.85
5.02
17.01
26.48
37.26
18.32
49.76
36.12
28.47
26.55
45.73
0.26
0.46
0.19
0.23
0.35
0.50
0.25
0.26
1.83
11.35
10.12
12.41
21.44
18.55
14.06
20.68
1.38
0.00
0.00
2.71
6.64
4.83
5.22
1.48
4.02
4.50
3.24
2.83
11.69
6.85
4.99
3.95
28.41
13.86
37.50
16.20
24.25
24.45
32.53
29.95
3.4
3.5
3.5
1.8
0.4
0.6
0.0
0.4
35.9
25.6
31.4
40.6
30.5
29.5
25.0
26.0
0.04
0.06
0.04

SEM Cohort
Test
BY
6.35
4.62
CD x TG
ANOVA
x Sex
5.89
2
8.13
10.07
~P30
12.79
CD x TG
ANOVA
x Sex
9.04
8.30
0.55
0.31
CD x TG
ANOVA
x Sex
0.52
3
0.27
0.69
>P60
0.48
KruskalGroup
Wallis
0.25
0.31
1.50
1.64
KruskalGroup
Wallis
0.00
3
2.57
4.88
>P60
6.43
KruskalGeno
Wallis
4.22
3.58
8.02
10.56
KruskalGroup
Wallis
5.14
3
12.40
1.84
>P60
7.37
KruskalGeno
Wallis
1.67
5.38
8.83
11.23
ANOVA
Group
5.08
3
17.59
12.04
>P60
10.07
KruskalGroup
Wallis
8.85
14.46
0.11
0.10
CD x TG
ANOVA
x Sex
0.09
3
0.12
0.11
>P60
0.12
KruskalGeno
Wallis
0.11
0.10
0.61
3.42
KruskalGroup
Wallis
2.81
3
4.39
7.15
>P60
6.56
KruskalGeno
Wallis
4.69
6.54
0.56
0.00
CD x TG
ANOVA
x Sex
0.00
3
0.96
2.21
>P60
1.71
KruskalGroup
Wallis
1.74
0.47
1.34
1.36
CD x TG
ANOVA
x Sex
0.90
3
1.00
3.90
>P60
2.42
KruskalGeno
Wallis
1.66
1.25
9.47
4.18
CD x TG
ANOVA
x Sex
10.40
3
5.73
8.08
>P60
8.64
CD x TG
rmANOVA
x Sex
10.84
9.47
0.9
1.0
ANOVA CD x TG
1.1
2
0.6
0.1
~P35
0.2
KruskalGeno
Wallis
0.0
0.1
9.0
7.1
CD x TG
ANOVA
x Sex
9.5
2
12.8
8.5
~P35
11.2
ANOVA CD x TG
8.8
6.5
0.01
Geno x
0.02
Sex
ANOVA
WITH
0.01
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Results

Notes

HA: F(1,86)=3.639, p=0.06

no significant differences, even when removing insignificant
factors, but HA trends lower.

First 10 minutes: Sex: F(1,86)=5.366, p=0.023
First 20 minutes: Sex: F(1,86)=4.644, p=0.034
First 30 Minutes: HA: F(1,86)=3.978, p=0.049

sex effect only in 1st 10 or 20 minutes; HA effect in first 30
minutes, but not last 30 min.

No significant differences

Used sqrt - didn't fix normality issue though

H(7)=3.735, p = 0.810

Since sqrt didn't fix normality issues so K-W is most applicable
test.

H(7)=36.340, p<0.001

Pairwise comparisons: FCD < MTG, FWT, MWT, FTG; FTG/CD
< MWT,< FTG

H(3)=30.208, p<0.001

CD << WT p<0.001
CD << TG p<0.001
TG/CD << WT p=0.002
TG/CD << TG p<0.001

H(7)=22.347, p=0.002

FCD << F WT & F TG/CD; plus others

H(3)=16.709, p<0.001

CD - TG p = 0.002
CD - WT p<0.001
TG/CD - TG p = 0.05
TG/CD - WT p=0.014

TG*Sex: F(1,69)=5.352, p=0.024

sqrt transformed but still not normal;
F TG < M TG

H(7)=9.785, p=0.201

separating by trial, the second trial is more different, though
none are significant.

Main effect of CD: F(1,69)=34.964, p<0.001
CD*HA interaction: F(1,69)=4.684, p=0.034

CD and TG/CD are lower than WT and TG
TG/CD is lower than TG

H(3)=29.487, p<0.001

CD -WT p=0.033
TG/CD - WT p<0.001
TG/CD - TG p<0.001
CD - TG p<0.001

H(7)=18.527, p=0.01

M CD << F TG and M&F WT; FCD << FWT

H(3)=16.919, p<0.001

CD < TG/CD p=0.046
CD < TG p=0.001
CD < WT p<0.001
*partial rescue?

Sex effect: F(1,69)=5.176, p=0.026
CD effect: F(1,69)=10.541, p=0.002
Sex*CD: F(1,69)=6.159, p=0.016

not normal, violates levene's

H(7)=19.69, p=0.006

FCD < F WT & FTG, and all males
FTG/CD < FTG, MWT, MTG/CD
(only looking at Geno, CD < WT and TG)

CD effect: F(1,69)=13.738, p<0.001
TG effect: F(1,69)=4.179, p=0.045
CD*TG: F(1,69)=3.946, p=0.051

not normal, violates levene's

H(3)=12.304, p=0.006

CD<TG p=0.006, CD < WT p=0.002
TG/CD < WT p=0.045
not powered enough to see sex*cd rescue effect apparent in
graph.

CD effect: F(1,69)=35.227, p<0.001
CD*TG: F(1,69)=6.977, p=0.01
Sex*CD*TG: F(1,69)=4.461, p=0.038

mostly normal, a few exceptions; average is normal: FWT>FCD
p<0.001, MWT>MCDp=0.003, MTG>MCDTGp=0.016;
CDF<CDMp=0.032; CDF<CDTGFp<0.001; WT>CD p<0.001,
TG>TGCD p=0.021, CD<CDTGp=0.009

Main effect of trial, p<0.001
trial*CD p=0.03
trial*CD*TG*Sex p=0.025

later trials are less normal, all meet levene's; When split by sex,
only females have TG*CD interaction and only males have
trial*CD interaction. See right for graph - maybe use that instead
of these two? Though F TG 2a not normal

Significant effect of CD allele:
F(1,90)=46.170, p<0.001

used sqrt_MBAvgBuried; removed nonsig. Sex from model; still
not passing assumptions for ANOVA so see below.

H(3)=34.458, p<0.001

mean rank: WT 59.47, TG 64.45, CD 33.13, TG/CD 30.19;
individual comparisons: <0.001 for TG/CD-WT, TG/CD-TG, CDWT, CD-TG; WT-TG are not different, TG/CD-CD are not
different.

Significant effect of CD allele:
F(1,86)=67.793, p<0.001

raw values; 1 group (F TG had 0.026 for Shapiro-Wilkes but no
sex effect so that would disappear when collapsed)

Main effect of CD: F(1,90)=76.712, p<0.001

remove sex from model, lower mean square error

Sex: F(1,45)=0.37, p=0.546
Geno: F(1,45)=4.815, p=0.005

Once controlled for weight, sex effects disappear (except in WT
p=0.046), only females are different from each other:
WT < TG p<0.001

La

Rota

not
shown

21

CD

20

Center Entries

WT

29

TG

21

CD

20

Average Combined Startle Average Startle to 120 dB
(N)
(N)

WT

15

TG

16

CD

11

TG/CD 12
WT

15

TG

16

CD

11

TG/CD 12
WT

Average Percent
Inhibition of Startle

T

Pre-Pulse Inhibition

Pre-Pulse Inhibition

not
shown

29

TG

TG/CD 24

Pre-Pulse Inhibition

R

WT

TG/CD 24

MARBLE BURYING

Q

Marbles Buried

MARBLE BURYING

TG/CD 19

TG
CD

15
16
11

TG/CD 12

M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M

8 88.73
9 106.67
10 90.80
2.6
16
3.1
13
3.0
11
2.2
10
0.2
13
0.2
7
0.0
8
0.2
16
16 162.4
13 157.3
11 149.2
10 161.9
13 96.3
98.1
7
8 114.5
102.4
16
0.05
7
0.15
8
10 0.14
0.17
6
0.11
6
0.11
5
0.14
5
0.16
7
0.05
7
0.11
8
10 0.11
0.12
6
0.07
6
0.07
5
0.12
5
0.13
7
7 32.08
8 32.41
10 30.09
6 42.78
6 28.46
5 37.85
5 21.65
7 28.07

24.45 8.64
32.53 10.84
29.95 9.47
3.4
0.9
3.5
1.0
3.5
1.1
1.8
0.6
0.4
0.1
0.6
0.2
0.0
0.0
0.4
0.1
35.9
9.0
25.6
7.1
31.4
9.5
40.6 12.8
30.5
8.5
29.5 11.2
25.0
8.8
26.0
6.5
0.04 0.01
0.06 0.02
0.04 0.01
0.03 0.01
0.05 0.02
0.04 0.02
0.01 0.01
0.05 0.02
0.02 0.01
0.05 0.02
0.04 0.01
0.05 0.02
0.03 0.01
0.04 0.02
0.01 0.01
0.04 0.02
11.70 4.42
12.03 4.25
5.74 1.82
11.85 4.84
8.28 3.38
10.38 4.46
5.17 2.31
11.53 4.36

rmANOVA

CD x TG
x Sex

ANOVA

trial*CD p=0.03
trial*CD*TG*Sex p=0.025

only females have TG*CD interaction and only males have
trial*CD interaction. See right for graph - maybe use that instead
of these two? Though F TG 2a not normal

CD x TG

Significant effect of CD allele:
F(1,90)=46.170, p<0.001

used sqrt_MBAvgBuried; removed nonsig. Sex from model; still
not passing assumptions for ANOVA so see below.

KruskalWallis

Geno

H(3)=34.458, p<0.001

mean rank: WT 59.47, TG 64.45, CD 33.13, TG/CD 30.19;
individual comparisons: <0.001 for TG/CD-WT, TG/CD-TG, CDWT, CD-TG; WT-TG are not different, TG/CD-CD are not
different.

ANOVA

CD x TG
x Sex

Significant effect of CD allele:
F(1,86)=67.793, p<0.001

raw values; 1 group (F TG had 0.026 for Shapiro-Wilkes but no
sex effect so that would disappear when collapsed)

ANOVA

CD x TG

Main effect of CD: F(1,90)=76.712, p<0.001

remove sex from model, lower mean square error

ANOVA

Geno x
Sex
WITH
Weight

Sex: F(1,45)=0.37, p=0.546
Geno: F(1,45)=4.815, p=0.005
Geno*Sex: F(1,45)=2.671, p=0.059

Once controlled for weight, sex effects disappear (except in WT
p=0.046), only females are different from each other:
WT < TG p<0.001
WT < CD p=0.017
WT < TG/CD p=0.002

rmANOVA

CD x TG
x Sex
WITH
Weight

Sex: F(1,45)=0.37, p=0.546
CD: F(1,45)=0.445, p=0.508
TG: F(1,45)=12.898, p<0.001
Trial*CD*TG: F(3,135)=4.787, p=0.003

FWT < FCD p=0.017
FWT < TG p<0.001
Borderline CD*Sex (0.074) and CD*TG*Sex effects (0.081)

rmANOVA

CD x TG
x Sex
WITH
Weight

Sex: F(1,45)=1.555, p=0.219
CD: F(1,45)=1.805, p=0.186
TG: F(1,45)=20.69, p<0.001
Sex*CD*TG: F(1,45)=6.295, p=0.016

KruskalWallis

Group

H(7)=21.133, p=0.004

FWT - M WT 0.008, MTG 0.01, F TG 0.001, F TG/CD 0.006, M
TG/CD <0.001
MCD - MTG/CD 0.017
FCD - FTG 0.048, M TG/CD 0.015

rmANOVA

CD x TG
x Sex
WITH
Weight

Sex: F(1,45)=2.538, p=0.118
CD: F(1.45)=3.511, p=0.067
TG: F(1,45)=0.636, p=0.429
CD*TG: F(1,45)=5.227, p=0.027

Not all individual sections are normal, but over all they are;
TG > TG/CD p=0.007
CD > TG/CD p=0.048
TG vs TG/CD sig at each level
CD vs TG/CD sig at trials 1 and 2

KruskalWallis

Group

H(7)=12.787, p=0.077

2
~P35

2
~P35

3
>P60

3
>P60

3

FWT < FTG p<0.001
MCD < MCDTG p=0.001
Test weight is also significant - is that bad? Also, data not all
normal, levens at 0.02 6 for one

>P60

TG
CD
TG/CD
WT
TG
CD
TG/CD
WT
TG
CD
TG/CD
WT
TG
CD
TG/CD
WT
TG

SEM Cohort Test BY
2.0
2.8
1.5
2
CD x
4.4
TG x
1.6
~P30
Sex
3.5
3.2
2.4
0.002
CD x
0.001
TG x
0.002
Sex
2
0.002
0.003
~P30
0.004
0.003
0.002
0.005
CD x
0.005
TG x
0.004
Sex
2
0.006
0.008
~P30
0.007
0.010
0.006
0.001
CD x
0.002
TG x
0.001
Sex
2
0.002
0.002
~P30
0.004
0.002
0.002
0.9
0.9
1.0
2
CD x
1.0
TG x
1.2
~P37
Sex
1.2
1.0
0.8
2.9
2.1
2.7
3
2.7
CD x
TG
3.3
adult
3.1
1.3
1.7
3.3
CD x
2.0
adult
TG x
3.3
Sex
3.5

TG: F(1,86)=3.682, p=0.058

no overall distances in velocity
(not shown);

Main effect of trial p<0.001

If only looking at the first 20
minutes, there is a sex effect
here (0.034), especially in first 10
min (0.016)

Main effect of Sex: F(1,86)=19.699, p<0.001
Main effect of CD: F(1,86)=6.107, p=0.015

Both sexes generally move faster
in the center but females still
move faster than males in the
center; CD moving faster than
WT

Main effect of trial p<0.001
Main effect of Sex: F(1,74)=23.195, p<0.001

some blank values because
animals spent 0 time in Center
during some bins

Main effect of TG: F(1,86)=6.052, p=0.016

TG allele slower than WT
allele…interestingly no sex effect
here - only center.

Main effect of trial p<0.001
Main effect of TG: F(1,86)=6.901, p=0.01

TG effect driven by first 30
minutes

no significant factors

Using raw values

no significant factors

used sqrt transformation

Significant CD*TG Interaction:
F(1,73)=424.277, p=0.011
Individual differences: WT - CD p=0.011, CD TG/CD p=0.026

Using raw values; F TG and M
TG were non-normal; variance
was okay; no effect of sex so it
was removed from the model to
decrease mean square error

Significant CD*TG Interaction:
F(1,73)=7.460, p=0.008
Individual differences: WT - CD p=0.009, CD TG/CD p=0.018

used
sqrt_RelativePercent_LITTM to
correct for two non-normal
groups (M/F TG). No sex effect,
removed from model.

Main effect of Sex: F(1,85)=5.944, p=0.017

raw data; minutes 3-5 of day 1,
training pTGse; F freeze more
tTGn M

ANOVA

used sqrt transformation

ANOVA

WT

Main effect of Sex: F(1,86)=12.210, p<0.001
Main effect of CD: F(1,86)=13.175, p<0.001
Main effect of TG: F(1,86)=7.935, p=0.006

rmANOVA

TG/CD

Using raw values

ANOVA

CD

Notes

rmANOVA

TG

Results
Main effect of Sex: F(1,86)=13.240, p<0.001
Main effect of CD: F(1,86)=11.962, p<0.001
Main effect of TG: F(1,86)=6.685, p=0.011

ANOVA

TG/CD

SD
8.0
10.0
4.8
13.9
5.9
9.3
9.1
9.7
0.007
0.005
0.005
0.007
0.010
0.009
0.007
0.009
0.020
0.017
0.014
0.019
0.028
0.020
0.029
0.025
0.006
0.006
0.005
0.007
0.008
0.011
0.006
0.008
3.8
3.1
3.4
3.3
4.3
3.1
2.7
3.3
8.7
7.1
9.7
7.6
10.0
8.7
3.9
5.4
13.2
7.3
11.0
11.2

ANOVA

CD

Mean
23.5
32.4
19.4
24.4
15.7
24.7
13.5
18.9
0.037
0.034
0.034
0.030
0.033
0.033
0.031
0.029
0.064
0.046
0.070
0.053
0.078
0.052
0.086
0.063
0.030
0.031
0.026
0.026
0.026
0.029
0.025
0.024
6.7
6.5
6.5
5.0
6.5
6.2
6.4
5.8
49.2
51.3
46.4
48.0
43.5
43.7
52.6
46.9
28.5
18.4
31.0
18.9

ANOVA

TG

n Sex n
F 16
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 16
29
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 16
29
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 16
29
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 16
29
M 13
F 11
21
M 10
F 13
20
M 7
F 8
24
M 16
F 9
20
M 11
F 13
21
M 8
F 9
17
M 8
F 9
19
M 10
F 16
29
M 13
F 11
21
M 10

29

89

ANOVA

Percent Time in Center
Velocity (m/s)
Center Velocity (m/s)
Perimeter Velocity (m/s)
Percent Time in Open
Arms

OPEN FIELD/1-HR
ACTIVITY

Percent Time in Light
Side

G

e Freezing ing

3

OPEN FIELD/1-HR
ACTIVITY

E

OPEN FIELD/1-HR
ACTIVITY

not
shown

OPEN FIELD/1-HR
ACTIVITY

not
shown

WT

WT

ELEVATED PLUS MAZE

not
shown

Variable Geno

LIGHT/ DARK BOX

A/B

Task

ED FEAR

Figure Panel

rmANOVA

Table S3. Statistical information for Figure 3 – Anxiety and Fear-Related Tasks

21

CD

17

TG/CD 19
WT

29

TG

21

CD

19

TG/CD 24
WT

29

TG

21

CD

19

TG/CD 24
WT

29

TG

21

CD

19

TG/CD 24
29

TG

21

CD

19

TG/CD 24

ANOVA
ANOVA

TG

CD x
TG

adult

ANOVA

20

CD x
TG x
Sex

adult

ANOVA

WT

CD x
TG x
Sex

adult

ANOVA

TG/CD 24

~P37

CD x
TG x
Sex

adult

ANOVA

20

CD x
TG x
Sex

adult

CD x
TG x
Sex

adult

CD x
TG x
Sex

adult

CD x
TG x
Sex

adult

Group

3
adult

no significant factors

Using raw values

no significant factors

used sqrt transformation

Significant CD*TG Interaction:
F(1,73)=424.277, p=0.011
Individual differences: WT - CD p=0.011, CD TG/CD p=0.026

Using raw values; F TG and M
TG were non-normal; variance
was okay; no effect of sex so it
was removed from the model to
decrease mean square error

Significant CD*TG Interaction:
F(1,73)=7.460, p=0.008
Individual differences: WT - CD p=0.009, CD TG/CD p=0.018

used
sqrt_RelativePercent_LITTM to
correct for two non-normal
groups (M/F TG). No sex effect,
removed from model.

Main effect of Sex: F(1,85)=5.944, p=0.017

raw data; minutes 3-5 of day 1,
training pTGse; F freeze more
tTGn M

Main effect of Sex: F(1,85)=5.606, p=0.02

sqrt transformation: FCD .032
SW,

Main effect of Sex: F(1,85)=4.599, p=0.035

raw data; minutes 1-8 of day 2; F
freeze more tTGn M;
underpowered to see
Sex*CD*TG interaction?

Main effect of Sex: F(1,85)=5.650, p=0.02

used sqrt transformation; 0.016
WTF, MCD 0.01 SW;

Main effect of TG: F(1,85)=29.860, p<0.001
TG*Sex Interaction: F(1,85)=11.861, p<0.001

raw data; minutes 2-10 of day 3;
TG allele increases freezing,
especially in F

Main effect of TG: F(1,85)=28.497, p<0.001
TG*Sex Interaction: F(1,85)=11.876, p<0.001

sqrt transformation; 0.056 MWT
SW; likely unnecessary to use
sqrt as SW not sig

CD*Sex Interaction: F(85)=6.540, p=0.012

RAW DATA; CD F < CD M

H(7)=14.778, p=0.039

sqrt doesn't fix normality issues,
but no individual group
differences withstand Bonferonni
correction.

CD x
TG x
Sex

ANOVA

CD

2

ANOVA

21

ANOVA

TG

16 0.024 0.008 0.002
3.8
0.9
16 6.7
3.1
0.9
13 6.5
3.4
1.0
11 6.5
3.3
1.0
10 5.0
4.3
1.2
13 6.5
6.2
3.1
1.2
7
6.4
2.7
1.0
8
3.3
0.8
16 5.8
8.7
2.9
9 49.2
7.1
2.1
11 51.3
9.7
2.7
13 46.4
7.6
2.7
8 48.0
3.3
9 43.5 10.0
8.7
3.1
8 43.7
3.9
1.3
9 52.6
5.4
1.7
10 46.9
3.3
16 28.5 13.2
7.3
2.0
13 18.4
3.3
11 31.0 11.0
3.5
10 18.9 11.2
3.2
13 23.2 11.5
7.7
6 26.6 19.0
3.5
8 36.4 10.0
3.4
16 29.3 13.8
2.9
16 18.1 11.4
6.5
1.8
13 11.6
9.9
3.0
11 19.2
3.2
10 15.2 10.2
7.7
2.1
13 11.6
5.1
6 12.0 12.4
5.8
2.0
8 17.8
7.2
1.8
16 11.0
3.6
16 29.5 14.5
2.9
13 32.7 10.5
5.4
11 51.1 17.9
3.6
10 36.8 11.5
8.1
2.2
13 19.8
5.3
6 30.0 13.1
5.0
8 50.0 14.3
3.6
16 37.6 14.3
0.0
16 0.1
0.0
13 0.1
0.0
11 0.2
0.0
10 0.2
0.0
13 0.1
0.2
0.0
6
0.1
0.0
8
0.0
16 0.2

KruskalWallis

Percent Time in Open
Arms
Percent Time in Light
Side
Percent Time Freezing Training
Percent Time Freezing Context
Percent Time Freezing Cue

29

WT

FLINCH

not
shown

ELEVATED PLUS MAZE

J/K

LIGHT/ DARK BOX

I

CONDITIONED FEAR

H

CONDITIONED FEAR

G

CONDITIONED FEAR

3

SHOCK SENSITIVITY

E

WT

M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M

Table S4. Statistical information for Figure 4 – Social Behavior Tasks

not
shown

Number of Calls

USV

n

Sex

WT

111 Age

TG

69

Age

CD

72

Age

TG/CD 66

Age

WT

35

Age

TG

21

Age

CD

23

Age

TG/CD 22

Age

Weight
Average Time to Right (s)
Percent Wins

E

USV

D

Righting Reflex

C

Task Variable Geno

Tube Test

Figure Panel

WT

18

TG

14

CD

17

TG/CD 18
WT

20

TG

21

CD

17

TG/CD 19

F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M

n
5
7
9
5
7
9
5
7
9
5
7
9
5
7
9
5
7
9
5
7
9
5
7
9
8
10
8
6
9
8
10
8
9
11
13
8
9
8
9
10

Mean
95.89
131.1
100.4
67.43
100.5
87.95
31.17
107.8
91.46
28.6
50.1
25.97
3.056
3.987
4.897
3.075
3.924
4.7
2.651
3.412
4.129
2.713
3.485
4.182
1.11
0.98
0.90
0.80
0.93
0.76
0.81
1.04
63.0
24.2
17.9
62.5
18.5
45.8
18.5
33.3

SD SEM Age
Test
BY
Results
Notes
13.7
13.7
Linear Geno x Geno: F(3,125.549)=7.892, p<0.001
13.9
Sex was not significant (p=0.112)
mixed
Age x
Geno*Age: F(8,217.406)=3.068,
WT >> than CD & TG/CD at all ages.
17.3
model
Sex
p=0.003
17.3
1
17.3
16.9
P5/7/9
16.9
16.9
n here represented each animal by each day; divide by 3 for number of animals
not sure if mean is affected by that distinction or not.
17.7
17.7
17.7
0.43 0.08
0.53 0.1
weight increases over time (Day)
0.62 0.12
F(3,97)=7.375, p<0.001
WT - CD p=0.001
rmANOVA Geno
Day and Day*Geno effects
0.5 0.1
WT - TG/CD p=0.005
0.61 0.12
1
0.72 0.15
0.39 0.1
P5/7/9
0.5 0.12
0.65 0.14
0.52 0.1
0.64 0.12
0.8 0.15
0.73 0.26
0.53 0.17
KruskalNormality and variance violations precluded
Geno
H(3)=0.595, p=0.898
parametric testing.
Wallis
0.29 0.10
1
0.18 0.08
0.26 0.09
P14
Group
0.14 0.05
KruskalNo differences.
(Geno*
H(7)=4.848, p=0.679
Wallis
0.17 0.05
Sex)
0.35 0.12
14.1
F CD - F WT p=0.009
F TG - F WT p=0.006
6.5
KruskalF TG - M TG p=0.002
Group
H(7)=19.356, p=0.007
Wallis
7.2
F TGCD - F WT p=0.014
3
and more
7.6
11.3
adult
Female: H(3)=8.339, p=0.04
Female: CD-WT 0.016, TG-WT 0.012,
15.3
KruskalTG/CD - WT 0.028
Geno
Wallis
8.1
Male: TG-WT 0.007, TG/CD-WT 0.047
Male: H(3)=7.797, p=0.05
8.1

90

USV

21

Age

CD

23

Age

TG/CD 22

Age

Weight
Average Time to Right (s)

E

Righting Reflex

D

TG

WT

18

TG

14

CD

17

TG/CD 18

Percent Wins

not
shown

Tube Test

WT

20

TG

21

CD

17

I

J

not
shown

M

TTDay 1 Wins Ratio
Average Attacks by
Resident

Resident Intruder

WT

20

TG

21

CD

17

TG/CD 19
WT

11

TG

7

CD

8

TG/CD 10
WT

29

TG

21

CD

20

TG/CD 24
WT

28

TG

21

CD

20

TG/CD 24
WT

29

TG

21

CD

20

TG/CD 24
WT

29

TG

21

CD

20

TG/CD 24
WT

28

TG

21

CD

20

TG/CD 24
WT

29

TG

21

CD

20

N

Investigation Bout
(s)

TG/CD 24

VEL OBJECT
VOIDANCE

4

Mean Novel Iinvestigation Mean Social Iinvestigation Social Investigation at 15 Novel Investigation Time Social Investigation Time
(%)
(%)
min bin
Bout (s)
Bout (s)

not
shown

Percent Time in
Investigation Zone

H

Modified Social Approach Modified Social Approach Modified Social Approach Modified Social Approach Modified Social Approach

G

NOVEL OBJECT
AVOIDANCE

F

Tube Test

TG/CD 19

WT

29

TG

21

CD

20

F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F

5
7
9
5
7
9
5
7
9
8
10
8
6
9
8
10
8
9
11
13
8
9
8
9
10
9
11
13
8
9
8
9
10

3.075
3.924
4.7
2.651
3.412
4.129
2.713
3.485
4.182
1.11
0.98
0.90
0.80
0.93
0.76
0.81
1.04
63.0
24.2
17.9
62.5
18.5
45.8
18.5
33.3
0.7
0.5
0.3
0.9
0.2
0.4
0.3
0.5

0.5
0.61
0.72
0.39
0.5
0.65
0.52
0.64
0.8
0.73
0.53
0.29
0.18
0.26
0.14
0.17
0.35

0.5
0.5
0.5
0.4
0.4
0.5
0.5
0.5

0.1
0.12
1
0.15
0.1
P5/7/9
0.12
0.14
0.1
0.12
0.15
0.26
0.17
KruskalWallis
0.10
1
0.08
0.09
P14
0.05
KruskalWallis
0.05
0.12
14.1
6.5
KruskalWallis
7.2
3
7.6
11.3
adult
15.3
KruskalWallis
8.1
8.1
0.2
0.2
ANOVA
0.1
3
0.1
0.1
adult
0.2
KruskalWallis
0.2
0.2

11

12.0

13.7

4.1

7

8.0

11.8

4.4

8

14.4

16.7

5.9

10
16
13
11
10
13
7
8
16
15
13
11
10
13
7
8
16
16
13
11
10
13
7
8
16
16
13
11
10
13
7
8
16
15
13
11
10
13
7
8
16
16
13
11
10
13
7
8
16
16
13
11
10
13

16.5
36.9
35.0
41.6
42.4
42.7
42.8
37.8
44.6
31.4
22.3
24.0
37.2
31.5
38.0
30.7
33.2
80.3
87.7
110.6
121.4
122.4
115.3
111.6
131.5
6.4
6.5
7.7
7.8
10.6
8.5
7.2
9.6
5.1
4.4
5.3
5.8
6.4
7.2
4.4
6.1
6.2
7.3
6.6
8.3
5.2
6.5
5.7
7.4
0.9
0.9
0.9
0.9
1.2

17.7
8.5
8.3
9.2
12.0
11.1
4.2
7.2
14.3
12.4
11.7
7.3
14.4
10.9
14.5
14.4
14.3
27.2
44.0
33.7
50.8
67.4
28.5
37.7
53.6
2.4
3.0
2.7
3.2
6.2
2.7
1.0
4.5
1.7
1.6
2.0
2.1
4.1
4.3
1.8
4.2
1.9
1.4
2.3
1.9
1.2
2.4
1.6
2.8
0.2
0.2
0.1
0.2
0.4

5.6
2.1
2.3
~P33
2.8
3.8
3.1
1.6
2.6
3.6
3.2
3.2
2.2
4.6
3.0
5.5
5.1
3.6
11.9
12.8
13.9
14.6
12.8
17.4
16.3
11.5
0.6
0.8
0.8
1.0
1.7
1.0
0.3
1.1
0.4
0.5
0.6
0.7
1.1
1.6
0.7
1.1
0.5
0.4
0.7
2
0.6
0.3
~P35
0.9
0.6
0.7
0.0
0.1
0.0
2
0.1
0.1
~P35

ANOVA

Day and Day*Geno effects

WT - TG/CD p=0.005

Geno

H(3)=0.595, p=0.898

Normality and variance violations precluded
parametric testing.

Group
(Geno*
Sex)

H(7)=4.848, p=0.679

No differences.

Group

H(7)=19.356, p=0.007

F CD - F WT p=0.009
F TG - F WT p=0.006
F TG - M TG p=0.002
F TGCD - F WT p=0.014
and more

Female: H(3)=8.339, p=0.04
Geno
Male: H(3)=7.797, p=0.05
CD x
TG x
Sex

Female: CD-WT 0.016, TG-WT 0.012,
TG/CD - WT 0.028
Male: TG-WT 0.007, TG/CD-WT 0.047

CD: F(1,69)=3.793, p=0.056
violates levene's & normality so not best test
Sex*TG: F(1,69)=3.13, p=0.081
but only way to see interaction effects?
Sex*CD*HA: F(1,69)=2.914, p=0.092

Group

H(7)=11.102, p=0.134

not significant but perhaps underpowered
due to potential sex*geno effects?

CD x
TG

CD: F(1,32)=1.167, p=0.288
TG: F(1,32)=0.03, p=0.864
CD*HA: F(1,32)=0.202, p=0.656

Mutually exclusive numbers (i.e. either R or I
attacks)
no significant differences - likely due few
animals actually engaging in attacks.

3
adult

remove non-attackers? Check to see how
attackers fared in Tube Test

ANOVA

CD x
TG x
Sex

No significant differences
CD*HA: F(1,86)=2.970, p=0.088

Not significant but perhaps underpowered to
find social effects, which are less
straightforward; The insignificant CD*HA
interaction is driven by females, which may
be misled by low TG/CD female n.

KruskalWallis

Geno

H(3)=8.916, p=0.03
Individual differences from WT:
TG: p=0.039, CD: p=0.013, TG/CD
p=0.016

one group violated normality, so ran
nonparametric analysis on Genotype alone
since no sex effect observed in ANOVA;
difference driven by 3rd timebin (10-15min)

Sex*CD*HA Interaction:
F(1,85)=5.893, p=0.017

Just looking at Novel Investigation Time; WT
M << CD M
WT M << TG M
HA F << HA M
appears only Males have higher?

H(7)=13.238, p=0.067

Perhaps Gtf2ird1 plays a larger role in M
social behavior?? Though underpowered to
see such effects clearly across all tasks.

ANOVA

CD x
TG x
Sex

KruskalWallis

Group

H(7)=14.366, p=0.045

incorporates sex

KruskalWallis

Geno

H(3)=13.160, p=0.004

eliminates sex; WT-TG p=0.009, WT-CD
p=0.014, WT-TG/CD p=0.001. Looks like
overexpression of TG allele has biggest
effect in this case??? Why - MvF n
probably...?

KruskalWallis

Group

H(7)=13.670, p=0.057

KruskalWallis

Geno

H(3)=12.574, p=0.006

WT << CD p=0.001
WT << TG/CD p=0.006

KruskalWallis

Group

H(7)=6.902, p=0.439

no differences

KruskalWallis

Geno

H(3)=3.072, P=0.381

no differences; similar visual trend but
perhaps stress dampened towards the floor
decreasing our ability to detect a difference.
It almosts looks like TG allele rescues in F
but not in M?? But hard to say because of
sample size.

ANOVA

CD x
TG x
Sex

Main effect of Sex: F(1,86)=11.069,
p<0.001
Main effect of CD: F(1,86)=4.203,
p=0.043

using raw values; some groups were slightly
non-normal (p<0.05 but >0.01), so also ran
sqrt transformation.

ANOVA

CD x
TG x
Sex

Main effect of Sex: F(1,86)=11.901,
p<0.001
Main effect of CD: F(1,86)=4.933,
p=0.029

used sqrt transformation

CD x
TG x
Sex

Main effect of CD: F(1,86)=11.013,
p=.001

raw values; assumptions for normality are
not met.
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ANOVA

Modified Social Approach

Mean Novel Iinvestigation
Bout (s)
Percent Time in
Investigation Zone

M

NOVEL OBJECT
AVOIDANCE

not
shown

WT

28

TG

21

CD

20

TG/CD 24
WT
TG
CD

29
21
20

U

Mean Investigation Bout
(s)
Social Cup Preference
Index

3-Chamber Social
Approach
3-Chamber Social
Approach

Novel Cup Preference
Index
Total Rewards (FR1
Mean)
Total Rewards (FR3)

T

Breakpoint (Learners)

S

Social Operant

not
shown

Social Operant

O/P

Social Operant

N

NOVEL OBJECT
AVOIDANCE

TG/CD 24
WT
TG
CD

29
21
20

TG/CD 24
WT

19

TG

21

CD

15

TG/CD 19
WT

19

TG

21

CD

15

TG/CD 19
WT
TG
CD
TG/CD
WT
TG
CD

18
12
13

TG/CD

9

WT

18

TG

12

CD

13

TG/CD

9

M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M

16
15
13
11
10
13
7
8
16
16
13
11
10
13
7
8
16
16
13
11
10
13
7
8
16
9
10
13
8
9
6
9
10
9
10
13
8
9
6
9
10
16
13
13
11
13
9
7
16
8
10
6
6
9
4
3
6
8
10
6
6
9
4
3
6

9.6
5.1
4.4
5.3
5.8
6.4
7.2
4.4
6.1
6.2
7.3
6.6
8.3
5.2
6.5
5.7
7.4
0.9
0.9
0.9
0.9
1.2
1.1
1.1
1.1
8.0
19.7
8.3
18.7
16.5
28.2
21.2
27.4
20.8
37.9
19.8
16.7
27.5
45.3
30.7
29.1
24.9
23.2
20.7
17.4
27.2
29.1
23.1
24.1
28.5
21.2
30.5
17.6
24.1
28.6
29.8
29.8
27.4
24.3
26.0
22.5
27.7
29.3
28.0
29.5

4.5
1.7
1.6
2.0
2.1
4.1
4.3
1.8
4.2
1.9
1.4
2.3
1.9
1.2
2.4
1.6
2.8
0.2
0.2
0.1
0.2
0.4
0.3
0.3
0.4
9.9
19.1
20.2
22.6
13.7
21.0
21.2
14.1
25.1
11.8
22.2
25.8
24.0
11.5
26.6
25.3

1.1
0.4
0.5
0.6
0.7
1.1
1.6
0.7
1.1
0.5
0.4
0.7
0.6
0.3
0.9
0.6
0.7
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
3.3
6.0
5.6
8.0
4.6
8.6
7.1
4.5
8.4
3.7
6.2
9.1
8.0
4.7
8.9
8.0
3.1
1.3
1.9
1.6
2.8
4.0
4.5
3.5
4.7
2.5
5.4
2.2
3.0
3.4
3.8
1.8
1.4
1.7
3.7
1.4
2.6
1.4
4.0
1.4

KruskalWallis

Group

H(7)=6.902, p=0.439

no differences

KruskalWallis

Geno

H(3)=3.072, P=0.381

no differences; similar visual trend but
perhaps stress dampened towards the floor
decreasing our ability to detect a difference.
It almosts looks like TG allele rescues in F
but not in M?? But hard to say because of
sample size.

ANOVA

CD x
TG x
Sex

Main effect of Sex: F(1,86)=11.069,
p<0.001
Main effect of CD: F(1,86)=4.203,
p=0.043

using raw values; some groups were slightly
non-normal (p<0.05 but >0.01), so also ran
sqrt transformation.

ANOVA

CD x
TG x
Sex

Main effect of Sex: F(1,86)=11.901,
p<0.001
Main effect of CD: F(1,86)=4.933,
p=0.029

used sqrt transformation

ANOVA

CD x
TG x
Sex

Main effect of CD: F(1,86)=11.013,
p=.001

raw values; assumptions for normality are
not met.

KruskalWallis

Geno

H(3)=11.271, p=0.010

on raw values; main effect of CD (higher
mean bout than WT)

ANOVA

CD x
TG x
Sex

Main effect of Sex: F(1,66)=5.414,
p=0.023
Main effect of CD: F(1,66)=4.99,
p=0.029

Males have higher pref index than females,
23.504 > 13.501
CD allele > WT allele pref index, 23.305 >
13.700

ANOVA

CD x
Sex

Sex: F(1,71)=6.061, p=0.016
CD: F(1,71)=5.527, p=0.022

removed TG allele, Mean square error is 306
lower than 327 is better fit

ANOVA

CD x
TG x
Sex

no significant differences
CD: F(1,69)=3.299, p=0.074
TG: F(1,69)=2.959, p=0.09
Sex*TG: F(1,69)=3.607, p=0.062

Mean square error examining all interactions
is 508.585; eliminate factors that aren't
contributing; trimmed to Sex, CD, TG,
Sex*TG; mean square error 487.886. Still
high error, but better fit.

ANOVA

CD x
TG

Main effect of TG: F(1,30)=6.914,
p=0.013

Split by Sex, showing Male results only female results insignificant. MWT > MTG

KruskalWallis

Geno

H(3)=7.961, p=0.047

INCLUDES LEARNERS & NONLEARNERS:
TG - CD 0.005; TG - WT 0.069, so likely
underpowered to see effects here, especially
if effects are only in males vs females.

ANOVA

CD x
TG x
Sex

Main effect of CD: F(1,47)=14.07,
p<0.001

LEARNERS ONLY. Levene's is satisfied with
sqrt of values; effect seems driven by males
(only M sig when split, but not enough power
to tell sex interaction effects).

ANOVA

CD x
TG x
Sex

CD*Sex interaction: F(1,44)=4.932,
p=0.032

CD greater than WT alleles; specifically M
WT vs MCD 0.015; and WT F vs M 0.006,
so we're missing a sex diff with CD allele.

ANOVA

CD x
TG x
Sex

Main effect of CD: F(1,22)=12.752,
p=0.002

Males Only

ANOVA

CD x
TG x
Sex

F(1,46)=4.405, p = 0.041 (CD allele)

CD TG Sex CD*Sex CD*TG; removed all
interactions with TG from model (TG*Sex
and CD*TG*Sex). Better fit, lower
MeanSquare error.

H(3)=8.092, p=0.044

LEARNERS - MALES
TG - CD p=0.05
TG-TG/CD p=0.029
WT - TG/CD p=0.04
WT-CD p=0.074 (likely underpowered)

2
~P35

2
~P35

3
adult

3
adult

2
adult

2
adult

2
adult
KruskalWallis
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Geno

Chapter 4: CONCLUSION
4.1

Summary and Significance
In this thesis, I have contributed the first manipulation of the oxytocin system in the context

of WS to directly test the oxytocin hypothesis in mice. An oxytocin antagonist had no significant
effect on fear learning and recall, despite the differences present in contextual and cued recall in
the CD mice. Interestingly, the exact phenotypes of the CD shown in Chapter 2 were not
recapitulated during our deep characterization of the model in Chapter 3, suggesting that the
Conditioned Fear task may be sensitive to other elements, making its reliability less than ideal. It
is possible the baseline stress created by daily injections within the first study interfered with the
expression of the phenotype. As the effect of oxytocin is known to be modulated by estrogen, and
estrogen is sensitive to the stress response, it is not out of the question that stress prevented
modulation of the phenotype by oxytocin. This outcome showed me it was important to fully
characterize the CD model to better understand its phenotypic features so that future mechanistic
studies will be more productive.
In Chapter 3, I completed this thorough characterization of the CD mouse modeling the
most common WS deletion. Given the struggle to show a social phenotype in any WS mutants in
our hands previously,117,139 it was reassuring to find that social approach measures were
consistently increased across tasks and correlated with social motivation increases. Compared to
our prior work,117,139 the expression of a hypersocial phenotype here but not in the previous papers
are most likely due to strain differences; the relative hyperactivity of the FVB/AntJ x C57BL/6J
hybrids we used previously could have interfered with our ability to see differences that were
apparent on the typical C57BL/6J background. Indeed, such strain affects have been documented
in other behavioral paradigms, such as those measuring activity and anxiety-like behaviors.216
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Thus, it would be interesting to further explore the effects of strain within the context of the WS
deletion, and this approach may yield even more information about how the rest of the genome
influences social behaviors, or other unreproducible findings, and provide insight into the
complexity and origins of the variability of the human phenotypes observed.
Within the context of the full deletion, we were also able to see clear roles for Gtf2ird1 in
sensorimotor and anxiety domains, though not in any social behaviors, which aligns with previous
studies implicating Gtf2i and not Gtf2ird1 in the social phenotype of WS. We were also able to
highlight effects of imbalanced Gtf2ird1 expression relative to the rest of the typical WS deletion
in the high reactivity to sound stimuli apparent in the acoustic startle and cued recall elements of
our suite of tasks. This work provides further evidence for Gtf2ird1’s role in sensory processing
or integration, especially of sound, which may give insight into the specific phobias of WS that
are often correlated with loud noises. In the future, it would also be interesting to study the impact
of Gtf2i duplication more fully and assess the effect of a Gtf2i rescue on the phenotypes I show in
the CD model; unfortunately, the BAC transgenic mice meant to overexpress Gtf2i did not produce
protein (data not shown), and I was unable to test it here.

4.2

Future Directions
In addition to its utility for modeling the single gene duplication of Gtf2ird1 and rescuing

expression in CD mutants, this same transgenic mouse line might have use as a molecular tool to
study the basic biology of the role of Gtf2ird1 isoforms in gene regulation. Specifically, the novel
Gtf2ird1 line could be the ideal tool to tease apart potential differences in the alternatively spliced
isoforms of the protein. This is because the HA tag on the exogenous Gtf2ird1 is only found on a
subset of the isoforms, due to alternative splicing of the last exons. Using antibodies specific to
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the HA-tagged isoforms, ChIP-seq analysis could indicate targets that are specific to the different
isoform variants, when compared to the overall binding of GTF2IRD1 (tagged or not).
In addition, further investigation of sensory processing and integration is implicated in the
results of my comprehensive study of the WS-relevant models. Sensitivity to light and sound may
be interfering with other measures and teasing apart their influence will help us better understand
the mechanisms underlying behavioral differences, especially those that rely on external stimuli to
successfully respond. In WS, balance deficits are present and are more apparent (compared to the
non-WS population) when individuals use their eyes, which requires integrating the sensory
information to coordinate movement.43 In mice, it is possible sensory integration of information
from the whiskers is altered, and could be used to model this sensory processing difference. The
deficits we observed in CD mice in the Rotarod and Platform tasks could be the result of such
altered sensory processing – locomotion, cliff detection, motor coordination, and even time in the
center of an open field is affected by loss of whiskers.204,217,218 To test whether abnormal processing
is affecting this traits, it would be interesting to evaluate the effect of partial or total loss of
whiskers, as previously published,204 in both CD and WT animals to see if differences in behavior
are eliminated. It would also be interesting to study possible differences in object localization by
whiskers via a head-fixed paradigm adapted for mice,219–221 or to employ sensory processing tasks
that target visual processing and measure eye movements and pupil dilation in the context of
learning related to integration of visual information.222,223 While scent is never explicitly tested
here, beyond inclusion in the Conditioned Fear Task, the olfactory system would also be
interesting to investigate, perhaps initially via scent discrimination tasks; tactile and taste
responsivity could also be integrated to create a broad sensory processing workflow to address
possible differences in other sensory systems.224 From there, an analysis of multisensory
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processing could better inform broader sensory integration capabilities or deficits in CD mice or
other WS-relevant models.225
Finally, a re-evaluation of the potential effects of oxytocin in WS is warranted. Given the
expansive influence of the oxytocin system on systems clearly affected in WS, and its popularity
as a treatment for atypical social behaviors, a targeted investigation of domains beyond
conditioned fear learning is necessary to confirm or contradict oxytocin’s role. By utilizing my
work in Chapter 3, where I identify phenotypes of interest in the CD model, others should be able
to determine whether oxytocin dysregulation in key to disruption in social or sensorimotor
domains, which may provide more reliable support for the various roles oxytocin may play. When
we initially chose to study fear learning, altered social behaviors were not evident in our hands;
now that we have defined assays showing altered social approach and motivation in CD mice on
the C57BL/6J background, there is a clear path forward to test the oxytocin dysregulation
hypothesis. In addition, it may be worthwhile to study the vasopressin system as well, given that
vasopressin and oxytocin have differential effect on anxiety-related measures, with vasopressin
tending to increase anxiety, which is reflected in my measurements of open-field and light
avoidance in the CD mice in Chapter 3. Alternatively, to best understand the potential implications
of a modified oxytocin system on underlying mechanisms contributing to neurodevelopmental
disabilities like WS, it may be required that we focus on an intermediary measure between the
transiently expressed oxytocin and the altered outcomes observed.

4.3

Summary
Overall, this thesis provides critical information for future studies on the mechanisms

underlying the effects of the CNVs in the WSCR. In Chapter 2, I showed overexpression of
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oxytocin was not causing conditioned fear deficits in cued and contextual recall and no large
effects of oxytocin receptor or serotonin transporter dysregulation existed. Despite the lack of
critical findings, I did provide evidence that certain regions warrant follow-up studies to
specifically examine with a more powerful study design. In Chapter 3, I comprehensively profiled
the Complete Deletion mouse line with a suite of behavioral tasks that highlighted key phenotypes
that can used in future studies focused on mechanistic discovery or pharmacological testing. I also
presented a novel transgenic Gtf2ird1 mouse line and demonstrated its use in modeling Gtf2ird1
duplication or its rescue in the context of the most common WS deletion when crossed to the
Complete Deletion line. This molecular rescue led to the discovery of three phenotypes where
Gtf2ird1 plays a significant role – Light/Dark Box, Sensorimotor Battery Platform, and Rotarod
tasks – highlighting the importance of Gtf2ird1 in sensorimotor processing. In addition to the work
I have done to eradicate erroneous statistical evaluations of the commonly used social approach
task, which is presented in the Appendix, I have specifically contributed to the field of WS genetics
by presenting a novel Gtf2ird1 transgenic line, new information about the role of the Gtf2ird1 gene
in the context of the complete WSCR deletion in a mouse model, and better characterization of
that CD mouse model with the hopes that these findings can propel research towards meaningful
discoveries to serve the WS population.
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A.1 Abstract
The Social Approach Task is commonly used to identify sociability deficits when modeling
liability factors for autism spectrum disorder (ASD) in mice. It was developed to expand upon
existing assays to examine distinct aspects of social behavior in rodents and has become a standard
component of mouse ASD-relevant phenotyping pipelines. However, there is variability in the
statistical analysis and interpretation of results from this task. A common analytical approach is to
conduct within-group comparisons only, and then interpret a difference in significance levels as if
it were a group difference, without any direct comparison. As an efficient shorthand, we named
this approach EWOCs: Erroneous Within-group Only Comparisons. Here, we examined the
prevalence of EWOCs and used simulations to test whether this approach could produce
misleading inferences. Our review of Social Approach studies of high-confidence ASD genes
revealed 45% of papers sampled used only this analytical approach. Through simulations, we then
demonstrate how a lack of significant difference within one group often does not correspond to a
significant difference between groups, and show this erroneous interpretation increases the rate of
false positives up to 25%. Finally, we define a simple solution: use an index, like a social
preference score, with direct statistical comparisons between groups to identify significant
differences. We also provide power calculations to guide sample size in future studies. Overall,
elimination of EWOCs and adoption of direct comparisons should result in more accurate, reliable,
and reproducible data interpretations from the Social Approach Task across ASD liability models.

Lay Summary
The Social Approach Task is widely used to assess social behavior in mice and is frequently
used in studies modeling autism. However, reviewing published studies showed nearly half do not
use correct comparisons to interpret these data. Using simulated and original data, we argue the
correct statistical approach is a direct comparison of scores between groups. This simple solution
should reduce false positives and improve consistency of results across studies.

A.2 Introduction
The Social Approach Task is one of the most widely used behavioral assays for
investigation of mouse models of liability factors associated with autism spectrum disorder
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(ASD).226–239 The use of the Social Approach Task has both helped identify ASD liability models
with good face validity and advanced our understanding of the circuitry underlying social approach
deficits. Unlike reciprocal social interaction assays requiring manual scoring, the Social Approach
Task is automated, making it ideal for mechanistic studies that require several experiments with
different interventions or genetic models. For example, a recent study showed the role of dorsal
raphe serotonergic connections to the nucleus accumbens in social approach behavior, and how
stimulation of this pathway can correct social deficits in the 16p11.2 deletion model associated
with ASD.240 Another group showed NMDAR activation rescued social approach behavior
in Shank2−/− and Tbr1+/− mutants.239,241 Together, these studies highlight the value in using this
task to identify pathways that contribute to social approach behavior and targets that can be further
interrogated as potential pharmacotherapy candidates.
The motivation behind the development of the Social Approach Task was to improve face
validity of murine social behavioral assays with regard to specific social impairments that
characterize ASD.205,242 Abnormal social approach is one such attribute of the ASD social
phenotype. This task was unique in the field because it required the sociability be initiated by the
test mouse. Thus, it was, and is, meant to help identify a lack of social interest in mice that may be
reminiscent of the social approach deficits in humans with ASD. The typical version of this task
comprises two test trials: the sociability trial and the preference for social novelty trial,205,242 along
with two preceding habituation trials. During the sociability trial, the test mouse can freely explore
the three-chambered apparatus to investigate either a novel conspecific stimulus in a restraining
container (inverted wire cup) or an empty but otherwise identical wire cup (Figure 1A). Likewise,
in the preference for social novelty trial, a new stimulus mouse is added to the empty cup, and the
same test mouse is then assayed to examine preference for the novel mouse over the familiar
mouse. The preference for social novelty trial is optional and some study designs require only an
investigation of sociability. In addition, there are various deviations often used, including
habituation to the wire cups, a novel object placed inside the nonsocial cup, and a 24-hr intertrial
interval for further social memory assessment, among others.243–245
The original Social Approach Task studies examined sociability and preference for social
novelty in inbred mouse strains.120,205,242 The main purpose of these studies was to establish that
most mouse strains exhibit sociability, and thus comparisons in these original studies were the
within-group comparisons of time spent in the chamber or time spent sniffing the stimulus mice.
As these were not comparisons of two groups, the experimental design of many of these original
experiments did not allow for between-subjects comparisons during analysis. Subsequently, as
researchers adapted this task to compare across groups, likely consulting these original studies for
experimental and statistical design, many failed to incorporate the appropriate between-subjects
comparisons needed for their own experimental designs. Thus, since the task was first developed,
the within-group only analysis has also been perpetuated across studies of between-group factors,
such as mutation of ASD candidate genes.
While it is relatively straightforward to test significance in the Social Approach Task with
only one group, where the null hypothesis is “the mouse will spend equal time with both stimuli,”
there is no gold-standard approach for comparing two different groups. One commonly used
approach is to separately test the null hypothesis within each group, and then compare those results
between groups. However, the accurate null hypothesis when comparing multiple groups is “the
social preference of one group equals the other.” Therefore, only considering the within-group null
hypothesis would result in a flawed interpretation because the accurate null hypothesis is no longer
tested. In other words, the lack of a statistically significant preference in one group is interpreted
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as a statistically significant difference between groups. We labeled this approach Erroneous
Within-group Only Comparisons (EWOCs).

Figure 1. Illustration of the Social Approach Task and two different analytical approaches. A) Schematic of Social Approach
Task apparatus and typical procedure. B,C) Example plots from simulated data using EWOCs. Two arbitrary groups (“Mut” and
“WT”) were tested for a within-group difference between the time spent with the social stimulus (stim) compared to the empty cup
(empty). Only the WT group showed significant preference (p < 0.05), while the Mut mice did not (p = 0.052, or p = 0.111). D,E)
Example of these same data plotted as a social preference index: time[stim] / (time[stim] + time[empty]) x 100 . Direct statistical
comparison of Mut to WT indices shows no significant difference (p = 0.743, 0.347).
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To directly test between groups, a commonly used and more statistically appropriate
approach is a repeated measures ANOVA with appropriate between-subjects factors to examine
stimulus interaction times. A related between-groups approach is to calculate a single value
summarizing social preference for each mouse for downstream statistical testing. A commonly
used social preference index is time[stim] / (time[stim] + time[empty]) x 100, which results in a value
from 0 (all time with the empty cup) to 100 (all time with the stimulus mouse), where 50 represents
equal time with both. Indices for each mouse can then be compared across groups with a t-test,
ANOVA, or appropriate nonparametric test for non-normal data. However, neither of these two
approaches alone is complete. Examination of the original data is still imperative in this situation
to confirm that the control group demonstrates a preference for time spent with the social stimulus
cup versus the empty/novel object cup.
Here, we further demonstrate why EWOCs should not be applied to identify a difference
between groups in the Social Approach Task by using data simulations to show how EWOCs can
be misleading. We also review recent mouse literature to characterize the widespread use of
EWOCs. We further show how direct comparison of an index, like a social preference score,
between groups may reduce false positives and improve consistency of results across studies, and
provide power estimates, parameterized in data from more than 400 mice, to guide future studies.
Finally, we present a standardized rubric for the analysis of the Social Approach Task between
groups. We believe that elimination of EWOCs from practice, and adoption of a standardized
approach, will result in more robust and reproducible social approach findings when modeling
ASD liability factors in mice.

A.3 Results
A.3.1 Interpreting EWOCs as a Difference Between Groups Is Fundamentally
Flawed Logic
We first present a simple illustration from simulated data to demonstrate how a withingroup only comparative approach to analysis could lead to erroneous inference (Figure 1B). In
these simulated data of a sociability trial, the mutant mice do not show a statistically significant
social preference, with p = 0.052. As this exceeds the critical alpha cutoff of 0.05, it does not result
in a rejection of the null hypothesis. The WT mice, however, reach p = 0.02, which passes the
cutoff. The null hypothesis is rejected, and the WT mice are considered to have shown a
statistically significant preference for the social stimulus. Even though the outcome of the tests
within the groups are different for mutant and WT mice, does this mean there is a significant
difference in the social preference between these groups or is it a false positive? In this example,
where p-values are just on either side of the threshold, it becomes obvious that a separate statistical
test is necessary to determine if the groups themselves are statistically different. Indeed, calculating
a social preference index and comparing them directly for these same data reveal that there is no
difference between the groups (Figure 1D). However, in an alternate scenario, where WT mice
exceed the critical alpha with p = 0.034 but mutants only reach p = 0.111 (Figure 1C), it may not
be obvious, despite the appropriate statistical test revealing there is no significant difference in this
case either (Figure 1E). To reiterate, a lack of difference in time spent with each stimulus within
one group does not indicate a significant difference in sociability between the groups.
Unfortunately, this simple statistical misinterpretation exists widely in the neuroscience
literature and is applied to many kinds of experiments.246 It also exists in key papers evaluating
genetic mouse models of ASD liability. In the studies reviewed from the SFARI database, EWOCs
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were employed in 13 of 29 (44.8%) studies showing a phenotype in the sociability trial and 11 of
the 25 (44.0%) studies that also included the preference for social novelty trial. Thus, the use of
EWOCs is widespread.
This raises important questions: To what extent might these represent false positive results?
Could widespread use of EWOCs account for why there are such challenges in finding
reproducible phenotypes in behavioral models?247 In order to determine how vulnerable this
approach is to false positive interpretations, we conducted extensive simulation studies as detailed
below.

A.3.2 Simulations Demonstrate EWOCs Result in an Elevated Rate of False
Positives, Dependent on Sample Number
We first modeled how likely false positive results would be when using EWOCs. To base
the simulation on real parameters, we examined social approach data from all mice previously
tested in our lab to identify typical mean interaction times and SDs. We also extracted the data
examined in all 29 data sets from the reviewed papers for comparison. We found the median group
size was n = 16 across the 29 papers (Figure 2A), with studies ranging from 6 to 30. We then
generated random data for two groups with no true difference in their social preference (drawing
from the same normal distribution) such that both “WT” and “Mut” groups should have a 1.5-fold
preference for the social stimulus over the empty cup (social preference index = 60; Figure 2B).
We then systematically varied the n in each group from 5 to 30 and conducted 10 simulations of
1000 studies at each n. When we simulated n at the median of published studies (i.e., 16 per group),
we observed a false positive rate of 25% using EWOCs (Figure 2C). Specifically, a false positive
result is when the conclusion is that the two groups are different (Figure 1B,C), since in these
simulated data the two groups were drawn from the same distribution. Even extending n to 25, we
still observed a false positive rate of 10%, which is two times higher than the false positive rate of
0.05 that is the standard accepted critical alpha in the field. Note that a solution for controlling the
false positive rate is quite simple: a t-test assessing the social preference index, with p < 0.05
critical alpha cutoff, results in the false positive rate of 5%, regardless of n (Figure 2D). Similar
results are also achieved if one analyzes the stimulus interaction times across groups using a mixed
ANOVA with between- and within-subjects simple main effects following significant interaction
terms (not shown). Importantly, if n is imbalanced, then statistical power is also imbalanced. For
example, sometimes mutants are harder to generate than WTs (indeed, one-third of the reviewed
studies had smaller mutant than WT groups). This might further inflate false positive rates when
EWOCs are used. By varying n for “Mut” but keeping n = 12 for “WT,” we show this is the case
(Figure 2E). Again, this can be corrected by directly comparing groups statistically (Figure 2F).
It is worth noting that even with equal n, other results can also occur. For example, if WT
and mutant mice are truly not different, there is an equal chance that the “Mut” mice will show a
significant preference for the social stimulus in the same trial that the “WT” mice do not
(Figure 2B,C; purple lines). There is also a chance, especially at low n, that neither group will
show a significant within-group result (Figure 2B,C; green lines). Given the known bias in
published literature for positive over negative results,248 it is likely that either of these possibilities
are underreported in the literature. For example, they may simply be considered failed trials by the
experimenters and repeated, since the positive control (i.e., a preference for the stimulus mouse in
the WT group) did not work. One danger of this repeated EWOCs approach is that it could further
increase the possibility of a false positive, as the experiment would be repeated until the outcome
is either both groups are social, or only the mutants have a deficit. Overall, even with a single
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experiment of simulated data at n = 16, there is only a <70% chance of correctly identifying both
groups as social.

Figure 2. Using EWOCs can result in substantially elevated false positive rates, especially at low sample sizes. A) Distribution
of group sizes (combined for genotype) across 77 groups in 29 papers. B) Cartoon of simulations and possible outcomes. Two
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groups (“Mut” and “WT”) are drawn from the same distribution with identical social preference magnitude, and then tested with
EWOCs (upper panel) or a social preference index (lower panel). C) Plot of simulations results as function of n, after 10 × 1000
simulated experiments for each n, drawing two groups from the same distribution and analyzing with EWOCs. The true result is
both groups are social (blue), so incorrect conclusions were drawn a substantial proportion of the time. D) Plot of t-test on social
preference index, showing false positive rate as a function of n. E) Simulation plot as a function of imbalanced n with “WT” n = 12,
and “Mut” n varied from 8 to 12, using EWOCs. F) Simulation plot as a function of imbalanced n, using t-test on the social
preference index.

A.3.3 Simulation Demonstrates EWOCs False Positive Rates Are Also
Influenced by Magnitude of Social Preference
Of course, statistical power is also a function of effect size—in this case, the magnitude of
the social preference. In our first model, we assumed a 1.5-fold preference for the stimulus mouse
over the empty cage, modeling a normal distribution with a mean interaction time of 126 sec with
the stimulus mouse and 86 sec with the empty cup (giving a social preference index of 60). While
this is a plausible social preference magnitude, and slightly higher than the mean we saw in our
reanalyzed mice (124.06), it is a bit below the median social preference index of published groups
(64.41 [58.96–69.70 interquartile range (IQR)]; across all 77 groups of extractable data from the
29 studies; Figure 3A). Therefore, we also fixed n at ten and varied the simulated preference of
all mice for the social stimulus. This showed a high rate of erroneous inference resulting from
EWOCs. Interestingly, a social preference index around 64 was particularly vulnerable to EWOCs
false positive interpretation (Figure 3B), with rates at nearly 25%. Note, differences in effect size
are also readily controlled by appropriately comparing the two groups statistically (Figure 3C).
Also worth discussion is the possibility that the published median social preference
magnitude is slightly inflated compared to the actual social preference, again, because of the bias
toward publication of positive results. Indeed, if we plot the social preference index of the last 421
mice analyzed in our lab (Fig. 3D), published or not, we see a median preference of 58.95 (48.95–
68.48 IQR) for the sociability trial, and 63.49 (51.69–71.64 IQR) for the mice that were also tested
in the preference for social novelty trial (n = 325, not shown). We also noticed a commonly used
inbred strain (FVB/AntJ, e.g., the standard background strain of FMRP mutants) showed a
marginally lower social preference index than the more ubiquitous inbred C57BL/6J strain (54.8
vs. 60.1, Welch's t-test t = 2.3128, p = 0.023, df = 107.03), and, generally, males showed a higher
social preference index than females across strains (60.98 vs. 55.04, t = 3.9615, p = 8.7E5, df = 418.72).
Thus, the expected magnitude of social preference in this task may vary by sex and strain,
and may be low enough to warrant increased n when using both sexes for experiments, which is
an important practice, and currently required by National Institutes of Health funding, for many
reasons, including the sexually dimorphic nature of various diseases.
Therefore, as a resource, we have estimated the number of animals required to have wellpowered studies detecting an absence of social preference (i.e., social preference index of 50 or
less) in a mutant group compared to a variety of potential WT group preference index levels. Our
estimates show that to have 80% power to detect a significant effect requires approximately 30
animals per group using both sexes of C57BL/6J mice, and possibly substantially more with other
strains (Figure 3E–G), though such strains may be better when assaying manipulations that
increase sociability. Further, social novelty trials, where the effect size is typically somewhat
larger, would require fewer animals. Finally, these power calculations highlight the nuance of
interpreting a negative result even with correct between-group comparisons (especially
reanalyzing historic data with smaller n): a p > 0.05 can always mean the effect of the mutation
could simply be too small to see reliably given the group sizes used in a particular study.
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Figure 3. Elevation of false positive rates depends on the magnitude of the social preference when EWOCs are used. A)
Distributions of average magnitudes of social preference indices across groups from the 29 reviewed studies. B) Plot of outcomes
as a function of social preference magnitude when using EWOCs. C) Plot of false positive rate as a function of social preference
magnitude when using t-test on social preference index. D) Distributions of magnitudes of social preference indices from all mice
run in our lab (n = 421). E) Power calculations showing required n per group as a function of the WT social preference index, to
have 70%, 80%, or 90% power to detect a difference at 0.05. F) Same, replotting boxed region from E).
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A.3.4 Simulation Demonstrates that Behavioral Disruptions that Increase
Variance in Mutants Will Also Lead to Higher False Positive Rates with
EWOCs
Finally, there are even more subtle features of mouse behavior that might lead to inflated
false positive rates with EWOCs. This is because commonly used test statistics are defined as the
difference in the means divided by a measure of variance. Thus, if one group is significantly
more variable than another, it is less likely to have a large test statistic and thus less likely to
achieve a significant p-value.

Figure 4. Increased variance in mutants can also lead to inflated false positive rates when EWOCs are used. A) Plot of false
positive results when using EWOCs as a function of increased variance in only Mut at n = 10, B) at n = 15, C) at n = 20. D) Plot
of t-test false positive rate as a function of increased variance at n = 10. SD ratio: the ratio of the Mut to the WT standard deviation
(SD; varied from 1 to 1.5).
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For example, if mutant mice tend to have a compulsive grooming phenotype making their
movement in the task more stochastic (i.e., they might spontaneously enter a long bout of
compulsive grooming), then their variance might simply be higher in this task compared to
controls. It is hard to determine how frequently such a thing might be occurring in the literature,
but it is straightforward to model—holding a constant n (10) and social preference index (60), we
altered the variance of the distribution from which we drew the “Mut,” but not the “WT,” group.
This profoundly decreased the ability to detect a significant social preference in the “Mut” group
(Figure 4A), and, interestingly, this phenomenon could not be readily rescued by
increasing n (Figure 4B,C). Thus, mutations that increase variability in mouse behavior, when
using EWOCs, can mask true social preference. Again, when you directly compare groups
statistically, the false positive rate stays at a well-controlled 5% (Figure 4D).
To demonstrate that the flawed logic of EWOCs extend to chamber time data, as well, we
duplicated all our above analyses using simulations based on means and SDs extracted from a
published paper using chamber time instead of investigation zone time.249 The results were
substantially similar (data not shown). This further indicates the results of our simulations were
robust across parameters derived from multiple groups.

A.4 Discussion
The Social Approach Task has been heavily relied on to assess social behavior phenotypes
in genetic liability factors for ASD. Thus, it is essential to use appropriate statistical approaches to
ensure proper interpretation of the results. Only this will allow for correct conclusions to be drawn
about the influence of ASD candidate genes and other liability factors on social approach circuits.
In almost half of published papers based on our sampling, the interpretation of results of
this task was based on within-group only comparisons without a direct comparison between the
experimental and control groups. Thus, EWOCs are frequently interpreted as a difference between
groups. The problem with using this approach, essentially concluding that “if the result is not
significant, sociability is absent,” is that statistical tests are designed only to identify significant
differences. They are not designed to identify a significant lack of differences. In other words, the
correct interpretation when p > 0.05 is not “We are 95% confident there is no difference in
preference between the mouse and the cup.” It is “We are not 95% confident that there is a
difference between the mouse and the cup.” Statistical tests would have to be completely
redesigned to be able to state with 95% confidence that there is no preference, and it is far simpler
to directly compare the relevant groups with standard tests. We refer the reader back to the example
in Figure 1B illustrating how EWOCs do not hold up against a direct comparison between groups.
Of course, when the p-value of the mutant group is presented and shown to be very close to 0.05,
the logical flaw becomes more evident and many scientists would interpret their own findings with
caution, even if using EWOCs. But consider alternate scenarios where WT mice were perhaps p <
0.04 and mutants were p < 0.12 (Figure 1C). Often a result of p < 0.12 would not be considered
approaching significance and would not be shown. Yet this result could equally fairly be stated as
“We are 96% certain that the wild-type mice are social, and 88% certain that the mutant mice are
social.” Expressed this way, few scientists would be confident that the mutant mice have a
significant social deficit.
It could be argued that sociability in this task should be considered a binary outcome
measure rather than a quantitative trait. Yet, evidence suggests this is not a categorical phenotype
and these data are indeed continuous. Multiple studies have now shown that typical sociability can
be heightened following stimulation of different pathways in the brain.240,250 For example,
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optogenetic stimulation of the dorsal raphe neurons or their fibers in the nucleus accumbens
increased the social preference index in WT mice.240 Pharmacological agents have also shown
promise as a means to ameliorating abnormal social approach behaviors. It was recently shown
that Melanotan-II, a melanocortin receptor 4 agonist that stimulates oxytocin activity, corrected
the social approach deficits in male mice of the maternal immune activation model.251 Thus, to
better screen for treatment effects in this task, which are likely to be quantitative and not
qualitative, it is valuable to analyze social approach as continuous. Clearly, this phenotype has a
range that can be altered and deserves appropriate quantification. We have tried to make the
argument here that directly comparing groups using an index, such as a social preference score,
creates a suitably quantitative design, provided sufficient n is used, to overcome variability
inherent in mouse behavior.
Furthermore, we have included power analyses to help guide the selection of sample sizes
that will be needed to confidently overcome this variability. These sample sizes also assume a
complete loss of sociability in the mutants. If the phenotype is only partial, sample size would have
to be correspondingly higher. Nonetheless, while the sample size required in C57BL/6J is
substantially higher than often used (Figure 2A), it is still reasonably achievable. However, the
very high sample size required in some combinations of sex and strain suggests that considering
new variations of the method that further automate the task, or that collect more repeated measures
of the same mice to reduce the per mouse variance, could offer pragmatic solutions to improving
power. Indeed, it is interesting that the social novelty trial is better powered (because of its larger
effect size) than the sociability trial. Since the preference for social novelty trial is typically run
with the same mice after they have experienced the sociability trial, it might be that further
exposing the same mice to the Social Approach Task over multiple days allows for better estimates
of the social preference of each, enabling studies that do not require as large of a sample size.
In our review of studies investigating high confidence ASD genes, almost half of studies
we examined used a flawed statistical logic to interpret the Social Approach Task results. Of these
studies, 85% (11/13) concluded that the mutation impaired social behavior, and it is worrying that
a substantial fraction of these might be false positives. Yet, despite the flawed statistical approach,
it is possible these studies would truly show a difference between mutant and controls if these data
were analyzed with an appropriate between-subjects design. For the authors with primary data, it
may be worth assessing whether this is the case. For example, in one of our prior publications,
along with the standard paradigm, we employed a variation of the task we hypothesized might be
more sensitive to measure preference for social novelty (cagemate vs. novel conspecific).229 We
also examined time spent investigating a cagemate vs. an empty cup. We encountered an odd
situation in which the mutant mice showed a significant preference for the cagemate, whereas the
control mice did not. We interpreted these within-subject differences as no deficits in sociability
toward a cagemate in the mutant mice given that there were no between-subjects differences in
time with the cagemate or empty cups. However, while we conducted a full repeated measures
ANOVA design that included between-group simple main effects, we did not provide those results
and explicitly state that the between-subjects comparisons were nonsignificant, thus creating
ambiguity in the interpretation of our results. Therefore, here we conducted a reanalysis of these
data using the preference score. This provides clear evidence that there was no difference between
genotypes for sociability toward a cagemate (control: M = 55.48, SD = 9.96;
Mutant: M = 62.72, SD = 13.38; t(16) = 1.226, p = 0.238). We provide this example of our own
data to demonstrate how ambiguous studies can be quickly reanalyzed for clarity. Similarly,
another published study, from which we drew simulation parameters,249 was able to rapidly
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analyze their data and confirm a between-group difference in their mutants (Matteloi, personal
communication). Other key studies that used EWOCs may benefit from corrigendums or preprint
postings clarifying the results when these data are reanalyzed using direct statistical comparisons
between groups. If prior studies were actually not significant, it could have important implications
on future studies involving these ASD liability genes.
It is worth noting that the use of a social preference index is only valid if used in
combination with some analysis of original data as well. Exclusive use of a preference score could
also lead to flawed conclusions under some circumstances. For example, without confirmation of
a preference for time spent with the social stimulus cup vs. the empty/novel object cup in the
control group, a direct comparison of a social preference index between controls and the
experimental group is meaningless; if there is not a within-group preference detected with a
reasonable n of control animals, this may indicate some problem in the execution of the task.
Likewise, the absolute time values of both groups are also important to examine during data
analysis. There may be an instance in which the social preference index is not different between
groups, but the absolute time spent with the stimuli is greatly reduced or increased in the
experimental group. A clear example of this can be found in Lee et al. (2015), in which the greatly
reduced absolute investigation times in Shank2 homozygous mutants was found to be due to motor
stereotypies.241 This interesting phenotype may not have been detected if only the social preference
index was examined. Visual investigations of absolute time plots and additional analysis with a
repeated measure ANOVA should always be part of the analytical pipeline of these data.
To provide a standardized rubric, we have included a decision tree (Figure 5) that
schematizes what we think is the best approach to analyze data from the Social Approach Task.
This includes a repeated measures ANOVA at the apex of the tree. The preference index should
be in addition to a full factorial repeated measures (mixed model) ANOVA as a substitution for
erroneous interpretation of multiple within-subjects comparisons but not as a substitution for
examination of the original data. We have provided a sample script
(https://bitbucket.org/jdlabteam/ewocs/src/master/social_approach_analysis_files/) for SPSS code
implementing such an analysis to facilitate adoption by the field.
While we have highlighted the occurrence of EWOCs with regard to this one assay, this
flaw certainly has been seen in a variety of other experiments in the past,246 and the same erroneous
logic could easily be applied to a variety of other experiments in behavior (e.g., novel object
recognition task) and beyond. A very similar paradigm in voles, the partner preference task, is
easily susceptible to a similarly flawed approach to analysis, and preference indices are being used
more frequently in this field, as well.252 We have been very deliberate in developing a novel term
as we hope that providing a simple name for the phenomenon (“EWOCs”) will aid in rapid
recognition of this flaw when it occurs. More importantly, we hope the presentation of a simple
solution (direct statistical comparisons) will encourage authors, editors, and reviewers to root out
this kind of inference from the literature generally, and from this assay specifically.
Excellent standardized behavioral assays are essential for assessing face validity of mouse
models of ASD liability and discovering new therapeutic options. A vital aspect of the validity and
reliability of an assay is appropriate interpretation of its data, which requires the correct statistical
approaches. The Social Approach Task is a valuable tool to assess mouse social approach behavior,
one domain that could be related to the abnormal social phenotype in ASD. As such, it has been
used extensively over the last 14 years and will likely continue to be frequently applied to various
mouse models. Our hope, moving forward, is to begin to apply more appropriate statistical
analyses to Social Approach Task data so that accurate, reliable, and reproducible conclusions are
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drawn across ASD liability models. This will allow the ASD research community to move forward
confidently with studies of new therapeutic strategies based on convincing and concrete results.

Figure 5. Social Approach Task data analysis decision tree. A decision tree schematizing a statistical pathway for Social
Approach Task data analysis, provided data are normal and meet the other assumptions of univariate analysis. The blue bubbles
present statistical tests with dependent variable of interest in parentheses. The green bubbles present interpretations of the test
results. Sig., significant; n.s., nonsignificant. Example graphs provide representations of possible data for each outcome (con,
control group; exp, experimental group).

A.5 Methods
A.5.1 Simulation Studies
We conducted multiple analyses of simulated data to explore the frequency of erroneous
inferences when using only EWOCs to determine a difference between groups. First, we collected
all Social Approach data previously generated in the lab, which includes 217 mice previously
published and an additional 204 mice subsequently tested (see Table 1 for descriptive data).229,233
Using these data, we calculated the mean interaction time in seconds with the stimulus mouse
(time[stim]; 124.06 ± 52.90 [standard deviation, SD]), and the mean time with the empty cup
(time[empty]; 87.51 ± 40.59 [SD]). We then wrote a simple function in R to generate 1000 random
experiments with a sample size of 10 per group using the function rnorm to sample two arbitrary
groups (“Mut” and “WT”) from the same normal distribution with parameters derived from data
above (time[stim] = 124 sec, time[empty] = 88 sec, SD = 47 sec). Using this function, we calculated the
frequency of incorrect interpretations when using EWOCs (conducting separate t-tests comparing
time[stim] to time[empty] for Mut and WT groups and comparing the results) and repeated the
thousand-experiment simulation ten times. Incorrect interpretations are any results that do not
reveal both groups to have a social preference (e.g., both groups are not social, only Mut is social,
or only WT is social). Second, we repeated this method and systematically varied the group sample
size (n) from 2 to 30 to illustrate the vulnerability of EWOCs to false positives across n, and what
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happens when n is mismatched between groups. In this case, a false positive is the conclusion that
the experimental group (Mut) is significantly different from the control group (WT), despite the
fact that preference data for both groups were drawn from the same distribution and, thus, an
appropriate statistical test would reveal they do not significantly differ 95% of the time. Third, we
modeled the consequences of varying the magnitude of social preference by changing the mean of
the sampled normal distributions across a range of values. We set indices for a range of social
preference values from 50 (no preference) to 75 (a threefold preference for the stimulus mouse)
by setting values of time[stim] from 106 to 159 sec (and correspondingly adjusted the mean for
time[empty]). Fourth, we modeled the effect of differential group variability by increasing the SD of
only the Mut group from 47 to 78 but keeping the mean preferences the same for both groups.
Table 1. Descriptive Statistics for Simulation Analyses Data Collected in the Dougherty Laboratory
Total sample Sex distribution
size
Females Males

Grouping distribution
Experimental Control

Background
strain

Reference

20

0

20

11

9

C57BL/6J

Dougherty et al.229

197

99

98

113

84

C57BL/6J

Maloney et al.233

121

69

52

75

46

Hybrid
C57BL/6J x FVB

Kopp et al.253

69

38

31

51

18

FVB

Unpublished

14

7

7

0

14

C57BL/6J

Unpublished

Total: 421

213

208

250

171

--

--

We then repeated all the above analyses but calculated the frequency of erroneous
inferences when transforming the time into a social preference index, defined as time[stim] /
(time[stim] + time[empty]) x 100, and then conducted a t-test comparing indices of the two groups. In
addition, we duplicated all our analyses using simulations based on parameters extracted from a
published paper,249 using chamber time instead of investigation zone time, which yielded
substantially similar conclusions.

A.5.2 Systematic Review of the Literature
To assess the potential impact of EWOCs in ASD-related research, we systematically
reviewed the literature referenced in the SFARI Animal Models database254 (accessed July 18,
2018) for genes with a score of 1, classified as high confidence. We further limited this to the 29
papers that used the Social Approach Task, including both the sociability (all 29 papers)
and preference for social novelty (a subset of 25 papers) trials. From these papers, we extracted
the results for the sociability and preference for social novelty trials, sample size, and whether
EWOCs were used. If a study used both within-group and between-group comparisons, it was not
counted as an EWOCs study. Finally, an independent researcher reread all studies to confirm only
this interpretation was used.
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A.5.3 Power Calculations
We estimated the required group sizes with the pwr.t.test function in R, using the settings
for two samples with a one-tailed hypothesis, where the direction of the effect is predicted prior to
the study. We ran the algorithm for three magnitudes of power (0.7, 0.8, and 0.9) and
systematically varied the effect size across a range of plausible values. We parameterized our
calculation of effect size (Cohen's d) using values based on the 421 mice from our lab. Specifically,
we set the pooled SD for the social preference index at 15.64 (the SD of our mice), calculated
effect sizes assuming a mutant group would have no social preference (a group mean of 50), and
varied the corresponding wild-type (WT) preference to between 54 and 66. These preference
values range from below the group mean of our least social group (54.81) to slightly above our
most social group (63.3) and the mean of the reviewed published studies (64.17). Resulting group
sizes were then plotted as a function of effect size and desired power.
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